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Abstract
Drug injection is an increasingly important risk factor in the transmission of blood-borne
pathogens, including the hepatitis C virus (HCV) and human immunodeficiency virus
(HIV). The purpose of the study was to examine the influence of social network factors
on HCV and HIV. The study was grounded in social network theory and sought to
determine whether social network characteristics affect high-risk sexual and drug
injection behavior as well as self-reported HIV and HCV status. The study design was a
quantitative cross-sectional survey. 181 participants in a needle exchange program
completed a survey in Spanish assessing individual drug and sex risk practices as well as
gathering information to describe the characteristics of participants’ personal networks
from an egocentric perspective. General estimating equation techniques were used to
analyze the data. Results showed that only social network size was related to risky sexual
behavior. Injecting risk behaviors were only impacted by personal network exposures,
measured by the average number of years network members had injected. HIV selfreported serum status was correlated with trust, closeness, and number of family
members named among the closest 5 network members. Last, HCV self-reported serum
status was only related to the years that network members had been injecting drugs. This
study has implications for positive social change in that public health practitioners may
gain a better understanding of the social network characteristics associated with high-risk
behaviors of those infected with HCV and HIV in order to develop health promotion
programs to lower infections and mortality.
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Chapter 1: Introduction to the Study
Background of the Study
Drug injection is an increasingly important risk factor in the transmission of
blood-borne pathogens. Blood-borne pathogens are a wide spectrum of biological agents
that are transmitted after blood exposure. Exposures can happen through sticks with a
needle or other sharp instrument contaminated with infected blood. Other exposures
involve contact of the eye, nose, mouth, or skin with infected blood (Center for Diseases
Control and Prevention [CDC], 2010a). Among the most relevant blood-borne pathogens
are the hepatitis C virus (HCV) and human immunodeficiency virus (HIV; CDC, 2010a).
By 2008, HCV was the most common chronic blood-borne infection in the United
States. It was estimated that almost 3.2 million persons were chronically infected with
HCV, and approximately 8,000 to 10,000 die each year (CDC, 2009a). Drug injection
results in a common and effective HCV transmission path. In general, those with large or
repeated percutaneous exposures with infected blood have higher risk of HCV; thus,
injecting drug users (IDU), recipients of blood or its derivatives before 1987, persons
with HIV infections, and chronic hemodialysis patients are at higher risk (CDC, 2009a).
Nevertheless, other routes of exposures for HCV have been suggested (such as sexual
transmission) but are inconclusive (CDC, 2008).
HIV is estimated to have affected more than 1.2 million people in the United
States during 2011, and 658,507persons have died since the epidemic started (CDC,
2015). As in the case of HCV infection, drug injection is an effective and common route
of exposure to the pathogen. However, different from the case of HCV, there is
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conclusive evidence that HIV is sexually transmitted and thus potentially affects a larger
portion of the general population (CDC, 2007c).
Thus, HIV and HCV are two of the main concerns in blood-borne virus
transmission among the IDU population; this transmission represents an important
challenge to public health agencies worldwide (Dumchev et al., 2009; Mathers et al.,
2008; Strathdee & Stockman, 2010; Sweeting et al., 2009). Strathdee and Stockman
(2010) reported that in 2007, drug injection was the third most relevant risk factor in the
spread of HIV among the general population. The authors also reported that since HCV
shares transmission patterns with HIV among IDU, it is not unusual to find cases of
comorbid HCV and HIV infection. However, HCV is less likely to be tested in the
population than HIV (CDC, 2009b).
There is evidence linking substance use and blood-borne virus risks with
behaviors of members of individuals’ social networks (Buchanan & Latkin, 2009). In
order to better understand the transmission of both blood-borne viruses (HIV and HCV),
analysis of social network variables is a logical approach. Wylie, Shah, and Jolly (2006)
defined social network analysis (SNA) as “a technique which measures and analyzes the
interactions that occur between people” (p. 2). SNA has the advantage that the
theoretical model and the method for analysis are the same, thus making it easier to
understand the phenomena under study. This is due to the matching of the theoretical
framework to specific analysis designs (Lozares, 1996).
Valente (2010) described five social network data collection techniques to help
analyze a social network. The first of the five collection techniques is survey, which
includes analysis of social networks using standard questions. Egocentric data analysis,
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the focus of the present study, is used to inquire about the social roles of people named
(i.e., altars) by a participant and how altars in networks influence behaviors. This
approach uses name generators and questions on the interaction between altars. The
sequenced data technique uses random walk to generate index cases; the participant
names altars, and a random subset of those altars is interviewed. Sequenced collection of
data involves the use of snowball sampling for finding altars named by the participant.
The fourth network analysis is census; in this approach, all members of a community are
interviewed and asked one or more social network questions. Last, the two-mode or joint
technique uses nominations of events attended or organization membership for collecting
the data and mapping associations among them. Each of these can be used for SNA, and
they have varying levels of capacity to analyze structural and relational measures.
Hepatitis C Epidemic
Hepatitis is the common name referring to inflammation of the liver that is caused
primarily by a group of viral infections. The known hepatitis viruses are Hepatitis A
(HAV), Hepatitis B (HBV), Hepatitis C (HCV), and Hepatitis D (HDV). The mode of
transmission differs by virus type. In the case of HCV, scientists have only identified
humans as known natural hosts (Shama, 2010). Therefore, the transmission of this RNA
virus is completely dependent on human-to-human contact and interaction (World Health
Organization [WHO], 2010). HCV is transmitted after contact with infected blood and/or
blood products (CDC, 2010c). Intravenous therapies and drugs also play an important
role in the transmission of the infection (Shana, 2010).
HCV is epigenetic and shows 11 different genotypes that have more than 100
different strains. Genotypes 1-3 are the most commonly found in the world; however,
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geographical differences have been observed. For instance, types 1A and 1B are found
worldwide and account for approximately 60% of the cases. South Asia is distinguished
for reporting genotype 3; and genotype 4 has been associated with the Middle East,
Egypt, and central Africa. Genotype 5 is almost exclusively found in South Africa, and
genotypes 6 through11 are distributed in Asia (WHO, 2010).
The incubation period of HCV is approximately 6 to 8 weeks, although for the
infected host the incubation period could pass unnoticed (Shana, 2010). This is why the
disease is frequently underestimated worldwide and is not typically recognized until
irreversible damage occurs. The WHO has reported that approximately 40% of persons
exposed to HCV are able to fully recover. The other 60% become chronic carriers with a
20% liver cancer incidence. It is estimated that 3% of the entire world population has
chronic HCV (WHO, 2010).
In Europe, more than 4 million persons suffer from HCV (WHO, 2010), and in
the United States, estimates indicate that 21,870 new infections of HCV occurred in 2012
in the USA alone; this represents a 75% increase from 2010 to 2012 (CDC, 2015b). The
CDC has reported that most HCV carriers are unaware of their status, and this may be
one of the reasons that since 2007, more people have been dying from HCV than from
HIV/AIDS. Currently, there are no vaccines for HCV prevention, and pharmacological
therapy is not always successful (CDC, 2010). Nevertheless, the CDC (2015b) reported
that some drugs result in 90% viral suppression; these are still in testing, and FDA
approval for release is pending. Prevention strategies to avoid contagion with HCV
include the following:
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Using sterile equipment during injection therapies, medical treatment, or drug
administration;



Avoiding using toothbrushes, razors, and other items that might be
contaminated with blood;



Never reusing or sharing needles, water, or drug preparation equipment; and



Assuring sterile equipment during body piercing and tattooing (CDC, 2010, p.
1).

The WHO (2010) included the following as high-risk groups for HCV:


Recipients of blood, blood products, and solid organs before 1992;



Recipients of coagulation factors before 1987;



Hemophiliac patients and hemodialysis center employees;



IDU;



Health care professionals exposed to unsterile medical or dental equipment;



Those employees working with blood, blood products, or organs;



Those administrating acupuncture and/or tattooing and their clients;



Health care workers; and



Newborns (due to perinatal transmission; WHO, 2010, pp. 1-2).

HIV Epidemic
HIV/AIDS is the most significant infectious disease contributing to mortality rates
worldwide (WHO, 2010b). Estimates show that in 2008, 2 million deaths in the world
were attributed to HIV/AIDS. At the end of 2008, 33.4 million people worldwide were
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living with HIV, and HIV incidence accounted for approximately 2.7 million new
infections that same year (WHO, 2010b).
As in most diseases, HIV/AIDS is more common among those with low
socioeconomic-status (SES). Vulnerable populations include the homeless, sex workers,
injecting drug users, men who have sex with men, transgender people, migrants, and
prisoners. Geographical disparities have also been reported, with a disproportionate
number of infections occurring in Sub-Saharan Africa (two thirds of the infected
populations are concentrated in this area; Joint United Nations Programme on HIV/AIDS
[UNAIDS], 2013). In the Caribbean, there were 240 million adults and children living
with HIV by 2008. New cases were estimated at 20,000 with a prevalence of 1% (0.9–
1.1%; WHO, 2009). However, UNAIDS (2013) reported that new cases fell by 30%
(approximately 14,000 per year). The estimated prevalence in the United States was 1.1
million people in 2006 (WHO, 2009), and this number increased in 2012 to 1.2 million
people (CDC, 2015c). Health disparities by race/ethnicity were observed, where
Hispanics were almost 3 times more likely to have HIV than Whites. Blacks were almost
8 times more likely to be HIV positive than Whites (CDC, 2008).
The virus works by invading the host cell and forcing it to synthesize its genes
(gag, pol, env, and others) using the host mRNA (Requejo, 2006). HIV has shown great
variation, which has made it difficult to develop effective public health measures to
effectively eradicate the disease (Heeney, Dalgleish, & Weiss, 2006). There are two
main strains of HIV: HIV-1 and HIV-2. HIV-1 has been more extensively reported and
studied than HIV-2, which is restricted to some regions of Western and Central Africa
(Heeney et al., 2006; Requejo, 2006). Lakhashe, Thakar, Godbole, Tripathy, and
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Paranjape (2008) reported that HIV-1 is classified under 11 subtypes (A to K), and
Requejo (2006) reported more than 15 circulating recombinant forms (CRFs) of the virus
worldwide.
Although subtypes are not strictly confined to a geographical area, some subtypes
have shown a geographical trend. For instance, subtype A has mostly been associated
with Africa and the former Soviet Union; subtype B with North and South America,
Australia, and Japan; subtype C with East Africa, South Asia, and South Africa; subtype
D with East and Central Africa; and subtype E with Vietnam and Thailand (it is also
highly related to IDU in the area). Other subtypes, such as F, have been identified in
Eastern Europe (Lakhashe et al., 2008; Resquejo, 2006), while subtypes G, H, J, and K
appear to be distributed throughout Africa (including Burkina Faso, Mali, Nigeria, Ivory,
Coast, Gabon, and Democratic Republic of Congo; Lakhashe et al., 2008; Resquejo,
2006). Current research has suggested that these subtypes have spread to South Europe
and Asia (Resquejo, 2006). Researchers have noted that the high diversity in HIV strains
and their increasing resistance to drug therapies could have significant implications for
appropriate clinical approaches to treating the HIV/AIDS epidemic (Heeney et al., 2006;
Lakhashe et al., 2008; Resquejo, 2006).
The CDC (2007) has reported that risk for HIV is exacerbated by a number of
injection drug use and sexual risk factors, including sharing injection equipment, having
sex with multiple partners or with partners who have sex with multiple partners, and
having sex with those with sexually transmitted diseases, among others (CDC, 2007, pp.
5-6). In addition to these risk factors, Ashwani, Singal, Bhupinderjit, and Anand (2009)
included sharing toothbrushes/razors, tattooing, and snorting drugs as risk factors for U.S.
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citizens. WHO (2009) specified additional populations having higher risk behaviors for
HIV, which included men who have sex with men, sex workers, prisoners, mobile
workers, low-SES individuals, and immigrants.
HCV and HIV Epidemic Interactions
Ashwani et al. (2009) noted that comorbidity of HCV and HIV in the United
States and its territories is common. Both HIV and HCV share routes of infection
transmission as well as other risk factors that facilitate coinfection (Ahswani et al., 2009;
WHO, 2007). It was estimated that HCV in the United States occurred in approximately
25%-40% of those who reported HIV infection, suggesting that nearly 300,000
individuals had an HIV/HCV-positive diagnosis (Ahswani et al., 2009). Worldwide
estimates suggest that 4 to 5 million patients are coinfected with HIV and HCV. The
most vulnerable population seems to be IDU, in which coinfection may be occurring in
90% of all cases (WHO, 2007; Deng, Gui, Zhang, Gao, & Yang, 2009).
HIV has been shown to alter the natural history of HCV infection (Ashwani et al.,
2009; Lo, Kostman, & Amorosa, 2008; WHO, 2007). The natural history of HCV
infection typically begins with acute hepatitis, which is followed by chronic hepatitis,
hepatic cirrhosis, hepatocellular carcinoma, decompensated liver disease, and death.
However, HIV/HCV coinfected persons develop cirrhosis and end-stage liver disease at
higher rates than those only infected with HCV (Deng et al., 2009; Lo Re et al.). In their
meta-analysis (considering 29 studies), Deng et al. (2009) stated that people with
HIV/HCV had an overall odds ratio of 3.40 to have liver cancer or death. Moreover, in
the case of IDU with HIV, the WHO (2007) wrote that HCV infection in injecting drug
users (IDU) is a major medical challenge due to concurrent substance abuse, comorbid
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mental health conditions, poor socioeconomic status, and complex, expensive and often
unavailable HCV treatment (WHO, 2007, p. 3). Thus, vulnerability in IDUs to develop
more serious health conditions is higher as compared to the general population.
Social Network Characteristics
Few empirical studies have examined the impact of the social network
characteristics on IDU in Hispanic populations (Pérez et al., 2004). Wylie, Shah, and
Jolly (2006) defined social network analysis (SNA) as “a technique which measures and
analyzes the interactions that occurs between people” (p. 2). Wasserman and
Galaskiewicz (1994) also defined it as an index individual and the individuals with whom
the index is connected by interactions or behaviors of interest (Wasserman &
Galaskiewicz, 1994, p. 2). SNA involves complex mathematical approaches to
understand the social conditions that facilitate the spread of disease. In social networks,
the focus is on understanding the actors (nodes) and how their relations with others
(edges) affect their health status. Conventional data analysis focuses on how the actor’s
(the individual respondent’s) attributes (characteristics such as sex, marital status,
income, and knowledge, among others) impact health status (Hanneman & Riddle, 2005).
In social network analysis, the principal aim is to describe how actors are located or
embedded in the overall network in relation to others. The researcher then seeks to
understand how the whole pattern of individual choices gives rise to more holistic
patterns (density of the network and ties among individuals). More clearly, this type of
analysis explains how an individual’s choices are affected by his or her social network
and how the social network is affected by his or her decisions. One purpose of this study
is to understand from an egocentric perspective (the perspective of those surveyed who
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described their networks) how the network characteristics are correlated with behaviors
and self-reported serum-status. The surveys included questions for participants to
describe characteristics of their networks, and these characteristics are used as correlates
to HIV, HCV, and risky sex behavior. Therefore, in the social network approach, the
relationships among members of the network (edges) themselves are just as fundamental
as the actors (nodes) to which they connect (Wiley, Shah, & Jolly, 2006).
The social network model is based on the assumption that communication within
and between people and groups impacts the behaviors of individuals. SNA is also
predicated on the assumption that communication and behaviors among individuals in the
network can impact the individuals’ behaviors in very complex ways. SNA was
developed to show how relations among members of a social group who are connected
influence attitudes, beliefs, and behaviors of individuals. Through SNA, a number of
network measures have been derived that define and hence identify multiple
characteristics of these relations.
Egocentric network analysis, the data collection and data analysis technique that
was adopted in the present study, is used to measure characteristics of the actors’
environment from their perspective. Egocentric network information has been shown to
be a good predictor of behavior (Valente, 2010). Egocentric network data collection and
analysis techniques assume that an individual’s behavior is often a function of his or her
perception of peers’ behaviors. For example, the extent to which an individual has a
connection to similar behaviors in the network impacts whether he or she adopts that
same behavior (called personal network exposure). Egocentric network analysis can lead
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a researcher to find the threshold where an actor can adopt or decline to adopt a particular
behavior.
Egocentric analysis is also used to measure and understand the strength of
relations within a network, using mathematical properties such as closeness; nature of
acquaintance; how long the participant has known the network member; frequency of
interactions; types of relationships (family, spouse, sex partners, and friends);
socioeconomic characteristics (educational attainment, wealth, and others); demographic
characteristics (age, marital status, and geographical area); content of communication
(communications related to health, religion, or family, among others); and risk behaviors
(sharing syringes, engaging in unprotected sex, and piercing practices; Valente, 2010). In
summary, analysis of self-reported data by a respondent (ego) regarding the social
characteristics of a number of people he or she has contact with (altars) and the type of
contact is called egocentric analysis (Jolly, Muth, Wylie, & Potterat, 2001). Also,
egocentric analysis involves the network in two respects: (a) its structure (the social
characteristics of the altars, size, age, educational level, family, friend, etc.); and (b) its
relational characteristics (personal network exposure, ties, etc.; Valente, 2010).
Limitations of egocentric analysis include potential inaccuracy of reports of alter
opinions and behaviors. Although this could occur because of lack of interaction, weak
connections, or high network turnover, it could also be for other reasons. For instance, the
participants might purposefully provide erroneous information on altars’ opinions and
behaviors to validate their own behavior. Although this study did not use social network
analysis techniques that required interviewing altars and understanding their connections
among each other, the egocentric network analysis approach and the use of ego responses
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to questions about altars have been shown to be useful for the purposes of program
planning for Puerto Rican IDU living with HIV (Kottiri, Friedman, Neaigus, Curtis, &
Des Jarlais, 2002).
Problem Statement
Substance abuse is an important challenge for public health systems due to the
number of persons affected and the increased health risks (specifically for HCV/HIV) of
this population (WHO, 2009). In 2006, the Hispanic/Latino population had HIV/AIDS as
one the five leading causes of death for those aged 25-34 years (CDC, 2009d), and by
2013, HIV/AIDS was the eighth leading cause of death among Hispanics/Latinos aged
25-34 and the ninth leading cause of death for those between the ages of 35 and 54 (CDC,
2015d). However, the CDC observed heterogenic trends within the Hispanic/Latino
population that have given rise to disparities even among subgroups of Hispanics/Latinos.
For example, Hispanics/Latinos born in Puerto Rico are at higher risk for HIV infection
than other Hispanic/Latino groups in the United States. HIV incidence in Puerto Rico
(26.4 per 100,000) during 2009 was higher than for the United States (22.8 per 100,000)
as a whole (CDC, 2011).
This evidence may suggest that risk factors for Puerto Ricans islanders are
different from risk factors for other Hispanics/Latinos in the continental United States.
WHO (2009) reported that transmission while injecting drugs plays a relatively modest
role in the epidemic in all Caribbean areas except for Puerto Rico. The statistics show
that in 2006, approximately 40% of HIV incidence among males and 27% of new
infections among females are directly related to injection drug use (WHO, 2009).
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Similar results have been reported for HCV infections among Puerto Rican
islanders, who have a higher risk of infection (compared with all United States residents).
Puerto Rico’s HCV general population prevalence has been reported at 2.4% (National
Health and Nutrition Examination Survey [NHANES], 2008); United States has a
prevalence of 2.3% for same age category (20–59 years) (NHANES, 2008). However,
the prevalence of HCV among IDU in Puerto Rico is approximately 80%, compared with
57.5% of IDU living in the continental United States (Pérez et al., 2004; Pérez et al.,
2010a; Pérez et al., 2010b).
In addition, the CDC has reported that among Puerto Ricans, both casual and
chronic substance users may be more likely to engage in risky sexual behaviors such as
unprotected sex when they are under the influence of drugs or alcohol (CDC, 2009c).
Therefore, given the disparities in HIV/HCV infection between IDU living in Puerto Rico
and IDU living in the continental United States, the lack of research concerning this
disparity, and the need to further understand the influence of social networks on
HIV/HCV risk behaviors, there is a need to investigate the characteristics of the social
networks of Puerto Rican injection drug users and their implications for blood-borne
virus transmission.
Purpose of the Study
The purpose of this exploratory quantitative study was to describe how social
network characteristics of Puerto Ricans participating in a needle exchange program
relate to personal engagement in risk behaviors. Risk behaviors included substance use
and sexual behaviors associated with transmission of HCV/HIV. The study included data
collection on risky behavior of the particpants in relation to injecting drugs and sexual
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contact and correlates of those practices. Then, participants were asked to name their
network members and provide information about them; this allowed perceived
characteristics to be associated with individual risk.
Nature of the Study
The nature of this study was exploratory. A quantitative, cross-sectional survey
design was used to describe how the characteristics of Puerto Ricans’ IDU social
networks, as described by the nodes, are related to engagement in risk behaviors at a
specific point in time. The Blood Borne Virus Transmission Risk Assessment
Questionnaire (BBV-TRAQ) developed by WHO, in combination with the Social
Network Instrument developed by Wyllie (2006), was used to measure network
characteristics. A total of 181 local Puerto Rican IDU and participants from 9 needle
exchange sites were recruited to participate. Research staff used a random number table
to select a number (eight) from one to nine, and every eighth person waiting in line to
exchange syringes was approached to determine study eligibility (consistent with
inclusion study criteria).
Research Questions and Hypotheses
There were two research questions, as described below. Key research
(alternative) hypotheses associated with each research question are reported. Detailed
statistical tests are included as an appendix showing dependent, independent, and
appropriate statistical tests as per hypothesis question.
Research Question 1: What are the relationships among personal network
measures and high-risk sexual and injection drug behavior?
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Ho1-1: Social network characteristics (closeness [psychological closeness,
frequency of contact, and trust]; geographic insularity; density; network size;
relationship type; personal network exposure [network member frequency of
injection, years network members had injected, pooling money with network
members, and social network]) do not contribute unique explained variance in a
measure of sexual risk behavior, as measured by the Sexual Risk Scale score from
the BBV-TRAQ instrument, in a regression model.
Ha1-1: Social network characteristics (closeness [psychological closeness,
frequency of contact, and trust]; geographic insularity; density; network size;
relationship type; personal network exposure [network member frequency of
injection, years network members had injected, pooling money with network
members, and social network]) contribute unique explained variance in a measure
of sexual risk behavior, as measured by the Sexual Risk Scale score from the
BBV-TRAQ instrument, in a regression model.
Ho1-2: Social network characteristics (closeness [psychological closeness,
frequency of contact, and trust]; geographic insularity; density; network size;
relationship type; personal network exposure [network member frequency of
injection, years network members had injected, pooling money with network
members, and social network]) do not contribute unique explained variance in a
measure of injecting risk behavior, as measured by the Injecting Risk Behaviors
scale score from the BBV-TRAQ instrument, in a regression model.
Ha1-2: Social network characteristics (closeness [psychological closeness,
frequency of contact, and trust]; geographic insularity; density; network size;
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relationship type; personal network exposure [network member frequency of
injection, years network members had injected, pooling money with network
members, and social network]) contribute unique explained variance in a measure
of injecting risk behavior, as measured by the Injecting Risk Behaviors Scale
score from the BBV-TRAQ instrument, in a regression model.
Research Question 2: What are the relationships among social network
characteristics and self-reported HIV and HCV status?
Ho2-1: Social network characteristics (closeness [psychological closeness,
frequency of contact, and trust]; geographic insularity; density; network size;
relationship type; personal network exposure [network member frequency of
injection, years network members had injected, pooling money with network
members, and social network]) do not correlate with self-reported HIV and HCV
status in a regression model.
Ha2-1: Social network characteristics (closeness [psychological closeness,
frequency of contact, and trust]; geographic insularity; density; network size;
relationship type; personal network exposure [network member frequency of
injection, years network members had injected, pooling money with network
members, and social network]) do correlate with the self-reported HIV and HCV
status in a regression model.
Theoretical Base
This study was based on egocentric network analyses, which are both a
methodological approach and a theoretical paradigm. Valente (2010) described five
techniques for network analysis, which include the classic SNA using closed systems,
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and techniques such as egocentric network analysis, in which the individual provides
information on members of his or her social network. This model has been used to
describe, explore, and understand structural and relational aspects of health (Luke &
Harris, 2007). In the present study, I sought to determine how structural and relational
characteristics of the network, as reported by the participants, correlated with risk of
blood-borne infections. Previous literature has supported the use of egocentric network
analysis for these purposes (Luke & Harris, 2007; Prithwish, Cox, Boivin, Platt & Jolly,
2007; Wylie, Shah, & Jolly, 2006).
Definition of Terms
Closeness: Closeness describes the importance or prominence of a given altar in
the ego’s network. In the present study, closeness was assessed using three measures
adapted from survey items: psychological closeness, frequency of contact, and degree of
trust (Luke & Harrison, 2007; Wylie, Shah & Jolly, 2006).
Density: Density refers to the extent to which nodes are connected to each other
within a participant network. High density indicates that all or many of the nodes know
each other (Tobin & Latkin, 2009). It is measured by calculating the ratio of observed
ties to possible ties (Luke & Harris, 2007). In this study, a matrix was provided to
participants, and they were asked to indicate how members of the network were
connected to each other.
Drug network members: Drug network members are people who injected drugs
with the interviewee, at the same time and in the same location, at least once during the
previous 6 months (Aitken, Higgs, & Bowden, 2008).
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Geographic insularity: Geographic insularity describes the proximity of the
participant and the network members based on geography (Tieu, 2015). For the present
study, participant and network members were asked to identify their zip code and/or
barrio. Data were coded such that the variable distinguished those participants who lived
in the same zip code as all of their network members and those for whom at least one
network member lived outside of the same zip code or barrio.
Injection: Injection is defined as a skin-piercing event performed with a syringe
and needle with the purpose of introducing a curative substance or a vaccine into a
patient by the intramuscular, intravenous, or subcutaneous route. This excludes all skin
surgery, tattoos, and body piercings (Simonsen, Kane, Lloyd, Zaffran, & Kane, 1999).
Network exposure: Network exposure refers to the percentage of the members an
individual’s personal network sharing some characteristic (Valente, 2010). In the present
study, network exposure was ascertained from questions concerning how often
participants injected with their network members, years the network member had
injected, frequency of pooling money with a network member, and social network
exposure.
Risk networks: Risk networks are networks of people with whom the respondent
has engaged in a potential risk event, such as injecting drugs or having sex, within a
designated time period (Braine et al., 2008).
Secondary syringe exchange: Secondary syringe exchange is a type of exchange
that involves secondarily obtaining large quantities of syringes from a sanctioned source
and redistributing them to other IDU for sale, trade, or altruistic purposes, or as part of
drug transactions (De et al., 2007).
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Sexual network members: Sexual network members are those with whom the
respondent had sex at least once during the previous 6 months, whether or not money was
exchanged (Aitken, Higgs, & Bowden, 2008).
Syringe exchange programs: These are programs that allow sterile syringes to be
obtained from sanctioned sources (De, Cox, Boivin, Platt, & Jolly, 2007).
Closeness: Closeness involves connections between participants and members of
their network (Valente, 2010).
Unsafe injection: Unsafe injection occurs when the syringe, needle, or both have been
reused without sterilization. This also includes the reuse of cotton, cookers, or any kind
of paraphernalia used in injection practices (Simonsen et al., 1999).
Assumptions
The social network model is based on the assumption that the communication
among, within, and between people and groups impacts the behaviors of individuals.
SNA is also predicated on the assumption that communication and behaviors among
individuals in the network can impact the individuals’ behavior in a very complex way.
Therefore, SNA is always a proxy of how relations among members of a social group
who are connected influence attitudes, beliefs, and behaviors of individuals. Another
critical assumption is that participants will report all relevant network members without
leaving out key members. The Principal Investigator limited this to five members; there
could be additional members who are important but are not counted. In addition, it is
assumed that participants report characteristics for each of the network members that
match the actual characteristics of the network members; in this type of egocentric
network analysis, individuals report information on their network members rather than
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network members themselves providing information. Additionally, SNA involves the
assumption that causes of behavior are primarily social rather than personality based
(Valente, 2010).
Limitations
This study had several limitations. First, actors who were not connected to others
(isolates) were not included in the study. Participant networks could have been more
homogenous than expected. This could have resulted in obtaining artificially stronger
ties (e.g., higher values of connectedness and solidarity and lower conflictual networks)
that would then result in overestimating the risk for transmission of HIV/HCV. Also, it
was not possible to identify all key members (and their characteristics) in order to
quantify how they affect the risk of HCV/HIV transmission. Therefore, there may have
been personal characteristics of the people in the social network that could have
influenced the transmission of HCV/HIV that were not reflected in this study. Finally, as
it is assumed in SNA that causes of behavior are primarily social rather than personality
based, the individual causes of behaviors tend to be downplayed or ignored in this kind of
analysis (Valente, 2010).
Delimitations
The population included all participants of NEPs receiving the services of
Iniciativa Comunitaria e Investigación Inc. (ICI Inc.). This program has approximately
24 centers around the island of Puerto Rico. This study was restricted to those who were
injection drug users; sexual risk practices are also important as transmission paths for
HIV/HCV but were considered only in the context of participants who were active IDU.
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As the primary focus of the study was egocentric network analysis, individual approaches
to understanding risk were in general not considered (although they are important).
Significance of the Study
Federal and local agencies have continued expanding their efforts to reduce the
rates of HCV/HIV in the Hispanic/Latino community. The efforts include better access
to culturally appropriate prevention care and treatment services and enhancing research,
policy, and community involvement, among others (CDC, 2009c). This study will
contribute (a) to expansion of the knowledge base on one of the most vulnerable
Hispanic/Latino populations within the United States territories; (b) to the development
of evidence for use by health agencies, community-based organizations, and
stakeholders; (c) to the development of health education and prevention programs based
on evidence; and (d) to increased knowledge of Hispanic/Latino IDU social networks and
their relationship to HCV/HIV transmission, which has not been documented.
Summary and Transition
HIV and HCV are among the most important blood-borne viruses worldwide
(WHO, 2010a, 2010b, 2007). Adverse health effects of these infections range from
simple infections to death; thus, life expectancy decreases. Although these epidemics
have a larger impact in developing countries and in countries in a transitional state, they
present a clear public health challenge in the United States. Both pathogens contributed
to increased health disparities in the nation. Disparities in these infections, especially
among racial and ethnic minorities, have been observed by researchers (CDC, 2009c)
Statistics show that Hispano/Latino populations have been disproportionally affected by
the epidemic in the United States. Within Hispano/Latino populations, intervention
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programs for Puerto Rican islanders need to be contextually and culturally relevant.
Epidemics among Puerto Rican populations tend to be more related to injection drug
practices than to risky sex behaviors (CDC, 2009c; Pérez, 2004, 2010a; WHO, 2009).
Chapter 2 includes a review of existing literature about how the characteristics of
different IDU social network impact engagement in risk behaviors related to the
transmission of HCV/HIV viruses. The chapter starts by providing a historical
background of social network analysis in a public health context, followed by a
description of the risk and protector factors documented for different social networks and
how these are associated with the transmission of HCV/HIV viruses. Finally, the chapter
includes a description of social network analysis theory that forms the theoretical
framework for this study.
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Chapter 2: Literature Review
Introduction
The purpose of the literature review is to give an overview of the research on the
social networks of needle exchange program (NEP) participants and of those not
participating in NEP in conjunction with their risk to blood-borne viral diseases. This
study was based on egocentric network analysis, which is both a methodological tool and
a theoretical paradigm. This model has been used to describe, explore, and understand
structural and relational aspects of health (Luke & Harris, 2007). Luke and Harris (2007)
showed that social network theory includes a multidisciplinary approach that includes
mathematics, statistics, sociology, anthropology, psychology, biology, physics, and
computer sciences. Social network theory has clear application to public health research
and can be a versatile framework within which to understand the transmission of diseases
and the influence of personal and social influences on health behaviors.
Literature Search Strategy
Multiple electronic databases of peer-reviewed journals (such as PubMed, A to Z
Ebscot, MD Consult, and Ocenet) were used to access information for this project.
Walden, University of Puerto Rico, University of South Florida, and Berkeley online
libraries were accessed for retrieving articles. Only articles obtained on these databases
and published from 1990 to 2010 were considered. Keywords for article searches
included social network, injecting drug use, needle exchange program, social network
analysis, Hispanics, drugs, syringe, HIV, HCV, AIDS, hepatitis, blood-borne pathogens,
addictions, epidemiology, and health programs. In addition, health authorities’ webpages,
books, and other statistical reports were consulted.
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IDU Subculture and Drug Use Patterns
Worldwide estimates suggest that there are approximately 16 million IDU
(Mathers et al., 2008; Strathdee & Stockman, 2010). However, the heterogeneity of this
group poses public health challenges to practitioners, as health problems tend to be
unique within subgroups. For instance, IDU characteristics vary in such ways as (a)
geographical area in which they live, (b) injecting practices, (c) risk behaviors, (d) social
norms, (e) network composition, (f) network role (centrality, propinquity, overlapping,
etc.), (g) how drugs are obtained and shared, (h) quantities of drugs used, (i) types of drug
used, (j) injection settings, (k) injection frequency, (l) race/ethnicity, (m) age, (n) legal
and social frameworks, (n) network turnover (the proportion of new IDUs in the personal
network during the past month relative to the number of members in the past 6 months),
(o) strength of ties to other network members, and (p) and sources of the virus. Thus,
personal attributes as well as influences from individual networks can shape the risk of
exposure to diseases such as HCV and HIV (Braine et al., 2008; Davey-Rothwell et al.,
2010; Junge et al., 2000; Koester, Glanz, & Barón, 2005; Latkin et al., 1995; Latkin et al.,
2009; Mathers et al., 2008; Rhodes & Treloar, 2008; Shaw et al., 2007; Strathdee &
Stockman, 2010).
Cultural Practices in Drug Preparation
The recognition of a culture of drug use and the potential risks associated with
transmission of blood-borne pathogens is essential to developing effective intervention
strategies. Researchers have documented that differences in HIV/HCV risk profiles can
be attributed to the places where IDU inject drugs, as these places have their own cultural
norms of injecting drug use (Hillier, Dempsey & Harrison, 1999; Jean-Paul et al., 1996;
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Koester, Glanz, & Barón, 2005; Miller-Day & Barnett, 2004; Nemoto et al., 1999). IDU
behaviors and attitudes can be influenced by the collective norms of their network
members, which can increase or diminish the risk of blood-borne virus infections (MillerDay & Barnett, 2004). However, as drug use is a forbidden behavior, specific practices
still remain unclear and in many places have been poorly documented (Andía et al., 2008;
Filinson et al., 2005; Jean-Paul et al., 1996; Miller-Day & Barnett, 2004).
Koester, Glanz, and Barón (2005) described injecting practices of IDU in Denver,
Colorado. They described the practices of a group of IDUs of several ethnic backgrounds
(including Whites, Blacks, and Hispanics/Latinos, among others). Koester et al. wrote
that their participants melted solid rocks of heroin pills (tar) of approximately 0.25 g each
in a cooker. The melted pills were mixed with water and then drawn into a syringe, which
was then divided among participants.
In a sample of drug users in the Netherlands, Jean-Paul et al. (1999) discovered a
different process. Dutch IDU acquired heroin as a hydrophobic powder that did not need
to be melted. Dutch users, however, needed to acidify the heroin in order to make it
soluble in water (by the use of lemon juice). Thus, they used a cocker (spoon) with a
couple drops of lemon juice, water, and the heroin, which they then heated until heating
resulted in a uniform solution that was injected. The differences in heroin preparation
could be attributable to the manufacturing source of heroin. Southwest Asian heroin,
which is frequently used in Europe, has a hydrophobic nature (Jean-Paul et al. (1999).
Conversely, in the United States, most of the heroin originates in Southeast Asia,
which has a hydrochloride form that is easily dissolved in hot water. Jean-Paul et al.
(1999) also stated that high-purity heroin and cocaine should dissolve in water at room
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temperature. The adulteration of the product makes necessary the use of heat or
acidification to increase water solubility.
In Puerto Rico, heroin also comes as a water-soluble powder that does not require
melting (Andía et al., 2008; Filinson et al., 2005). On the island, the drug is dissolved in a
cooker by briefly moving the cooker in a circular way and heating the solution as
necessary to accelerate dissolving. Thereafter, a small part of a cotton ball or cigarette
filter is placed at the cooker with the intention of filtering prior to syringe loading. In
most cases, the drug solution is divided among the participants by any of three methods:
backloading, which involves adding contents to the back end of a syringe once the
plunger is removed; frontloading, which involves removing the needle from the host
syringe and inserting the needle from the second syringe into the host and drawing
contents; and sharing directly from the cooker (Andía et al., 2008; Filinson et al., 2005).
The differences in the risks through drug preparation are notable (Jean-Paul et al.,
1999). The researchers showed that, in the case of Dutch IDU, acidification of the
solution could result in lower risks for disease transmission. Similarly, other authors
have shown that the point to which IDU heat the solution, combined with the time heat is
applied, could reduce the risks of HCV/HIV (Andía et al., 2008; Filinson et al., 2005).
Theoretically, those who receive the drug in soluble form would then face an increased
risk of blood-borne transmission, as the solution is only heated once (to make it a uniform
solution); those who receive the drug as a rock must heat it for a prolonged period of time
in order to melt it.
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Cultural Differences in Drug-Sharing Practices
The drug-sharing culture among IDU is complicated, variable, and multifaceted.
There are several ways in which IDU divide the drug solution; each has its own
associated risks and varies by geographical area (Andía et al., 2008; Filinson et al., 2005).
Backloading is one of the techniques used for sharing drugs and requires a skillful
injector who is able to perform it without spilling the drug solution (Jean-Paul et al. ,
1996). Backloading requires the sharing of the drug by delivering it using the back part of
a full syringe that delivers it to the empty one (Jean-Paul et al., 1996). The injector needs
to balance the full syringe at an angle sufficient to deliver the solution but not sufficient
for the solution to be spilled. The technique is rarely used but has been documented for
New York and other North American and European cities (Andía et al., 2008; Filinson et
al., 2005, Jean-Paul et al., 1996). The main risks associated with backloading are related
to contamination of clean syringes with used ones.
A variation of this technique has also been reported in the Netherlands by JeanPaul et al. (1999), in which a syringe is used as storage and every injector draws doses
from it. This modality requires a big syringe (> 2 ml), which may be the reason why this
practice is rarely used. Jean-Paul et al. (1996) also noted that this modality could be used
for frontloading.
Frontloading, rarely seen in the United States, involves the use of a syringe with a
detachable needle. Frontloading happens when the needle is removed from the hub of a
receive syringe and the needle is inserted through the hub at the front of the receptor
syringe. This practice is commonly seen in European countries where syringes have
detachable needles. In the United States and its territories (including Puerto Rico), the
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most common syringes used are diabetic syringes, which are not detachable (Andía et al.,
2008; Filinson et al., 2005). However, while uncommon, this practice has been
documented among Puerto Rican islanders (Andía et al., 2008; Filinson et al., 2005).
Gaughwin, Gowans, Ali, and Burrell (1991) established that the type of syringe is
directly related to blood-borne diseases, as detachable syringes have 55 times more blood
than diabetic syringes after usage. Thus, detachable syringes increase the risks for bloodborne diseases, as they have the capacity to deliver a higher viral load, which implies that
frontloading (theoretically) has up to 55 times more of the virus being transmitted than
what occurs during backloading. Thus, the risks of drug sharing associated with
backloading and frontloading as well as the geographical location can increase or
diminish the risk of HIV/HCV.
Finlinson et al. (2005) documented that on the island of Puerto Rico, almost 40%
of IDU use backloading; the others tend to prepare the solution and discharge it in the
cooker for division among IDU. Sharing the cooker can be considered an indirect needlesharing practice that poses a different kind of risk for HCV/HIV. Frontloading and
backloading tend to expose the user more directly to the virus, resulting in higher risks
for these practices (and hence lower for cooker sharing). However, indirect needle
sharing practices also can expose the user to the virus through contamination of the
source and not the syringe (De et al., 2007a; Latkin, et al., 2009a; Paintsil et al., 2009).
Additionally, other paraphernalia and equipment related to injecting behaviors are shared,
including cotton, tourniquets, and water (De et al., 2007a; Latkin et al., 2009a; Paintsil et
al., 2009).
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Jean-Paul et al. (1996) noted that cooker sharing is most common among diabetic
syringe users because backloading requires great skill and is also time consuming. This
practice is done after drug preparation and involves several modalities. One of them is
common in the Netherlands, where injectors make a simultaneous draw into syringes of
the drugs. Other cooker-sharing practices are performed after injectors reach agreement
on the proper division of the drug; each sharer draws the surplus in a specific order
(Andía et al., 2008; Filinson et al., 2005). This modality is the one that predominates in
Puerto Rico, and it has been noted that Puerto Rican islanders practice it more than
Puerto Ricans in the continental United States (Andía et al., 2008).
IDU in South Florida and Brooklyn have reported a different cooker-sharing
practice during which cocaine and heroin are prepared separately in different cookers and
syringes. Thereafter, the IDU make the proper mixture by squirting the cocaine into the
syringe containing the heroin, and half of the resulting mixture is then transferred from
the second syringe into the first syringe (Chitwood, McCoy, & Comerford, 1990; Inciardi
& Page, 1991).
Cookers pose a risk of infection with HCV/HIV, as sharing contaminates new or
noninfected syringes in the process, and the cooker is a necessary step in the injection
process. Likewise, the use of plungers (rubber tips) for mixing the drug with water also
increases the risks for HCV/HIV (De et al., 2007a; Koester, Glanz, & Barón, 2005;
Latkin et al., 2009). The cotton used for filtering the solution into the syringe and the
water for disinfecting and dissolving the drug in shooting galleries are not always clean;
thus, both factors constitute a focus of infection that increases blood-borne virus diseases
(De et al., 2007, 2007b; Filinson et al., 2005; Gyarmathy & Neaigus, 2006).

30
Other Facts Related to Subculture
Braine et al. (2008) and Koester, Glanz, and Barón (2005) stated that drug
acquisition in the United States is done by selected persons within IDU networks who are
allowed to buy the heroin; these people receive part of the injection as a reward.
However, in Puerto Rico, IDU typically obtain heroin from a drug dealer without an
intermediary (i.e., selected person). Drug dealers accessible to IDU in Puerto Rico are
known as tiradores (Finlinson et al., 2005). Tiradores are usually established in
permanent sites and serve as a connection between the IDU and the bichote (a highvolume drug dealer who does not work with IDU but rather directly with the tiradores).
The tiradores are considered secondary distributors (who may or may not be users) in
charge of the street markets that include, in some cases, the shooting gallery (a place
where IDU inject). Puerto Rican islander IDU tend to be lower, as the risk of infection
attributable to drug acquisition tends to be equally distributed in this population
(Finlinson et al., 2005). This is the case for islanders where the drug is bought by the IDU
and he or she uses it; however, in the continental United States, the drug is acquired by a
third person from the dealer and is then given to the IDU, who is obligated to share it
with the third person. This specific practice is not within the social norms of Puerto Rican
islanders. Thus, in general, this drug sharing increases the risk of contagion with
HCV/HIV among mainland IDU.
Among Puerto Rican islanders, risk of infection with HCV/HIV is linked to other
socially approved norms related to needle sharing in all its modalities (backloading,
frontloading, and paraphernalia sharing). This has been found to be a significant factor in
the transmission of HCV/HIV, as islanders engage in riskier behaviors than do U.S.
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continental Puerto Ricans who are injectors (Andía et al., 2008). Authors have
documented that drug and needle sharing is more common among islanders who develop
strong social bonds with other IDU. Hillier, Dempsey & Harrison (1999) and Miller-Day
and Barnett (2004) also found that strong bonding leads to permissive attitudes towards
risk behaviors among IDUs in the United States and Australia.
Filliston et al. (2005) also noted that when Puerto Rican islander IDU pooled
money or drugs, the quantity of drug to be injected was determined by the proportion
each participant had contributed. Also, when only one syringe was available, the
proportion of money spent determined the order of injection (Finllinson et al., 2005).
Similar findings were suggested by Jean-Paul et al. (1996) and Nemoto et al. (1999), who
documented that the quantity of drugs and money each participant contributes is
proportional to the quantity of the solution to be injected and the order of injection. The
implications for blood-borne transmission are that the economic contribution can increase
risk by the load of virus being injected. This would be determined not only by the
quantity of drug, but also by the turn an IDU takes in the chain of injection.
Another factor in the Puerto Rican IDU culture that impacts transmission is
frequency of injection. Several researchers have determined that NEP participants have a
frequency of injection that ranges from 6 to 8 times per day (Dávila-Torres & ReyesOrtiz, 2010; Finlinson et al., 2005). Frequency of injection is an important factor for
exposure to HCV/HIV through indirect injection practices (cooker, cleaning, etc; JeanPaul et al., 1996). Many authors have suggested that Puerto Rican IDU are less likely to
know their HCV and HIV serum status, which impacts their risk of exposure to those
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who share needles or equipment with them (Andía et al., 2008; Finlinson et al., 2005;
Kang et al., 2005; Pérez et al., 2010b).
HCV and HIV Prevalence and Risk Factors Among IDUs
HCV
HCV and HIV are among the top 10 viral infections in the world that result in
high morbidity and mortality rates (separately and as comorbid infections; WHO, 2007,
2010a, 2010b). HCV global estimates indicate an estimated 130 to 170 million cases
(Alter, 2006, 2007; Pérez, 2004; WHO, 2010c). In Europe, more than 4 million persons
suffer from this condition (WHO, 2010), and in the United States, estimates indicate that
3.2 million Americans live with chronic HCV (Armstrong, 2007). The CDC has reported
that incidence rates are approximately 17,000/year (CDC, 2010c) in the United States.
These data may underestimate the total number of HCV infections, because they
do not reflect more than half a million persons who are incarcerated and do not
participate in the health studies conducted by different health agencies (Armstrong,
2007). Estimates of HCV infection in this population are higher than in the general
population (moderate estimates suggest a 30% prevalence (Armstrong, 2007). Armstrong
(2007) and Estrada (2005) documented health disparities that disproportionally affect
minority populations. They noted that HCV prevalence is higher among Hispanics than
non-Hispanic Whites, findings supported by other researchers (CDC, 2009c, Sprading et
al., 2010; WHO, 2009,). In addition, the authors noted that Hispanic IDU have the
highest infection risk ratios within the United States.
Puerto Rican islanders are not included in many research activities due to their
political status. Only some of the data provided by the CDC and the WHO present Puerto
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Rican islanders separately from mainland Puerto Ricans. For example, the National
Health and Nutrition Examination Survey (NHANES) study provides self-reported
estimates of HCV and HIV for the 50 states but excludes other American territories such
as Puerto Rico (Armstrong, 2007; Pérez, 2010b). The study by Pérez et al. (2010b) is one
of the few studies, and maybe the only study, to examine HCV prevalence (as confirmed
by laboratory tests taken from 2005–2008) of Puerto Rican islanders. Pérez and
colleagues reported an HCV weighted prevalence of 2.3–2.7% among Puerto Rican
islanders, most of whom (80%) were unaware of their HCV serologic status. In the case
of mainland Puerto Ricans, the prevalence is similar (2.3%) among those aged 20 to 59
years. However, among islanders reporting lifetime drug use, prevalence of HCV was
approximately 80%. These data are significantly different from reports from NHANES
1999–2002 from which HCV seroprevalence of 57.5% was reported among Puerto Rican
mainland lifetime drug users (CDC, 2007b).
Recently, Reyes-Ortiz et al. (2014) reported that for the Mayagüez (western) and
Ponce (southern) regions of the island, the total number of cases registered in the Puerto
Rico Department of Health was 4,434. HCV was most prevalent among males of these
regions than from females and it was documented that only 25.8% of all cases had a PCR
diagnostic test. The authors also reported significant differences for age of diagnosis
between males and females where women are diagnosed younger than males (p < 0.000).
Differences between regions were observed being Mayagüez the health region with
higher prevalence in comparison with Ponce region (p=0.01).
However, the data given by Reyes-Ortiz et al. (2014) for HCV although is the first
data published by the Puerto Rico’s Health Department does not cover the metropolitan
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area of Puerto Rico. This is important as this region is more likely to have a higher
prevalence of the disease in comparison to the rest of the island as per Pérez et al.
(2010b). Neither the report discriminates for lifetime drug use cases, which for the
purpose of this study are relevant. The study however, counts all the reported cases of
people living within those health regions and takes in consideration the incarcerated
people who reported their permanent address to be within those municipalities. Last this
study data could not be compared with other populations in USA or Latin America.
Several studies conducted during the first decade have compared Puerto Rican
IDU living in mainland and those living on the island. The results of subject profiles
regarding risk factors and health behaviors indicate significant differences between the
two groups. For instance, Puerto Rican islanders start using heroin younger than that
Puerto Rican IDU living in mainland (33.2 vs. 38.4 years of age, respectively). Islanders
are also less educated (high school level or less), have less family support (talking,
housing, etc.), and use less cocaine in their drug solution than Puerto Ricans in the
mainland (islanders indicate a preference for pure heroin). Puerto Rican islanders also
report increased rates of injection and drug solution being injected (5.4 times per day
compared with 2.8 times per day among mainland IDU; Amill et al., 2004; Colón et al.,
2001).
Amill et al. (2004) and Colón et al. (2001) have also reported that islanders have
more exposure to drug environments, more access to drugs, and do more pooling for
buying drugs than mainland Puerto Ricans. Puerto Ricans living on the mainland are
more aware of their HCV/HIV status and report more participation in methadone
programs. Therefore, the research suggests that the social environment and HCV risk for
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islanders is unique from those in the mainland U.S. IDU (Puerto Rican or other groups).
In fact risks of infection among Puerto Ricans for HCV are still increasing at alarming
rates in comparison to other ethnic backgrounds as African American IDU and White,
non-Hispanics IDU, which had rather decreased or remained steady, (Cooper et al., 2008;
Pérez, 2010b). Thus, HCV prevalence among Hispanic IDU population is a significant
health problem to be addressed. However, among the Hispanic populations within all the
U.S. territories, Puerto Ricans islanders seem to be the most vulnerable population to
infection.
HIV
HIV/AIDS is currently the most prevalent infectious disease worldwide, and its
contribution to mortality rates exceeds that of any other communicable disease (WHO,
2010b). HIV cases worldwide increased from 7.6 million in 1990 to 33.4 million in 2008.
Incidence rates accounted for approximately 2.7 million new infections for 2008 (WHO,
2010b). The WHO reported that approximately 25 million persons have died from AIDS
since the beginning of the pandemic (WHO, 2010d). The report shows that 2 million of
deaths due to HIV occurred in 2008 (WHO, 2010b). The CDC (2010d) has estimated that
for 2008, in the USA the prevalence of HIV/AIDS was estimated in 862,434 persons. The
agency reported health disparities by race and observed that Hispanics were almost three
times more likely to have HIV than whites, and blacks were almost eight times more
likely to have HIV (CDC, 2008).
In the Caribbean, 240,000 of adults and children were living with HIV in 2008;
new cases were estimated at 20,000 (with a range of 16,000–24,000; WHO, 2009). Most
of the inhabitants of the Caribbean islands are Hispanics, and Puerto Rico is a USA
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territory within the Caribbean. Transmission of HIV in the island is more similar to the
trends in the rest of the Caribbean than in the USA (CDC, 2009). In general, within the
Caribbean region, injecting drug use plays a relatively modest role in the epidemic.
However, when examine by countries, the role of injecting drug use represents the most
common transmission route for Puerto Rico accounting for 40%–51% of HIV incidence
among males in 2006 and 27% of new infections among females (Amill et al., 1999;
CDC, 2009c). This compares to 25% of the cases of HIV in the USA due to injection
drug use. Similar statistics are found in Brazil (20%) and Canada (22%; Amill et al.,
1999). Others have reported that injecting drug use accounts for approximately 10% of
HIV infections globally, although rates could be as high as 49.7% in countries other than
Africa (Strathdee & Stockman, 2010).
Pérez et al. (2010b) found that in Puerto Rico, the prevalence of HIV is 1.1%
(95% CI: 0.5%–2.3%). This could be representing 25,000 persons (95% CI: 12,000–
51,000) of which 9,100 are estimated to be unaware of their HIV status (Pérez et al.,
2010b). Unfortunately, Pérez, et al. do not report specific data for IDU; however, they
report higher risk for those aged 40–49 years, MSM, individuals with a history of STIs,
those who received a blood transfusion before 1992, and those with a record of
imprisonment. The estimates made by Pérez et al. are higher than the data reported for
the US adult population (1.1 % in Puerto Rico vs. 0.5% in the USA). Also, lack of
awareness of HIV status is significantly higher among Puerto Rican islanders than in the
general population in the U.S. (36.4% in Puerto Rico vs. 21% in the U.S.). The authors
explained that these differences are due mainly by the increased frequency of injection
and injecting behaviors observed in the Puerto Rican Islander IDU. Also, Pérez et al.
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noted that this population of IDU are hard to reach and are underserved with respect to
health services. They suggest that it is necessary to assess characteristics of social, sexual,
and drug using networks using network analysis.
In addition, documented risk factors for HCV/HIV in the Puerto Rican islanders
IDU population suggest being similar to other Hispanic or ethnic groups (Baumbach,
2008; Pérez et al., 2004; Pérez, 2010b). These risks include (a) injecting with used
injection equipment; (b) having sex for money or drugs; (c) having sex with an HIV
infected person; (d) having more than one sex partner; (e) having a sex partner who has
had other sex partners; (f) sharing injection drug needles and syringes or injection
equipment; (g) having risky sex behaviors (for instance sex without a condom); (h) ever
having had a sexually transmitted disease, like chlamydia or gonorrhea; (i) having
received a blood transfusion or a blood clotting factor between 1978 and 1985; (j) ever
having had sex with someone who has done any of those things; (k) using toothbrushes,
razors and other items that might be contaminated with blood; (l) using non-sterile
equipment during body piercing and tattooing; and (m) being a newborn of an infected
mother (due to vertical transmission) (CDC, 2007; CDC, 2010; WHO, 2010a).
Needle Exchange Programs and HCV/HIV
The purpose of needle exchange programs (NEP, also known as syringe exchange
programs [SEP]) is to allow an opportunity for IDU to exchange used syringes for new
ones. SEP aim to reduce and control the transmission of blood borne pathogens and other
adverse effects related to drug injection (Batos & Strathdee, 2000; Delgado, 2004;
Downing et al., 2005; Hagan et al., 1999; Pollack, 2001; Stancliff et al., 2003; Vlahov,
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Robertson & Strathdee, 2010). However, these programs include more than syringe
exchange; they also provide health information, condoms, paraphernalia, drug treatment,
and rehabilitation services to IDU during the exchange. SEPs differ depending in their
geographical location, the context of the legal system in which they operate, and cultural
environment (Batos & Strathdee, 2000; Stancliff et al., 2003).
The first SEP was founded in Amsterdam, Netherlands in the 1980s (Bastos &
Strathdee, 2000; Knittel, Wren, & Gore, 2010). Thereafter, most developed countries
implemented NEPs as a harm reduction strategy. The first SEP in the U.S. territories was
implemented in Connecticut in 1986 (Knittel et al., 2010). Stancliff et al. (2003) reported
that by 1998, in the U.S., there were 131 SEP operating in 31 of its territories. However
Downing et al. (2005) reported that there are as many as 209 SEP in 36 of its territories
that are serving IDU.
Multiple strategies used by SEP to implement services have been documented,
including face-to-face exchange, enhanced pharmacy services, exchange by clinicians,
exchange with medical prescription, exchange without medical prescription, and vending
machines (Downing et al., 2005; Knittel, Wren & Gore, 2010; Stancliff et al., 2003;
Vlahov, Robertson & Strathdee, 2010). Currently in Puerto Rico, SEPs provide the above
mentioned services via face-to-face exchange, vending machine, in pharmacies, and
during outreach routes of different community based organization /non-governmental
organizations. All legal SEPs in Puerto Rico are regulated by the Department of Health.
NEPs have played an important role in the decreased of HIV among IDUs and
modifying injection risky behaviors (Batos & Strathdee, 2000; Delgado, 2004; Downing
et al., 2005; Hagan et al., 1999; Pollack, 2001; Robertson & Strathdee, 2010; Stancliff et
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al., 2003; Vlahov, Knittel, Wren & Gore, 2010). Pollack (2001) attributed many of the
reductions in HIV infections in cosmopolitan and rural cities to SEPs. There is also
sufficient evidence pointing that SEPs do not alter social networks structure among IDUs
(including density, turnover, centrality among others; Batos & Strathdee, 2000; Delgado,
2004; Junge et al., 2000).
Yet HCV data are inconclusive regarding the benefits of SEPs. Pollack (2001)
and Hagan et al. (1999) concluded that since HCV has a high virulence, SEPs are not
completely effective in combating its transmission. The biological properties of HCV
result in successful transmission of the virus to susceptible hosts in 3 – 9% of all HCV
positive needle-sticking cases; while only 1% of all HIV positive needle-sticking cases
become infected (Pollack, 2001). However; interventions used in SEPs typically only
provide clean syringes and do not provide other health promotion materials. Indeed,
Delgado (2004) and Knittel et al. (2010) remarked that the benefits of SEPs in combating
the HCV epidemic have not been thoroughly evaluated; because of this, current literature
does not be reflect the scope of health interventions provided to IDU through SEPs.
Social Networks and HCV/HIV
Social Networks Theory
Social network theory (SNT) can be traced back to the 18th century, when
Leonhard Euler used a visual representation to show a city network of bridges and rivers.
Euler’s intentions were to solve the riddle regarding whether or not a person could cross
the city without passing twice through the same bridge. During this exercise, Euler
invented graph theory, which provides one of the mathematical foundations for network
analysis (Luke & Harris, 2007).
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During the 19th and early 20th centuries, the concept of network analysis had
evolved and was being applied to social ties. Specific terminology was developed that
applied analysis of social networks. In fact, during the early 20th century, social scientists
were discussing the concept of six degrees of separation (any person is separated from
other by no more than six persons; Luke & Harris, 2007). The sociogram is considered
the first specific network analytic tool. The new tool was an innovation in the analysis of
relationships that could be represented on paper. The sociogram was based on two
elementary concepts: people (represented as points), and interpersonal relationships
(represented by lines that connect individuals; Luke & Harris, 2007).
It was not until mid 1990’s that mathematicians Erdős and Rényi demonstrated
that as network size increases, the needed connections between nodes decreased for the
network to be completely linked (Luke & Harris, 2007). Granovetter (1973) added the
concept of weak ties. This referred to casual acquaintances that helped held the network
together. Conversely to strong ties, which fulfill the primary necessities of the node
(mainly represented by, family, neighbors, and coworkers), weak ties were considered
casual but were completely necessary to fulfill other needs of the person. Granovetter’s
work provided two advances. First, it was possible to develop a sophisticated and realistic
model of network structure. Second, Granovetter’s work provided an explanation of
social networks structure and was perhaps the first time human behavior was described
using this approach (Luke & Harris, 2007).
Contemporary scientists, including mathematicians (Montanari, Saberi, 2010),
anthropologists (Perelberg, 1983), public health researchers (Sabbah, 2011), and
biologists (Sigman, 2009) have started examining the fundamental properties of
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theoretical and real world networks. In general, SNA posits that individuals are tied to
one another by invisible bonds that represent specific social structures. These invisible
bonds (social structures) are independent and unique among individuals and create a
distinct and significant social environment that affects behaviors, norms and risk taking
activities (Scott, 1988). Also, these social bonds can change the social environment as
well as be changed by it, generating a dynamic interplay between social environment and
behavior over time. Therefore, analysis of social networks is necessary for public health
researchers in order to understand and explain the nature of risk behavior and to then
implement solutions that impact both individuals and their networks.
Luke and Harris (2007) summarized social network theory as consisting of three
sets of analyses. Individual (ego-centric) analysis is performed with the purpose of
identifying the position or location and characteristic of an actor within a network.
Measures used in egocentric analysis include degree (the simplest of centrality measures,
the extent to which an actor is connected to others; Luke & Harrinson, 2007), centrality
(the importance or prominence of a given actor or node; Luke & Harrison, 2007), and
structural equivalence (two nodes are said to be exactly structurally equivalent if they
have the same relationships to all other nodes; Hanneman & Riddle, n.d.). Subgraph
analysis is performed for the purpose of examining the characteristics of the group under
observation. Common measures include the dyad (a pair of actors and the (possible) tie(s)
between them; Wasserman & Faust, 1994), triad (a subset of three actors and the
(possible) tie(s) among them; Wasserman & Faust, 1994), k-core (k-core are defined as
areas of relative high cohesion within the map created by the graphical representation of
the connections among nodes, Scott, 1991), and the cliques (maximal set of vertices that

42
have the potential to become social groups (within a network) and which should have at
least three nodes; Wasserman & Faust, 1994). Network level analysis is performed to
describe and make inferences based on the structure of the entire network. These network
level analysis measures include density (the extent to which nodes are connected to each
other within a participant network; Tobin & Latkin, 2009), diameter (the length of the
longest path between connected actors; Wasserman & Faust, 1994), and centralization
(the distance from an actor to all others in the network by focusing on the distance from
each actor to all others; Wasserman & Faust, 1994).
These four areas are transmission networks, information networks, social
networks, and organizational networks. Transmission networks involve social systems
and are interest on what flows between actors in the network (such as diseases or
information). There are two main types of transmission networks: disease and
information. Disease transmission networks are networks of individuals connected by ties
that can spread infection (Friedman & Aral, 2001). Analysis of disease transmission
networks has successfully been applied to tuberculosis (CDC, 2005), HIV/AIDS
(Buchanan & Latkin, 2009; Aitken, Higgs & Bowden; 2008), sexually transmitted
diseases and sexually transmitted infections (STD/STI) (Wylie et al., 2010), gonorrhea
(Stroner, Whittington, Hughes, Aral, & Holmes, 2000), severe acute respiratory
syndrome (SARS) (CDC, 2003), and pneumonia (Myers, Newman, Martin, Schrag,
2003), among others. Information networks refer to the dissemination of information
within a network; information network analysis is used mainly by health promotion
practitioners and researchers (Luke & Harrison, 2007). Researchers can use this type of
approach to explain how health information is transmitted through and to health
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consumers. An example of SNT applied to the transmission of information is the National
Cancer Institute’s Tobacco Harm Reduction Network (the only national research network
on tobacco and health disparities) and the Global Tobacco Research Network (Global
Tobacco Research Network, 2009; National Cancer Institute, 2008). Both of this
organizations use the SNT to evaluate the dissemination of anti-tobacco information and
how networks prevents health damages.
Social networks focus on how social structure and relationships (defined in terms
of social capital and social support) act to promote or influence health and health
behaviors. Social network analysis has been used, for example, to compare social support
and social capital index and its relation to the mortality and morbidity of diseases within
a community (Luke & Harrison, 2007). Finally, organizational networks consider
connections among different organizations and their impact in health services care.
Organizational network analysis differs from analyses of transmission and social
networks only in that the networks are comprised of agencies rather than of individuals.
Organizational network analysis has been used to compare public versus private health
services (Luke & Harrison, 2007).
In summary, SNT is both a methodological and theoretical framework that allows
the researcher to pose and answer important health issues from a holistic, multilevel
perspective. This theory is not considered to be reductionist, as it includes analysis of a
variety of levels (for instance egocentric level and organizational network analysis)
representing different aspects of the network, and each level has its own properties and its
specific analysis strategies. SNT was developed using a multidisciplinary approach; thus,

44
it provides a powerful model for social structure analysis and measuring how networks
impacts the health of a community.
In the drug user’s social context, egocentric network analysis can be used to
assess personal network characteristics of an individual; thus, such analysis can provide a
robust estimate of risk for HCV and HIV infection. Egocentric network analysis has been
used to show that IDU network characteristics are important in understanding risk for
infection. These studies include IDU among (a) the homeless (Latkin et al., 2009), (b)
injecting in shooting galleries (Latkin et al.,1995, 2009; Wylie, Shah, Jolly, 2006), (c)
injecting in public (Koester, Glanz, Barón, 2005; Wylie, Shah, Jolly, 2006), (d) sharing
paraphernalia (Davey-Rothwell, Latkin, Tobin, 2010; De et al., 2007b; Koester, Glanz,
Barón, 2005; Latkin et al., 2009; Rhodes & Treloar, 2008; Latkin et al., 1995); (e) poly or
multi drug use (Wylie, Shah, Jolly, 2006), (f) incarceration (Braine et.al., 2008;
Montgomery et al. 2002), (g) number times the person had been arrested (Braine et al.,
2008), (h) number of sexual partners the person has(Aitken, Higgs & Bowden, 2008;
Wylie, Shah, Jolly, 2006), (i) types of sexual practices (Aitken, Higgs & Bowden, 2008;
Junge et al., 2000; Latkin et al., 2009; Wylie, Shah, Jolly, 2006), (j) number of persons
sharing needles (De et al., 2007b; Koester, Glanz, Barón, 2005, Wylie, Shah, Jolly,
2006), (k) geographical area (Wylie, Shah, Jolly, 2006), (l) sex work (Braine et.al., 2008;
Junge et al., 2000), (m) number of person within the network (De et al., 2007b ; Koester,
Glanz, Barón, 2005; Latkin et al., 1995; Wylie, Shah, Jolly, 2006), (n) frequency of use
(De et al., 2007, 2007b; Junge et al., 2000), (ñ) years as an IDU (Aitken, Higgs &
Bowden, 2008 ) (o) network density and overlapping (De et al., 2007b; Koester, Glanz,
Barón, 2005; Latkin et al., 1995, 2009;) (p) HIV and HCV knowledge (Rhodes &
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Treloar, 2008), (q) joint purchases of drug (Koester, Glanz, Barón, 2005; Rhodes &
Treloar, 2008), (r) employment status (Davey-Rothwell, Latkin, Tobin, 2010; Latkin et
al., 2009), among others are widely associated to HCV and HIV risks. However, there
have been no studies that have examined social network characteristics in Puerto Rican
IDU networks.
HCV and HIV transmission have also been analyzed using egocentric network
analysis. Social norms theory postulates that individuals in a network will behave in ways
that are consistent with what they think others within the network believe and do
(Gottileb, 1985). This represents perception of behavior, which may be independent of
what the nodes know or the extent of their actual beliefs. Berkowitz (2004) and DaveyRothwell et al. (2010) stated that social norms theory helps explain why an IDU may
overestimate the permissiveness of networks attitudes and/or behaviors with respect drug
use. Stern et al. (1999) explained that when high density, overlapping (describing when a
node has one or more social areas or functions in common with other node during a
specific time period), and centrality are found in social networks, social norms become
stronger and individuals may act on the network’s norms for reason other than selfinterest. This phenomenon is also stronger when social support, significant interactions
and low network turnover is observed (Stern et al., 1999). Latkin et al. (2009) postulated
that once norms are established with a group, they are constantly reinforced to maintain
network infrastructure. Davey-Rothwell et al. (2010), Latkin et al. (2009), and Rhodes
and Treolar (2008) reinforce that social norms can be dynamic and new norms may
influence individuals to engage in healthy behaviors changing the network risk.
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Density
Density refers to the number of nodes that know each other within a participant’s
network. High density indicates that all or many of the nodes know each other (Tobin &
Latkin, 2009). Density is measured by calculating the ratio of observed ties to possible
ties (Luke & Harris, 2007). A tie is defined as a link between two nodes (Valente, 2010).
Within the research literature, high and low density do not have a fixed threshold;
however, typical values associated with high density are .60 – .70 or higher.
Latkin et al. (1995) reported that higher density networks (defined as density
greater than .60) among IDU were associated with more risky sexual and injecting
practices than those with lower density networks. De et al. (2007b) found that higher
density was associated with increased risk for HCV and HIV. However, Costenbader,
Astone, and Latkin (2006) found similar results for HIV risk behavior for networks with
a density index less than 0.43 (increased risk of 31%). The low density associations to
HIV risk behavior were explained as due to high turnover rates1 which tend to decrease
the density of a network; so that changes in network risks were primarily the result of
characteristics of new members entering the network that increased overall HIV risky
behaviors. Thus, the impact that density has in the HCV/HIV risks seem to be affected by
the characteristics of the network.
Tobin and Latkin (2008) reported that high density networks among MSM were
associated with increased risk for HIV infection (due to harmful injecting practices and
sexual behaviors); they found nearly a five-fold increase in risk compared to bisexual,

1

Network turnover refers to the proportion of new IDUs in the personal network during the past
month relative to the number of members in the past 6 months (De et al.., 2007).
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and gay identified men. Similarly, Paintsil et al. (2009) reported that higher density
networks among IDU were associated with higher risk of HCV.
Other authors have found a negative association between network density risk of
risky sexual practices and infection risk for blood borne diseases (Rothenberg, 2006). Suh
et al. (1997) remarked that street IDU with lower density networks (< 0.75) had a 3%
higher risk of HIV infection than those with high density (> 0.76). El-Bassel (2006)
found in a study of 2,067 participants enrolled in seven methadone maintenance therapy
programs (MMTP) that lower network density among IDU increased their sexual risk
behaviors and HIV infections 60%.
Other researchers have found no association between density and risk for
HCV/HIV transmission. Aitken, Higgs and Bowden (2008) analyzed social networks of
Vietnamese IDU living in Australia and found that they reported higher density
(connected) networks than other populations. Density was reported to be 8 times higher
than values for other groups of Asians, Philippinos, and Australians; however, the density
was not significantly associated to the prevalence or risks of transmission of HCV/HIV or
any other blood borne disease (Aitken, Higgs & Bowden, 2008). The authors did find
higher density was related to risky injecting behaviors among them than among
comparison groups. Likewise, Latkin et al. (2009) in a sample of 818 IDU in Baltimore
found that network density was not associated with increased risk related to injecting
practices.
The literature reviewed has not examined density among Hispanic IDU networks
and its relationship to risk. In addition, Puerto Ricans islanders have not been studied
using social network analysis. Therefore, a gap in the literature remains in this area.
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Homophily
Shaw et al. (2007) found in their study of syringe sharing among IDU that
network homophily (similarity of characteristics among network members; also referred
to by some authors in terms of heterogeneity) was associated with decreased risky
injection behaviors. Latkin et al. (2009) compared four groups with different sex and
injecting behaviors and concluded that those reporting networks with highest
heterogeneity in behaviors and structure had higher risks of becoming infected with
HCV/HIV. Tucker et al. (2009) reported that high heterogeneity networks increased risk
of blood borne disease among homeless women.
Similarly, Tobin and Latkin (2008) showed that higher age, as well as gender
heterogeneity, in the network increased the injecting and sex risk behaviors among MSM.
Rothenberg (2006) found that gender and age heterogeneity in a network increased blood
borne diseases. Rothenberg explained that networks for homosexual and bisexual IDU
with high homophile increased their risks for HIV. This increased risk by gender is also
documented by Latkin et al. (1995). Other studies found that employment (Braine et al.
2008; Latkin et al. 2009, 2009a), homelessness (Braine et al. 2008; Koester, Glanz &
Barón, 2005; Latkin et al. 2009; Tucker et al., 2009), type of relationship and/or marital
status (Latkin et al. 2009, 2009a; Tucker et al., 2009), educational level (Costenbader,
Astone & Latkin, 1995; De et al., 2007; Latkin et al., 1995, 2009,2009a; Wylie, Shah and
Jolly, 2006), overdosing (De et al., 2007), pooling resources for drug acquisition
(Koester, Glanz & Barón, 2005), imprisonment and arrests history (Braine et al., 2008;
Latkin et al., 2009), injecting in public places (De et al., 2007a; Latkin et al., 1995;
Paintsil et al., 2009; Wylie, Shah and Jolly, 2006; De et al., 2007), injection frequency
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(Aitken, Higgs & Bowden, 2008; Latkin et al., 1995; De et al., 2007; Paintsil et al., 2009)
and years injecting (Aitken, Higgs & Bowden, 2008; De et al., 2007, 2007a; Latkin et al.,
1995, 2009; Paintsil et al., 2009; Wylie, Shah and Jolly, 2006) among IDUs were related
to higher risks of HCV/HIV infections.
Propinquity
Wylie, Shah, and Jolly (2006) found in a Canadian study that IDU whose
networks consisted of members who live in the same geographical area (in this study, by
zip code) were at increased risk for HCV/HIV infection. The authors reported that
shooting galleries are high risk environments for blood borne diseases in that they
increase risks for exposure to contaminated equipment (syringes and other sharp objects)
left in the floor; galleries serve as a bridge from infected IDU to uninfected IDU.
Rothengerg (2006) explained that geographical location plays a crucial role in the
distribution of a disease within a community, even when geographical areas distance is
low. He also argued that geostatistical approaches using areas such as domicile, public
places and other clusters could explain the risks of transmission of a disease.
Braine et al. (2008) also argued that IDU sharing a geographical space (zip-code)
also share similar risk factors for blood borne disease. Braine et al. show in their study
that sexual and injecting practices are more similar among those within a geographical
area than those with different areas that accidentally share the location for injecting or
making a sexual transaction.
Shaw et al. (2007) showed that Canadian IDU who injected in hotels increased
their risk of infection with HCV/HIV by 2.36 times compared to other injecting places
(not including shooting galleries). The authors also found that those who injected in
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shooting galleries did not have a significant increased risk of infection in comparison
with those who did not. On the other hand, those who reported injecting with other IDU
practiced more risky behaviors than those injecting alone (not joining an injecting
network). Kang et al. (2005) studied Puerto Ricans living in the continental United States,
and on the island. The researchers reported significant differences in drug use, HIV
status, and sexual behaviors based in geographical location (mainland versus the island)
during the time of the study. Interestingly, participants reported changes in risk
behaviors after changing their location (mainland versus the island), which also impacted
their social networks. The participants of the study reported changes in network structure
(overlapping, gender, size, race/ethnicity, age, and drug use patterns); risk
communication about HIV/AIDS, sex lives, and condom use; social norms; and selfefficacy. All participants self-identified as Puerto Rican, and those behavior changes
were significantly altered only by changing location (to or from mainland versus the
island), even when the change was recently done. These results are similar to those found
by Delgado et al. (2008) who studied the acculturation phenomena of Puerto Ricans
moving to Massachusetts. In this case islanders were 2.1 times more likely to participate
in risky injecting practices than those in mainland.
Thereby, propinquity measures could be measured by zip code, geographical
location (latitudes), or apartment location.
Network Structure: Turnover, Overlapping, and Network Size
Latkin et al. (1995) examined network structure in relation to drug related HIV
risks. They found that lager networks were associated with increased injecting risk
behaviors. On average, larger drug networks were associated with more needle sharing
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behaviors. Authors explained this finding by positing that individuals with larger
networks are more likely to have a needle sharing partners in their network. Suh et al.
(1997) found similar results in their study among street injection drug users in the US.
Those IDU with larger networks, and who had more persons in the network who they
reported not providing social support were 2.13 more likely to inject in public places (i.e.,
shooting galleries). Researchers also described that those with larger drug networks who
also had reported more social support from sexual partners and/or other IDU had
increased risk of sharing needles than those without.
El-Bassel et al. (2006) completed a social network profile of IDU in New York,
and showed the relationships with HIV sexual risks practices. The authors’ findings
showed that those with larger networks had more risky sexual practices (more than one
sexual partner, had traded sex for drugs or money, or had sex with an HIV positive
person). Costenbader, Atone and Latkin (2006) found in a United States sample that
increased network size and turnover (the proportion of new IDU in the personal network
during the past month relative to the number of members in the past 6 months) resulted in
increased risky injection practices by a factor of 1.3. This study specifically included
turnover as a factor, and the authors showed that turnover increases rather than decreases
risky injecting behaviors.
De et al. (2007) showed in a Canadian sample that increased turnover, network
size and nodes overlapping increased the risk of HCV/HIV infection by a factor of two
among IDU. De et al. (2007b) explained that lager network size provides more
opportunities for using contaminated equipment; large network size also tends to be
associated with higher turnover and thus more unstable networks. Turnover can also be
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increased as higher network size includes positive HCV/HIV persons, and many quit the
network as a protective measure2. It is also hypothesized that overlapping function
creates close social bonding (stronger ties) that promote unsafe injecting practices and
sexual behaviors among IDUs.
Aitken, Higgs and Bowden (2008) found different results. In their study of
Vietnamese living in Australia, they did not find that the increase in network size or
turnover rates were related to the risks of blood borne infection. Paintsil et al. (2009), in a
study conducted in Russia, did not find an association between network size, turnover, or
overlapping and increased risk of blood borne transmission either. No information
regarding Hispanics network size, overlapping or turnover could be identified in the
literature reviewed.
Nodes Distance and Centrality
Only one article was found that examined the relationship between node distance
and / or centrality and IDU blood borne transmission risk. Bell, Atkinson, and Carlson
(1999) demonstrated that HIV transmission is impacted by the centrality of an individual
within the network. The authors stated that degree of centrality, power/prestige, and
eigenvector centrality3 are the best predictors of HIV infection among cocaine injecting
drug users4. However, it seems that centrality measures have not been fully explored

2

Network turnover refers to the proportion of new IDUs in the personal network during the past
month relative to the number of members in the past 6 months (De et al.., 2007).
3
Is a measure of the relevance a node has in a particular network (Bonacich, 2007)
4
Centrality is the importance or prominence of a given actor or node, and is measured by one or
more of the following measures (a) Betweenness (extent to which a node lies between 2 nodes that would
not otherwise be connected); (b) Closeness (how close an actor is to all other actors on the basis of distance
between nodes); (c) Degree (extent to which an actor is connected to others; the simplest of centrality
measures); (d) Prestige (specifically for directed networks; extent to which other members chose a given
actor or node) (Luke & Harrison, 2007).
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among IDU, particularly among Hispanic IDU. In order to better assess centrality and
node distance and how it relates to disease transmission other populations and diseases
were explored.
Christely et al. (2005) measured centrality to estimate individuals’ risk of
infection. The researchers performed a simulation study in which susceptible-infectiousrecovered models were used. Researchers found, based on results from the computer
simulation models, that centrality measured by the number of contacts, random-walk
betweenness (proportion of times an individual lies on the path between other
individuals), shortest-path betweenness (the proportion of times an individual lies on the
shortest path between other individuals), and farness (the sum of the number of steps
between an individual and all other individuals) did impact the risks of infection for an
individual. That is, the higher the centrality, the higher the risk of infection. The authors
also noted that the time for an individual to become infected by an infectious agent
during an outbreak is shorter when the centrality is higher. However, Bell, Atkinson, and
Carlson (1999), found that this centrality measures were neither precise nor specific for
HIV transmission among IDU.
On the other hand, Gundlapalli et al. (2009) described how centrality impacts the
risk of infection among health care workers and patients in healthcare setting. The data
showed that there were no increased risks for health workers of becoming infected based
on centrality measures. The findings of Hawe and Ghali (2008) are consistent with those
of Gundlapalli et al. (2008) in that centrality does not appear to have a net effect in the
transmission of the disease.
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Literature on Review of Methods
The literature reviewed in the study shows that injecting drug use has not been
frequently assessed using social network theory in Hispanic IDU populations. Several
methods have been found for assessing drug use but very few of those using social
network analyses were based on theory. Most literature involving social networks among
IDU has used quantitative approaches rather than qualitative or mixed methods. The
majority of the researchers used a cross-sectional study design involving egocentric
social network analysis, which only provides data about the prevalence of the behaviors
while not focusing in its causes (Costenbader et al., 2006; El Bassel et al., 2006; Shu et
al., 1997; Wylie, Shah, & Jolly, 2006). However, a cohort study design was performed by
Hagan (1999) and one case-control design (intervention) was addressed by Latkin
(2009a). Egocentric social network analysis is the strategy being employed in the current
study.
Social network analysts have commonly used an egocentric approach. However,
the egocentric approach does not provide an independent validation of the behaviors of
IDU in the risk network (Braine et al. 2008; Shaw et al., 2007; Wylie et al., 2006; Yeonkang et al., 2005). Also, in egocentric approaches, the time periods studies are typically
limited to the past 30 days. This might have brought bias to the study, as individual
behaviors are explored (typically) for the previous 6 months (Latkin et al. 2009, 2009a;
Wylie et al., 2006).
Other researchers have reported the use of self-report of the networks, which also
might influence participants' responses due to social desirability (Costenbader et al.,
2006; Kang et al., 2005; Shu et al., 1997). This, in conjunction with the truncated
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network report (using only part of the network nodes reported), tends to introduce bias
into the studies (Kang et al., 2005, Shaw et al., 2007, Wylie et al.; 2006). Also,
researchers have used non random sampling techniques that limit their power to
generalize results (Latkin et al., 2009a; Shaw et al., 2007; Shu et al., 1997); others have
also reported that participants have refused to participate (El Bassel et al., 2006), which
also creates bias.
In general, the methods for assessing social networks seem to be rustically
designed among different studies. The measures differ from one study to another; the way
questionnaires are administrated or the basic scales are different. This can create
differences in interpretation of the findings across studies. There have not been found a
consensus among researchers in respect of social network questionnaire and how to
delimit the frontiers of subject instrument in order to standardize social network
assessment. There are still challenges for researchers conducting social network research
for instance sample size (how far in the network should be gone?); network size (how
many persons should be taken in consideration for egocentric analysis?), and time frame
of the questions (Should questions go one or six months back in time?). Also, the use of
qualitative or mixed methods was not used in any of the reviewed studies. This approach
could be very useful to more clearly understand the qualitative nature of networks and
risk.
In summary, literature reviewed shows that IDU networks among Hispanics have
not been widely studied using social network analysis. In addition, literature has also
showed that Puerto Rican islanders IDU have different injection practices than those
living on the mainland, other Hispanics, or non-Hispanics whites. Therefore, the study
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will contribute to understand Puerto Rican islanders’ social networks and what
characteristics are more likely to be related to risky behaviors for HCV/HIV and selfreported serum status. Last, there is scare literature that allows proving the effectiveness
of NEP on Puerto Rican Islanders’ IDU, and this study will contribute to that
understanding.
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Chapter 3: Research Method
Introduction
This chapter includes a detailed description of the methods of this exploratory
study, whose purpose was to assess the characteristics of social networks of Puerto Rican
injecting drug users and their implications for blood-borne virus transmission. The
chapter is composed of the sections on the following topics: (a) the study design; (b) the
method of sample selection; (c) the sample size; (d) the participants’ demographics; (e)
the assessment instrument; (f) the research question and hypothesis; (g) data analyses for
testing the hypotheses, (h) procedures used to ensure protections for participants; and (i)
summary of the information presented in the chapter.
Research Design and Approach
Egocentric network analysis involves analysis of data concerning a participant’s
acquaintances at a given point in time. This enables researchers to assess how network
characteristics, as reported by the participant, influence the participant’s behavior. Data
obtained concerning an egocentric social network includes descriptions of members of
the network surrounding the individual (i.e., kinds of persons and roles played), network
size, the strength of the relationships between the participant and members of his or her
networks, content and extent of communication between the participant and network
members, and personal network-related exposures. Egocentric network questionnaires
differ somewhat from simple surveys in that these questionnaires are focused not solely
on the attributes of the respondent, but also on the respondent’s social network. The
egocentric approach is based on information provided by the participant about his or her
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social network members; this differs from sociometric approaches in which the ego and
all his altars are directly interviewed (Tieu, 2015).
Cross-sectional studies can provide understanding of the status of the disease
under investigation at a precise point in time (Aguilar et al., 2003; Silva, 2000).
Moreover, cross-sectional designs are useful in the identification of a community profile
regarding risk factors. In comparison to longitudinal study designs, which can also be
used, cross-sectional designs bring the advantages of low budget and short time period
evaluations. It is also important to note that social network analysis is important because
it facilitates the analysis of the influences on risk practices of those perceived to be close
to the participant. Given that the aim of this study was to describe and analyze
characteristics of Puerto Rican IDU social networks that are related to engagement in risk
behaviors within a specific time point, a cross-sectional study using social network
analysis was the best epidemiological design to accomplish this objective and intentions
under time and budget constraints.
Setting and Sample
Iniciativa Comunitaria, Inc. (ICI) was incorporated as a nonprofit, communitybased organization in April 1992. ICI has been a tax exempt agency under the 501 c (3)
code since 1993. ICI has 16 years of experience providing health-related services to the
community. The organizational mission is to develop innovative models of clinical,
direct, and preventive services accessible to the most unattended and underserved
populations affected by the HIV/AIDS epidemic. These include drug users, those who are
homeless, sex workers, sex partners of drug users, teenagers, and HIV-positive persons.
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ICI actively participates in the formulation of public policy that benefits the target
community. As a community-based organization (CBO), ICI offers services that have
been developed and sustained by community members who also comprise the staff and
volunteers. This component has been essential for responding effectively and efficiently
to the cultural and social needs of the target population.
Currently, ICI has been recognized at the local, national, and international levels
as a pioneer grassroots agency with aggressive strategies to provide HIV prevention
programs as well as direct services for underserved and unattended populations highly
affected by the HIV/AIDS epidemic. The organization has developed experience in such
areas as (a) counseling services before and after HCV/HIV testing; (b) primary care
services; (c) group counseling; (d) preventive case management; and (e) other support
services that target special populations such as IDU, women, and adolescents. Newly
added services include rehabilitation and treatment for female IDU, services for the
homeless, and peer educator programs.
Syringe Exchange Programs
For more than a decade, data have consistently demonstrated that access to sterile
needles and syringes is an important component of a comprehensive HIV prevention
program (Braine et al., 2008; Hurley, Jolley & Kaldor, 1997; Vlahov & Junge, 1998). In
addition, studies have shown that syringe exchange programs (SEP) have the potential to
decrease HIV transmission directly by lowering the rate of needle sharing and the needles
available for reuse, as well as indirectly through activities such as bleach distribution,
referrals to drug treatment centers, provision of condoms, and education about risk
behavior (Hurley, Jolley & Kaldor, 1997; Vlahov & Junge, 1998). ICI offered the first
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SEP in Puerto Rico (Punto Fijo), which serves the IDU population. Essentially, SEPs
provide sterile syringes in exchange for used syringes to reduce transmission of HIV and
other blood-borne infections associated with reuse of contaminated syringes among IDUs
and enable safe disposal of used syringes. Often, SEPs provide other public health
services, such as HIV testing, risk-reduction education, and referrals for substance abuse
treatment.
Punto Fijo (PF) is currently working in the San Juan and eastern areas of the
island to provide street outreach, preventive case management, and HIV testing and
counseling. The program goal is to reduce HIV incidence among IDU 18 years of age and
older using a harm reduction perspective. PF offers services using three basic modalities:
(a) walking routes (outreach via foot), (b) vending machines, and (c) syringe exchange
rooms.
From July 2009 to March 2010, a total of 4,473 IDU participated as new clients of
the program; these were in addition to 5,424 follow-up IDU clients in the San Juan and
East areas. Over 4,000 syringes were exchanged, and similar quantities of prevention kits
(band aids, hygiene material, and prevention information) were distributed. Also, PF staff
offered over 8,000 orientation sessions about harm reduction strategies and HIV/STD and
other blood-borne diseases; PF distributed 1,300 brochures well as other health education
materials. In addition, PF provided approximately 890 meals to its participants. By 2010,
PF had registered over 154,848 exchange interventions; however, over 85% of the
interventions involved IDU 30 years of age or older.
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Sample
Data were gathered from selected participants of nine needle exchange sites in
Puerto Rico. A random number table was used to select a number (eight) from one to
nine, and every eighth person waiting in line to exchange syringes was approached in
order to determine study eligibility according to the inclusion criteria described below. A
total of 22 participants were selected from each of the nine centers to ensure that there
were 191 participants. Face-to-face interviews were conducted during daylight hours at
each site to maximize the representativeness of NEPs’ participants. Participants were
included in the study after exchanging needles if they met the criteria and were interested
in the research study. If they responded “yes,” I assured that all inclusion criteria were
met; thereafter, information regarding the project was provided. After all questions were
answered by participants regarding the procedure and their understanding was assured,
the interview was conducted. The interview took approximately 45 minutes and was
conducted by me in a separate area within the facilities provided by ICI. After interview
completion, the participant had the syringe exchange service provided and was not
contacted again by me.
Eligibility criteria. To be considered eligible to participate in the study,
participants had to be active injection drug users about to make an exchange who had
used the syringe exchange services on at least one occasion prior to the present time.
Participants were required to self-report at least two instances of illicit injection drug use
in the past 6 months (they were asked how many times they have used illicit injection
during that time frame) to participate. To verify evidence of injection drug use, all
participants were asked to show injection marks on visible areas of the body such as the
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arms, legs, and neck. Participants were required to be at least 21 years old and capable of
understanding the invitation to participate.
Participant demographics. Preliminary studies conducted at PF suggested that
the median client age was approximately 32 years (range 20 to 60 years; Dávila-Torres &
Reyes-Ortiz, 2010). The majority of clients were male (90.9%). Previous reports had also
shown that the median number of years that participants reported having injected drugs
was 10 (range 1 to 29 years) and that the median injection frequency was 8 times/day
with a range between 2 and 30 times/day.

Sample Size
The sample size of nodes required to provide information on the networks was
determined using the following cross-sectional formula reported in Aday and Cornelius
(2006). The formula states that
[Z21-alpha/2 * p * (1-p)] / d2; where
d=precision
Z=1.96
p=the probability of exchanging needles or paraphernalia5
1-p=the complement of p
Therefore,
[(1.96)2 * (.15) * (.85)] / (.05)2
= 190.82 ~ 191 participants

5

Observational data collected by Dávila-Torres and Reyes-Ortiz (2010) in this specific
population.
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To achieve 191 participants, it was estimated that approximately 636 persons
would need to be contacted; however, 506 participants were contacted to obtain the
sample. This represented a 36% participation rate based on a sample size of 181. This
percentage was very close to the original 30% response rate expected from ICI’s
participants. The original estimate of 636 persons was obtained by inflating the sampling
number using the following formula: n/RR, where n=sample size and RR represents the
expected response rate [191/.30=636].
Instrumentation and Materials
The instrument used in the research was a modified version of one published by
Wyllie (2006). The questionnaire was divided into three sections. The first section
(DEM1 – DEM22) addressed sociodemographic data, including age, age of initiation of
injecting drug use, gender, level of education completed, main source of money for
living, nationality, type of residency, and zip code. Modifications in this section included
questions regarding incarceration and arrest history as well as HCV/HIV serostatus.
The second section represented a modification to the instrument used by Wyllie
(2006). This part incorporated questions from the Blood Borne Virus Transmission Risk
Assessment Questionnaire (BBV-TRAQ) developed by WHO (2011). The purpose of the
inclusion of the BBV-TRAQ is to quantify the degree of exposure of injecting drug users
to blood-borne infections. BBV-TRAQ includes questions for the respondent regarding
specific injecting, sexual, and other risk practices reported in the last 30 days. For
instance, information collected in the BBV-TRAQ includes needle and syringe
contamination, injecting equipment sharing, contamination by a second person, and
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sexual practices. In addition, four questions were included regarding syringes’ sources,
for a total of 35 questions.
The third section included social network questions. Participants were asked to
think back over the last 30 days about the people with whom they had had more than
casual contact. These were people whom they had seen or had spoken to on a regular
basis. Most of these close contacts were people such as friends, family members, sex
partners, people they injected drugs with, or people with whom they lived. If additional
prompts were needed, participants were provided additional information. For example,
they were told to think of people with whom they had used drugs or had sex during the
past 30 days. If the participant was a sex worker, he or she was asked to list a maximum
of 10 sex partners. If the participant had a regular sex partner or partners, he or she was
asked to include the partner(s) on the list. Participants were also prompted to think of
friends, relatives, and other individuals whom the participant felt close to, lived with, or
hung out with. All network members were identified using initials or nicknames to assure
anonymity. Participants were able to name up to 20 persons within their network (Valente
& Vlahov, 2001); however, participants could provide more names if needed. For each
network member, the participant was asked to identify whether the person in the network
(Questions 1-7 on the network survey) had done the following: (a) injected drugs in the
last 6 months; (b) smoked/snorted/inhaled drugs (other than marijuana) in the last 6
months; and (c) been a sex partner of the participant in the last 6 months. For each
member of the network, the following additional information was requested: (a) gender,
(b) age, and (c) type of relationship (family member, lover, spouse, girl/boyfriend, friend,
acquaintance, or stranger; Braine et al., 2008; Wylie, Shah, & Jolly, 2006).
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The next set of questions included those related to interactions among each of the
network members. I asked, for each member of the network, whether that person knew
the other network members. The result was a matrix (see Appendices C and D, Social
Network Survey section) used for data analysis, from which density was calculated.
Next, the characteristics and interactions of the first five persons named in the list
were explored in depth with additional questions on the survey. Researchers have
demonstrated that the first three to six persons on the list are the most significant persons
in a network, and they have recommended using this core network for deeper network
analysis (Bell, Belli-McQueen, & Haider, 2007; Braine et al., 2008; El-Bassel et al.,
2006; Kang et al., 2005; Shaw, et al., 2007; Suh et al., 1997; Valente & Vlahov, 2001;
Wylie, Shah, & Jolly, 2006). Valente and Vlahov (2001) found that the first two named
network members are more likely to be engaged in any kind of risk behaviors than those
named thereafter. Researchers have also found that providing more than five or six names
can make the survey too long, which introduces recall and maturation biases, especially
when working with hard-to-reach populations (Bell, Belli-McQueen, & Haider, 2007;
Valente, 2010). Researchers have recommended that participants name all persons they
can (which averages 15 to 20 network members) to yield a measure of the total network
size. Thereafter, full SNA can be performed with the most significant members of the list.
Therefore, following these recommendations, detailed questions pertaining to the first
five network members were collected from participants. This information allowed for
indirect assessment of ties, accepted social norms, intimacy, injecting drug behaviors,
sexual behaviors, and the type of relationships these persons shared with each of the
members of the network, among others that are described in the variable section below.
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Translation. A translation of the questionnaire was made into Spanish by a
translator, and back translation was performed from Spanish to English by an
independent translator. Quality of the translation was assured by a panel of experts who
assessed the equivalence of the content. These experts were obtained from among the
bilingual personnel working at the CBO.
Reliability and Validity
Wylie stated that the instrument he used in his research did not have demonstrated
reliability or validity (personal communication, September 20, 2010). The BBV-TRAQ
had been shown to have adequate internal reliability (Cronbach’s alpha) in its English
version (α=.74 – 0.84; Fry & Lintzeris, 2002; Stoové & Fry, 2006). The test-retest results
of the instrument were high (r=0.84; Fry & Lintzeris, 2002). However, there was no
information regarding the reliability or validity coefficient for Spanish translations;
neither of the WHO persons contacted had been able to provide this information
(personal communication, January 8, 2010).
Definition of Operational Measures
An operational definition consists of a summary of measures that indicates how a
concept is made measurable (Reynolds, 1986). An operational definition includes the
dependent, independent, and dummy variables. Dummy variables are considered
categorical dichotomous variables recoded as either 0 or 1 value. A 0 recode refers to
lack of the attribute, and 1 indicates presence of the desired attribute. In general, dummy
variables facilitate the use of multivariate statistical analysis as a decision tool. Dummy
variables are known as design variables, Boolean indicators, or proxies elsewhere
(Garavaglia & Sharma; 1998). In addition, dummy variables as used in regressions aid in
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accounting for how a factor impacts the dependent variable, diminishing errors and
avoiding a biased assessment of impact.
The operational definitions are explained in detail in Appendix B including the
Spanish translations. The operational definitions for variables included in this study are
the following:
Injecting Drug Risk Index
Injecting drug risk was measured by the sum of variables NeSyrCo1 to
2PerCo15b; each had a scale value of 0 to 5 points. This sum was made after recoding
according to the accompanying protective factors validated by Stoové, and Fry (2006).
The validated document determined that risk practices are recoded to the lowest value (0)
whenever the associated protective practice question (part b) scored a 4 (“Every time,”).
Maximum possible value is 215 points (scoring 5 for all 15 items). In the scale, higher
scores represent riskier behavior associated with IDU. Stoové, and Fry’s validation of the
scale considered scores higher than 56 points (25% or more) to be high risk behavior
scores (Stoové, & Fry, 2006). Thus, in the present study, this demarcation was
maintained to differentiate among low and high risk injecting practices.
Sexual Behavior Risk Index
The sexual risk behavior index was created by summing variables SexPra17 to
SexPra22, each of which is measured on a scale ranging from 0 to 5 points. Maximum
possible value was 35 points. In the scale, a higher score represents riskier behavior
associated with sex risk.
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Closeness
Closeness was measured using three different measures. Each of the three
measures was entered separately in GEE analyses. These measures were:
Psychological Closeness was measured using questionnaire item INT1 (“How
close are you to [person]”?) that measures the closeness of the participant to
others in the social network. Responses for all individuals in the participant’s
network were summed and then divided by the size of the social network to get an
average score for psychological closeness. The higher the score, the closer the
participant feels on average to the people in the social network.
Frequency of Contact was measured using questionnaire item INT2 (“How
frequently would you say you have contact with [person]?”) Responses for all
individuals in the participant’s network were summed and then divided by the size
of the social network to get an average score for frequency of contact. The higher
the score, the more frequently on average the participant has contact with the
people in the social network.
Trust was measured using the sum of items INT3 to INT10 to create an index that
assesses the extent to which the respondent would rely on this person for a
number of things (one example question is, If I had an emergency this [Person]
would be there for me). Items INT3 to INT10 were summed and divided by 8 to
provide an average index score. The index score was then summed across
network members and divided by the size of the network, thus resulting in an
average trust score. A higher index score represents a higher degree of trust.
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Geographical Insularism
This is a measure of physical proximity that was constructed using the zip code or
barrio name provided by the ego from his geographical location and the geographical
location of his/her altars. The participant provided either zip code or barrio where he/she
spent most of the time and the zip code or neighborhood where the altars spent most of
their time. If the participant and all network members report the same zip code or barrio,
the variable is coded as 1; otherwise, it was coded as zero.
Density
Density is the degree to which a person’s network members are connected to one
another (Tieu, 2015; Valente, 2010). This was operationalized using a matrix that
indicated whether each network members, as reported by the participant, knew the others
in the network. Density was calculated by summing the degree to which each of the altars
is connected to others in the personal networks. The formula DE=l/N(λ) (where l=number
of links N=network size, and λ=maximum numbers of nominations requested) defines the
mathematical analysis that allows measure of density in a network. For instance, if a node
has 7 links, his/her network consists of 15 persons, but it was requested to nominee 20
persons then the equation would be 7/(15*20) (where l=7, N=15 and λ =20) (Valente,
2010). Density could vary from 0 to 100% whereas the higher the number the higher
density.
Network Size
Network size is a continuous variable and defined as the sum of reported network
members. This measure was obtained from a list generator question in which the
participant was asked to mention the names of those people closer to him. The list
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provided for generating up to 20 people although if the participant had more it was
provided additional space for it.
Relationship Type
In the original survey, this is a nominal variable with 4 categories (F=family
member, L=lover, spouse, girl/boyfriend, R=Friend, C=Acquaintance/Stranger). For each
member of the network, the participant was asked to provide the nature of the
relationship. For each of the 4 categories, a code of 1 was assigned if those specific
relationships were reported. Thus, for a given participant, the value of each of the 4
variables could range from zero to a maximum corresponding to the size of the network.
This was then entered into analyses as a continuous variable.
Personal Network Exposure
Personal network exposure was assessed using four measures. Each of these
measures were entered separately in the GEE analysis. These measures were:
Network Members Frequency of Injection was measured using the questionnaire
item CDR1, which explored knowledge regarding network injecting practices in
the last past month. Theoretical range was 0 to 4; a higher value indicates a higher
frequency of injection by the network member (as reported by the participant).
Responses for all individuals in the participant’s network were summed and then
divided by the size of the social network to get an average score for frequency of
injection.
Years Network Members Had Injected was measured using the questionnaire item
CDR2. CDR2 item explored length of time network members had been injecting
drugs. This was an open-ended question in which participant provided the number
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of years as a continuous variable. Responses for all individuals in the participant’s
network were summed and then divided by the size of the social network to get an
average years injected. The highest the score the highest the personal social
network exposition to blood borne virus the participant had.
Pooling money with Network Members was measured using the questionnaire
item CDR3, which explored the frequency in which people in the network
combined or pooled money to buy drugs or injecting equipment as reported by the
participant. The theoretical range was 0 to 6; higher scores indicated higher the
frequency of the behavior. Responses for all individuals in the participant’s
network were summed and then divided by the size of the social network to get an
average score for frequency of pooling money for drugs.
Social Network Exposure was measured by creating an index by adding the
responses of questions CDR4 to CDR9, each ranging from 0 to 4. Responses for
all individuals in the participant’s network were summed on these items; the index
scores were then summed and divided by the size of the social network to get an
average score for social network exposure.
Data Collection and Analysis
The data were entered using Access software at the time participants answered
each question. Participants were approached to complete the survey. Those who were not
able to finish at one session were given a follow up appointment in accordance with ICI
NEP protocols. Those who did not attend the follow-up session were eliminated from the
sample. This helped minimize the quantity of errors during data entry and also helped in
clarifying data that could be missing or incorrect in the process.
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The data were checked during and after the interview and prior to data analysis in
order to assure quality. Van de Broeck, Argeseanu, Cunningham, Eeckels, and Herbs
(2005) described the data cleaning process as a two-phase process including (a) screening
and diagnosing, and (b) treating. The screening and diagnosing phase assures completed
questionnaires were entered in the database correctly after the interview. Also, screening
and diagnosis allowed the identification of patterns of missing data or inconsistencies in
data values (such as wrong numbers or codification).
Prior to the data analysis, spot checks of 40 randomly selected questionnaires
(20% of the sample) were completed to ensure quality. Any errors identified or
inconsistencies not due to incorrect data entry as in the case of missing values or outlier
values were examined. If the amount of missing data is not negligible, multiple
imputation procedures should be used to replace missing data (Rubin, 1996). According
to Schafer (1997) single imputation methods treat imputed values the same as the
observed ones, whereas multiple imputation is a device for representing missing-data
uncertainty. Multiple imputation techniques are more attractive for exploratory or multipurpose analyses involving a large number of variables. In addition, as part of the quality
process outliers were evaluated to test assumptions and to determine if a manipulation of
values was needed. More specific information on missing data analysis is provided in
Chapter 4.
Data Analyses
Data analyses were conducted using STATA (Version 12.0). A probability value
p < .05 was used as the standard for significance (unless corrected using Bonferoni
techniques as described below). Univariate analysis included descriptive data for each of
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the key variables. Bivariate analysis of the data included Spearman and Pearson
correlations tests and t-tests as appropriated to variable distribution and type. In the case
where the data were not normally distributed, non-parametric tests were considered.
Research Questions and Hypotheses
There were two research questions. Key research (alternative) hypotheses
associated with each research question were reported. Detailed statistical tests were
included as an appendix showing dependent, independent and appropriate statistical tests
as per hypothesis question.
Research Question 1: What are the relationships among personal network
measures and high risk sexual and injection drug behavior?
Ho1-1: Social network characteristics (Closeness [Psychological Closeness,
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size;
Relationship Type; Personal Network Exposure [Network Member Frequency of
Injection, Years Network Members had Injected, Pooling Money with Network
Members, and Social Network]) do not contribute unique explained variance in a
measure of sexual risk behavior, as measured by the Sexual Risk Scale score from
the BBV-TRAQ instrument, in a regression model.
Ha1-1: Social network characteristics (Closeness [Psychological Closeness,
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size;
Relationship Type; Personal Network Exposure [Network Member Frequency of
Injection, Years Network Members had Injected, Pooling Money with Network
Members, and Social Network]) contribute unique explained variance in a
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measure of sexual risk behavior, as measured by the Sexual Risk Scale score from
the BBV-TRAQ instrument, in a regression model.
Ho1-2: Social network characteristics (Closeness [Psychological Closeness,
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size;
Relationship Type; Personal Network Exposure [Network Member Frequency of
Injection, Years Network Members had Injected, Pooling Money with Network
Members, and Social Network]) do not contribute unique explained variance in a
measure of injecting risk behavior, as measured by the Injecting Risk Behaviors
scale score from the BBV-TRAQ instrument, in a regression model.
Ha1-2: Social network characteristics (Closeness [Psychological Closeness,
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size;
Relationship Type; Personal Network Exposure [Network Member Frequency of
Injection, Years Network Members had Injected, Pooling Money with Network
Members, and Social Network]) contribute unique explained variance in a
measure of injecting risk behavior, as measured by the Injecting Risk Behaviors
Scale score from the BBV-TRAQ instrument, in a regression model.
Research Question 2: What are the relationships among social network
characteristics and self-reported HIV and HCV status?
Ho2-1: Social network characteristics (Closeness [Psychological Closeness,
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size;
Relationship Type; Personal Network Exposure [Network Member Frequency of
Injection, Years Network Members had Injected, Pooling Money with Network
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Members, and Social Network]) do not correlate with the self-reported HIV and
HCV status, in a regression model.
Ha2-1: Social network characteristics (Closeness [Psychological Closeness,
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size;
Relationship Type; Personal Network Exposure [Network Member Frequency of
Injection, Years Network Members had Injected, Pooling Money with Network
Members, and Social Network]) do correlate with the self-reported HIV and HCV
status, in a regression model.
Due to the number of hypotheses developed in this study, there is the possibility
of increased Type I error when performing the statistical analysis. To reduce this
possibility, the Bonferroni adjustment (Logan, & Rowe, 2004) was used. This technique
is used to maintain the experiment wise error rate to a significant level specified. The way
it was done for this study was to divide the significant level by the number of
comparisons dictated by the hypotheses. In addition, multivariate statistics were adjusted
for individual socio-demographic characteristics to assure network contribution to riskier
behaviors.
For all hypotheses, multivariate analyses were performed using generalized
estimating equations (GEE). Adamis (2009) defined GEE as an extension of linear
models capable of estimating population-averaged estimates even with repeated
measurements in the dependent variable. As participants can select several members in
their networks, data violate the assumption of independence required for multiple
regression; GEE allows for analyses with correlated data.
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GEE is a semi-parametric method that works with population averages in cases
where normal linear regressions cannot be applied (Adamis, 2009; Carbonari, Writz,
Muenz, & Stout, 1994). GEE is a flexible method for analyzing different numbers of
observations and variable types simultaneously. Interval, dichotomous, ordinal and
categorical variables can be used in GEE to assess the relationships between dependent
(network characteristics) and independent (risky sexual practices and risky injecting
practices) variables (Carbonari, Writz, Muenz ,& Stout, 1994). GEE assumes that
variance is a known function of the mean and requires specifying (a) the link function (b)
the working correlation matrix and (c) a method for estimating the variance-covariance
matrix (Katz, 2006).
The link function is the type of model used to fit the data, which in this research
will be a linear model (Adamis, 2009; Carbonari, Writz, Muenz, & Stout, 1994). This
assumes that the independent variable fits the Gaussian distribution. The correlation
matrix for this research was the exchangeable working correlation matrix, which assumes
that any two observations within a cluster have the same correlation used when
observations are not independent (Adamis, 2009). Finally, the method for estimating the
variance-covariance matrix is the model-based estimated as cluster, since there were less
than 20 cases per altar (Horton & Lipsitz, 1999).
The GEE equations tested whether the social network characteristics (size, outdegree, density, tie strengths, type of relations, personal network exposure, and
propinquity) explained variance in self-reported HIV and HCV status, sexual risk
behavior, and injecting risk behaviors.
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Protection of Human Participants
The participants answered a structured interview conducted by a trained
interviewer. All participants selected from lines in the exchange programs were brought
to a private area for the interview. The interviewer read to the respondent a statement
approved by the University of Puerto Rico, Medical Sciences Campus that explained the
purpose of the study, methods, and the measures taken to assure confidentiality of the
information given by the respondent and the voluntary participation in the study.
All questionnaires were confidential and had a serial code to avoid identification
of the participants. In addition, all the data collected is kept in a secure place with limited
access to general public in order to assure the confidentiality of data. A database
containing questionnaire data was used by the PI. The PI assured that no participant
could be identified.
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Chapter 4: Results
The purpose of this exploratory quantitative study was to describe how social
network characteristics of Puerto Ricans participating in a needle exchange program
related to personal engagement in risk behaviors. Risk behaviors included substance use
and sexual behaviors associated with transmission of HCV/HIV. Egocentric network
variables were analyzed in regressions to explain the relationship between the network
measures, as reported by the participant, and high-risk sexual (blood-borne virus
transmission, sexual risk behaviors) and injection (syringe exchange behaviors)
behaviors. The chapter presents the sociodemographic and general characteristics of the
sample, distribution of network and behavior measures, data cleaning and management,
missing data imputation procedures, and multivariate statistical analyses for hypothesis
testing.
Sociodemographic Characteristics
The sample consisted of 180 out of an expected 191 participants recruited in
seven different locations; this represents approximately 95% of the total desired sample
size. Participants excluded from the study included those who did not meet all inclusion
criteria (n=26) or refused to participate (n=299). Mean age of participants was 41.97
years (SD=10.29, range 22 to 85); 86.74% (n=157) self-reported as males, and none of
the participants self-identified as female/male transgender. A total of 88.64% (n=156) of
the participants were born on the island, and 11.36% (n=20) reported being born in the
United States.
Tables 1 and 2 illustrate the educational level and income sources of the
participants. Most of the participants (91.16%, n=165) had an educational level of high
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school or less, and the majority reported panhandling for a living (66.30%, n=120). The
second most frequent income source was regular work (13.81%, n=25), and 6.63%
reported receiving welfare, employment insurance, pension, or other government support
as their main source of income.
Table 1
Frequency Distribution of Participants’ Educational Level
Educational level

n

%

Did not complete HS/grade school

89

49.17

Graduated Grade 12

75

41.44

Some university/college

5

2.76

Associate’s degree

6

3.31

Bachelor’s degree

5

2.76

Trade school

1

.55
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Table 2
Frequency and Distribution of the Main Income Sources Reported by Participants
Income source

n

%

Panhandling

120

66.30

Regular work

25

13.81

Welfare, EI, pension, or other government support

12

6.63

Money from family/friends

7

3.87

Sexual Work/prostitution

6

3.31

Stealing

6

3.31

Dealing or doing drug runs

1

.55

Other:

3

2.21

Pimp/hustler

1

---

Not specified

2

---

Note. EI=Employment Insurance.
Injecting drug users (IDU) participating in the syringe exchange program (SEP)
were also asked where they spent most of their time by zip code or city area, as shown in
Table 3. Most of the participants in the sample spent most of their time at La Collectora
(n=29; 16.02%), followed by Sellés, Vista Hermosa, and Bitumul communities (n=25,
13.81% each). The communities of Hato Rey and El Guano contributed with 23 cases
each (12.71%). It is important to note that 76.10% of participants stated that they spent
most of their time in the same communities in which they were surveyed and had not
moved from or to other communities; however, on average, participants reported living in
two different places within the community (SD=1.89, range 1 to 10).

81
Table 3
Frequency and Distribution of Communities Where IDUs Reported Spending Most of
Their Time
Community

n

%

La Colectora

28

16.02

Bitimul

25

13.81

Sellés

25

13.81

Vista Hermosa

25

13.81

El Guano

23

12.71

Hato Rey

23

12.71

Buen Consejo

11

6.08

Manuel A. Pérez

8

4.42

La Perla

5

2.76

Río Piedras

3

1.66

Santurce

3

1.66

Carolina

1

.55

180

100%

Total

Continued residence in the island was high; only 4.02% (n=7) reported living on
the island for less than a year. Incarceration prevalence during the last 6 months was low
(14.92%, n=27), but lifetime incarceration was high (87.71%, n=157). The mean years in
prison for the sample was 5.58 (Q2=4.48, SD=5.11, range .04 to 21), and the mean years
out of prison was 5.31 (Q2=3, SD=5.24, range .002 to 21.93).
Participants were very likely to know their HIV status. Self-reported HIV positive
status in the sample was 12.29% (n=22), and negative status was self-reported by 86.03%
(n=154). Only three IDUs (1.68%) reported an unknown/unsure HIV status. However,
86.03% of participants had not had an HIV laboratory confirmation test for the past 6
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months. Those with a self-reported HIV negative status were the least likely to have a
laboratory test confirming their serum status. Conversely, almost all (95.54%) of those
who reported being HIV positive had a laboratory confirmation test. In general, the
average time since last tested for HIV was 16.64 months (Q2=8 months SD=36.00, range
0 to 279 months).
HCV self-reported serum status in the sample was positive for 35.56% (n=64),
negative for 62.22% (n=112), and unsure/unknown for 2.22% (n=4). Only about a third
(31.66%) of the sample reported having a HCV test in the last 6 months, and as with
HIV, few with a self-reported negative status had a laboratory test that confirmed their
serum status (8.19%). Conversely, 95.51% of those who reported being HCV positive
had laboratory confirmation tests. In general, the average time since last tested for HCV
was 16.64 months (Q2=8 months, SD=36.03, range 0 to 280 months).
Table 4 summarizes participants’ lifetime drug use. Heroin use was reported by
95.56% (n=172) of the participants, cocaine by 97.78% (n=176); marijuana by 72.22%
(n=120); and crack by 68.89% (n=124). Age at first injection ranged from 9 to 40 years
old, with a mean of 19.83 years (Q2=18, SD=5.39). Almost all (98.90%) IDU reported
daily injection, with the average injections per day being 7.14 (Q2=6, SD=4.58, range 1 to
40). The preferred substance reported by IDU was speedball (cocaine and heroin;
92.82%, n=168), followed by heroin without cocaine (5.52%).
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Table 4
Frequency and Distribution of Drugs Used in Lifetime by IDU
Drug used

n

%

121

67.22

6

3.33

Xanax/Valium

32

17.78

Amphetamines

5

2.78

Barbiturates

7

3.91

Cocaine

176

97.78

Crack

124

68.89

Morphine

19

10.59

Sedatives or tranquilizers

26

14.53

Ecstasy

9

5.00

Gasoline or other solvents

5

2.78

130

72.22

6

3.31

60

33.33

172

95.56

Mushrooms

10

5.56

Percocet

83

46.11

Methadone

18

10.00

6

3.33

Alcohol
Methamphetamines

Marijuana
PCP
Tylenol or Panadol PM
Heroin

Methadone without prescription

Note. A participant could choose more than one option; thus, the summary of all
percentages could be higher than 100.
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The Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ)
After sociodemographic information and drug use were assessed, all participants
were asked to respond to the BBV-TRAQ questionnaire to quantify risk practices. As per
BBV-TRAQ interpretation, all values over 56 points are considered high risk. Table 5
summarizes the responses to the BBV-TRAQ. The average risk score was 27.61 points
(Q2=14; SD=32.25; range 0 to 131) of a total 215 possible points in the scale.
Furthermore, 18.37% (n=18) reported a high risk score; 80.63% (n=80) reported low risk
scores. In comparison with the original validation of the BBV-TRAQ, the Cronbach’s α
for the total scale in this study (0.84) is similar to results from other studies (0.74–0.84;
Fry & Lintzeris, 2002; Stoové & Fry, 2006).

Table 5
Frequency and Distribution of Blood-Borne Virus Transmission Risks Assessment Questionnaire Items
BBV-TRA questionnaire item
In the last month, how many times have you injected with another person’s used needle/syringe? (n=179)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times
On those occasions, how often did you rinse it with a combination of full strength bleach and water (i.e., the
“2x2x2” method) before you used it? (n=23)
Never
Rarely
Sometimes
Often
Every time

n

%

155
1
3
12
7
1

86.59
0.56
1.68
6.70
3.91
0.56

10
__
7
3
3

43.48
__
30.43
13.04
13.04

154
4
7
6
3
3

87.01
2.26
3.95
3.39
1.69
1.69

In the last month, how many times have you injected with a needle/syringe after another person has already
injected some of its contents? (n=177)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times

(table continues)
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BBV-TRA questionnaire items

n

%

In the last month, how many times have you received an accidental needle stick/prick from another person’s used
needle/syringe? (n=176)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times

133
3
18
19
3
__

75.57
1.70
10.23
10.80
1.70
__

In the last month, how many times have you reused a needle/syringe taken out of a shared disposal/sharps
container? (n=174)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times

167
1
1
4
1
__

95.68
0.57
0.57
2.30
0.57
__

On those occasions, how often did you rinse it only with full-strength bleach before you re-used it? (n=7)
Never
Rarely
Sometimes
Often
Every time

2
3
1
1
__
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28.57
42.86
14.29
14.29
__
(table continues)

BBV-TRA questionnaire items

n

%

140
5
13
14
4
1

79.10
2.82
7.34
7.91
2.26
0.56

In the last month, how many times have you injected a drug that was prepared in another person’s used spoon or
mixing container? (n=179)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times

81
9
22
56
8
3

45.25
5.03
12.29
31.28
4.47
1.68

On those occasions how often did you clean the spoon or mixing container before using it? (n=94)
Never
Rarely
Sometimes
Often
Every time

49
6
19
6
14

52.12
6.38
20.21
6.38
14.89

In the last month, how many times have you injected a drug that was filtered through another person’s filter?
(n=177)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times

(table continues)
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BBV-TRA questionnaire items

n

%

In the last month, how many times have you injected a drug prepared with water which had been used by another
person? (n=136)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times

101
10
11
11
3
__

74.26
7.35
8.09
8.09
2.21
__

In the last month, how many times have you injected a drug which had come into contact with another person’s
used needle/syringe? (n=178)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times

159
4
5
9
1
__

89.33
2.25
2.81
5.06
0.56
__

In the last month, how many times have you wiped your own injection site with an object (e.g., swab, tissue,
hanky, towel etc.) which had been used by another person? (n=177)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times

160
2
8
6
1
__

90.40
1.13
4.52
3.39
0.56
__

(table continues)
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BBV-TRA questionnaire items

n

%

In the last month, how many times have you injected a drug that you prepared immediately after “assisting”
another person with their injection (e.g., injecting them, holding their arm, handling used needle/syringe;
touching their injection site to feel for a vein, to wipe blood away, or to stop bleeding)? (n=177)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times

96
6
15
38
13
9

54.24
3.39
8.47
21.47
7.34
5.08

On those occasions, how often did you wash your hands before preparing your mix? (n=81)
Never
Rarely
Sometimes
Often
Every time

51
7
13
7
4

62.96
8.64
14.81
8.64
4.94

In the last month, how many times have you injected a drug that was prepared by another person who had
already injected or assisted someone else’s injection?
No times
Once
Twice
3–5 times
6–10 times
More than 10 times

72
5
17
21
9
1

57.60
4.00
13.60
16.80
7.20
0.80

(table continues)
89

BBV-TRA questionnaire items

n

%

On those occasions, how often did they wash their hands prior to handling the needle/syringe that you used?
Never
Rarely
Sometimes
Often
Every time

41
2
5
2
2

78.85
3.85
9.62
3.85
3.85

In the last month, how many times have you been injected by another person who had already injected or
assisted in someone else’s injection? (n=126)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times

54
7
18
30
10
7

42.86
5.56
14.29
23.81
7.94
5.56

On those occasions, how often did the person injecting you wash their hands before injecting you? (n=73)
Never
Rarely
Sometimes
Often
Every time

55
7
7
2
2

75.34
9.59
9.59
2.74
2.74

(table continues)
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BBV-TRA questionnaire items
In the last month, how many times have you injected with a needle/syringe which had been handled or touched by
another person who had already injected? (n=126)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times
On those occasions, how often did they wash their hands prior to handling the needle/syringe that you used? (n=50)
Never
Rarely
Sometimes
Often
Every time
In the last month, how many times have you touched your own injection site (e.g., to feel for a vein, to wipe away
blood, or to stop bleeding) soon after "assisting” another person with their injection (e.g., injecting them, holding
their arm, handling their use needle/syringe; touching their injection site to feel for a vein, to wipe away blood, or to
stop bleeding)? (n=124)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times

n

%

78
9
15
19
4
1

61.90
7.14
11.90
15.08
3.17
0.79

74
12
10
__
4

74.00
12.00
10.00
__
4.00

88
6
11
14
4
1

70.97
4.84
8.87
11.29
3.23
0.81

(table continues)
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BBV-TRA questionnaire items

n

On those occasions, how often did you wash your hands before touching your own injection site? (n=36)
Never
Rarely
Sometimes
Often
Every time
In the last month, how many times has another person touched your injection site (e.g., to feel for a vein, to
wipe away blood, or to stop bleeding)?
No times
Once
Twice
3–5 times
6–10 times
More than 10 times
On those occasions, how often did the person wash their hands before they touched your injection site?
Never
Rarely
Sometimes
Often
Every time
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%

31
1
2
1
1

86.11
2.78
5.56
2.78
2.78

101
4
8
9
1
__

82.11
3.25
6.50
7.32
0.81
__

19
1
__
1
__

86.36
9.09
__
4.55
__

Table 6
Frequency and Distribution of Sexual Risk Behavior Scale Items
Item
In the last month, how many times have you engaged in unprotected vaginal sex with another
person (i.e., penetration of the vagina with the penis)? (n=179)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times
In the last month, how many times have you engaged in unprotected vaginal sex with another
person (i.e., penetration of the vagina with the penis) during menstruation? (n=177)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times
In the last month, how many times have you engaged in unprotected vaginal sex with another
person (i.e., penetration of the vagina with the penis) without lubrication? (n=176)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times

n

%

135
1
8
23
10
2

75.42
0.56
4.47
12.85
5.59
1.12

143
8
13
11
2
__

80.79
4.52
7.34
6.21
1.13
__

137
1
13
18
7
__

77.84
0.57
7.39
10.23
3.98
__

(table continues)
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Item

n

%

In the last month, how many times have you engaged in unprotected oral sex with another
person (i.e., lips and tongue come into contact with the vagina, penis and/or anus)? (n=177)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times

137
4
8
20
8
__

77.40
2.26
4.52
11.30
4.52
__

In the last month, how many times have you engaged in unprotected manual sex with another
person (i.e., fingers and hands come into contact with the vagina, penis and/or anus) during
menstruation? (n=177)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times

145
9
13
9
1
__

81.92
5.08
7.34
5.08
0.56
__

In the last month, how many times have you engaged in unprotected manual sex with another
person (i.e., fingers and hands come into contact with the vagina, penis and/or anus) after
injecting? (n=175)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times

136
1
10
19
9
__

77.71
0.57
5.71
10.86
5.14
__

(table continues)
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Item
In the last month, how many times have you engaged in unprotected manual sex with another person (i.e., fingers
and hands come into contact with the vagina, penis and/or anus) without lubrication? (n=176)
No times
Once
Twice
3–5 times
6–10 times
More than 10 times
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n

%

141
2
10
17
6
__

80.11
1.14
5.68
9.66
3.41
__
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Sexual Risks Behaviors Scale (SRSBS)
In addition to the injecting risk factors, the sexual risks factors were also assessed.
An index was constructed by adding the response scores of the seven questions included
in the questionnaire. Table 6 illustrates the distribution of participants’ responses to the
SRSBS questionnaire. On average, the IDU scored 3.94 points (Q2=0; M=7.21; range 0
to 24) of a total 35 possible points in the scale. Cronbanch’s α for this scale was 0.96.
Most of the participants reported that they were not sexually active at the time of the
study.
Syringe Exchange Behaviors
As part of the CBO collaboration, a requirement of the study was to assess the
syringe exchange behaviors of participants with four questions. Participants were asked if
they had exchanged needles or had acquired new needles at a syringe exchange program
during the last 6 months. Nearly all participants (n=178; 98.69%) reported having done
so. In addition, IDU were asked how many syringes they usually obtained at a syringe
exchange program with answers ranging in five categories. One hundred and fifteen
(63.54%) reported obtaining all syringes at the syringe exchange program, and a third
(33.70%) reported obtaining most but not all syringes, accounting for 97.24% of those
surveyed. IDU were asked to report if they exchanged their syringe themselves or if
someone else did it for them. Interestingly, the same two people that reported not to have
gotten new syringes at a syringe exchange program during the last 6 months reported to
have other people to do it for them. All other participants (n=179, 98.90%) reported
doing it themselves. Lastly, 62.98% (n=114) of IDU responded that obtaining a new
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syringe was very easy; 30.94% (n=56) said it was easy, and 6.08% (n=11) reported to be
very hard.
Social Network
On average, the size of social networks was 2.66 (Q2=3; SD=1.05; range 0 to 6)
and the average age of the personal network members was 38.94 years (Q2=38.5;
SD=7.43; range 19 to 59). Likewise, on average there were 2.25 network members the
participants identified as injecting drug users (Q2=2.27; SD=1.22; range 0 to 5), and an
average of 1.33 network members were identified as drug inhalers (Q2=1; SD=1.45;
range 0 to 5). Only 12.29% of participants reported having a sexual partner in their
network. The majority (87.71%) of participants did not have any network members
identified as a sexual partner, and 9.50% (n=17) reported to have on average one member
of the network as a sexual partner. Only 5 of the participants (2.79%) reported to have
more than one sexual partner in their network.
The social networks were in general very homogenous in terms of the sex of their
personal network members. A total of 121 out of 177 participants (68.36% of those
surveyed) reported having only males in their social network. About a third (31.64%) of
the participants reported having at least one woman in their social network, and only
2.90% reported that their social network was entirely composed of women. None of the
IDU reported having a transgender in their social network at the time of the study. Last,
personal social networks described by participants lacked family members (97.22%
n=175) and lovers (94.44%, n=170). Personal network members were more likely to be
identified as friends (60.00%, n=108) or acquaintance (41.01%, n=73). Table 7 provides
more detailed information.
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Density
The participants’ social network average density was .33 (SD=.20, range 0 to 1),
reflecting low density in the participants’ social networks. Refer to Table 8 for more
details.
Information on the Top 5 Network Members
Information was obtained for a total of 468 personal network members from their
social networks. Participants stated that these closest persons were mostly friends.
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Table 7
Summary of the Social Network Structure
Social network structure

Range

Average

SD

Injecting drug users (n =173)

0–5

2.26

1.22

Altars inhaling drugs (n=172)

0–5

1.33

1.45

Assortative mixing related to drug use

Demographic characteristics of the network members
Members reported as males (n=173)

0–5

2.25

1.07

Members reported as females (n=173)

0–4

0.38

0.69

--

--

--

0–4

0.14

0.53

19 -59

38.93

7.43

Family (n=173)

0–1

0.23

0.15

Lover (n=173)

0–2

0.06

0.27

Acquaintance (n=174)

0–5

1.00

1.35

Friend (n=174)

0–5

1.58

1.52

Members reported as transgender
(n=173)
Members reported as sexual partners
(n=172)
Network’s average age
Type of relationship

Note. Means represent averages across top 5 network members.
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Tables 8 and 9 describe the socio-demographic characteristics and the type of
injecting behaviors held the participants’ closest five network members. The length of
these relationships averaged 6.96 years (SD=7.29, range 0.83 to 40 years). Most of the
participants did not know the educational level of the closest five network members, and
among those who did know it, they reported low education. Similar to respondent’s own
occupational situation, most of the network members were reported to be panhandlers
(66.02%, n=309), and very few of them had a job (11.53%, n=54). In most cases,
network members were from the same geographical area6 that participants reported to be,
while very few cases (less than 5%) indicated they were from different places.

6

Geographical insularity
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Table 8
Frequency and Distribution of the Social Network Sociodemographic Characteristics
Social network sociodemographic characteristics

n

%

Unknown / not sure

295

63.85

Less than high school

78

16.88

High school

78

16.88

University

9

1.95

Vocational School

2

0.44

Panhandling

309

66.02

Fulltime job

54

11.53

Welfare or other government support

25

5.34

Other

34

7.26

Stealing

16

3.42

Dealing or doing drugs runs

14

3.00

Unknown / not sure

12

2.57

Sex worker

4

0.86

Yes (From the same geographic area)

409

95.11

No

21

4.89

Educational Level (n=462)

Main income sources (n= 468)

Geographical Insularism (n=430)
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Participants’ network members appear to have a very low risk injecting behavior
profile (Table 9) even when participants reported that they injected everyday (74.89%,
n=343); those network members reported to be injecting drugs every day had an average
report of 8.23 injections per day (median=8, SD=3.68, range 2 to 40). Most participants
(83.81%, n=355) also reported having pooled money for drugs with at least one of the
five closest members in their network.
In the past 6 months, 76.03% (n=352) of participants reported never using a
needle for injecting drugs after at least one of their altars used it. IDU surveyed reported
that none of the network members had ever injected with a syringe previously used by
them in 75.66% (n=342) of the cases. About 29.13% (n=134) stated they did not know or
were not sure if their altars had shared the syringes with other people. A more detailed
description of the network injecting practices including paraphernalia sharing and sex
trading can be seen in Table 9.
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Table 9
Frequency and Distribution of the Social Network Injecting Risk Behaviors
Characteristics
Social network behavioral characteristics
N
Frequency of the network members injection
Everyday

%

(n=458)
343

74.89

Regularly 3-4 times/week

8

1.75

Sometimes 1-2 times/week

4

0.87

Occasionally but not every week

4

0.87

Never

44

9.61

Unknown / not sure

55

12.01

> than 100 times

13

2.84

50 – 99 times

56

12.25

25 – 49 times

72

15.75

10 to 24 times

114

24.95

5 -9 times

69

15.10

2 – 4 times

27

5.91

Once

4

0.88

Never

74

16.19

Unknown / not sure

28

6.13

Never

352

76.03

Occasionally

38

8.21

Sometimes

16

3.46

Usually

--

--

Always

3

0.65

Pooling money for drugs (n=457)

Frequency of the network members injection
after the participant injected (n=463)

Unknown/n/a

54

11.66

104
Social network behavioral characteristics

N

%

(table
continues)
Frequency of the participant injection after the
network members injected

(n=452)

Never

342

75.66

Occasionally

48

10.62

Sometimes

11

2.43

Usually

--

--

Always

3

0.66

Unknown/n/a

48

10.62

Never

175

38.38

Occasionally

147

32.24

Sometimes

46

10.09

Usually

27

5.92

Always

10

2.19

Unknown / n/a

51

11.18

Paraphernalia sharing behavior (n=456)

Mixing drugs in a syringe previously used for
injection by an network members

(n=462)

Never

334

72.29

Occasionally

46

9.96

Sometimes

11

2.38

Usually

6

1.30

Always

2

0.43

Unknown/n/a

63

13.64

Network members syringes sharing behaviors
with third parties
Never

(n=460)
295

64.13
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Social network behavioral characteristics

N

%

Occasionally

15

3.26

Sometimes

11

2.39

Usually

3

0.65

Always

2

0.43

134

29.13

Unknown/n/a
Network members sex behaviors [sex worker
or trade sex for drugs]
Never

(n=464)
316

68.10

Occasionally

6

1.29

Sometimes

4

0.86

Usually

1

0.22

Always

1

0.22

Unknown / n/a

49

29.31
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IDU were asked about closeness of the relationships with their network members.
Very few of those surveyed reported to have people very close to them (n=49, 10.52%) or
very distant (n= 10, 2.15%), and only 17 (3.65%) of them reported their node relationship
as distant. Thus, the network members were somewhat close (17.60%, n=82) or close
(65.02%, n=303).
Other measure taken was the frequency of communication between the network
members and the participants was in fact very high. A total of 428 network members
(92.04%) had daily communication pattern with the participants. Other 6.02% (n=28)
said they had communication almost every day followed by 1.29% (n=6) who reported
communicating once per week with the network members. Only 3 of the participants
reported to have a communication pattern of less than once per month (0.65%). Besides
the regularity of the communication with their network members, IDU of the SEP
mentioned the type of communication they had with the network members. These
measures are detailed in Table 10.
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Table 10
Frequency and Distribution of the Level Intimacy Measures Between Altars and Egos
Premise

n

%

Yes

342

79.17

No

85

19.68

Unsure/not know

5

1.16

Yes

315

67.74

No

129

27.74

Unsure/not know

21

4.52

Yes

342

73.55

No

117

25.16

6

1.29

Yes

379

81.51

No

78

16.77

Unsure/not know

8

1.72

Yes

351

75.48

No

100

21.51

Unsure/not know

14

3.01

Yes

275

59.27

No

146

31.47

Unsure/not know

43

9.27

Yes

284

62.01

No

152

33.19

Unsure/not know

22

4.80

Yes

287

63.22

No

151

33.26

Unsure/not know

16

3.52

Would you talk to [person] about things that are very personal and private?

If you needed to borrow $25, would [person] lend or give it to you if they had the
money?

Would you ask [person] for advice or help about health problems like infections,
AIDS, or hepatitis C?

Unsure/not know
If I had an emergency this [Person] would be there for me.

If I ask this [Person] would do anything for me if it is legal.

If I ask this [Person] would do anything for me even if it is not legal.

If I ask this [Person] would obtain drugs for me.

If I ask this [Person] would obtain needles or other equipment for me.

(table continues)
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Premise

n

%

Yes

290

62.50

No

152

32.76

Unsure/not know

22

4.74

Yes

287

63.22

No

151

33.26

Unsure/not know

16

3.52

If I ask this [Person] would obtain drugs for me.

If I ask this [Person] would obtain needles or other equipment for me.

Data Cleaning and Management
Missing data across the BBVA-TRAQ (basis for the dependent variables)
presented a challenge for the data analysis. This problem has been observed elsewhere by
multiple researchers in the behavioral field (Roth, 1994; Lee, Galati, Simpson and Carlin,
2011; Otero-García, 2011). Therefore, and in accordance with the statistical plan,
multiple imputation was performed for data. Using multiple imputation for bivariate and
multivariate analyses increases statistical power while reducing bias in the parameter
estimations (Roth, 1994).
There are many methods for imputing data including listwise deletion, pairwaise
deletion, mean substitution, regresion imputation, colddeck imputation, and maximum
likelihood, among others (Roth,1994; Otero-García, 2011). In this study, hotdeck
imputation was used. Hotdeck imputation is a non-parametric procedure based in the
assigment of a value for missing cases stochastically rather than deterministacally (OteroGarcía, 2011). Hotdeck imputation is convienent for small sample sizes as it preserves
the distributional characteristics of the variable (Roth, 1994).
Schonlau’s hotdeck imputation in STATA 12.0 was used in this study. This
hotdeck technique replaced missing values not only taking in consideration the most
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similar cases in data based but also replacing values using the same variable as reference
for substitution (Schonlau, 2006). Each ordinal value is replaced with the ordinal value
from the most similar case for which the variable is not missing (Stoddard, 2012). A
missing value is defined instrinsically from the same sub-population defined in the data
base rather than from an allien sub-popualtion within the database that would increase
bias estimation.
Before imputating the data, analyses were performed to determine whether
personal characteristics of the participants were related to missingness in the BBVATRAQ score. Differences by place, gender and the way they obtained money for a living
(pandhandling or not) were noted. Therefrore, these three paramaters were taken into
consideration for establishing the most similar case for imputation of data. These values
were imputated on those from the same community/zipcode, sex, and whether or not they
pandhandled.
Hypothesis Testing
Statistical analyses were completed in three steps. First, bivariate analyses were
performed to understand relations among variables. Next, participant’s characteristics
were tested using ordinal and logistic regression to determine whether any impacted one
or more of the four dependent variables. Then, if any of the participant’s characteristics
were related to dependent variables, they were included in the GEE analysis to assure all
possible explanations were obtained.
Two research questions are addressed in this study. The first involved
understanding the relationships among network measures and high risk sexual and
injection drug behavior. The second question involved understanding the relationships
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among social network characteristics and self-reported HIV and HCV status. For this first
question, the following null and research hypotheses were developed.
Research Question 1. What are the relationships among network measures and
high risk sexual and injection drug behavior?
Sexual Risk Behavior
Ho1-1: Social network characteristics (Closeness [Psychological Closeness,
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size;
Relationship Type; Personal Network Exposure [Network Member Frequency of
Injection, Years Network Members had Injected, Pooling Money with Network
Members, and Social Network]) do not contribute unique explained variance in a
measure of sexual risk behavior, as measured by the Sexual Risk Scale score from
the BBV-TRAQ instrument, in a regression model.
Ha1-1: Social network characteristics (Closeness [Psychological Closeness,
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size;
Relationship Type; Personal Network Exposure [Network Member Frequency of
Injection, Years Network Members had Injected, Pooling Money with Network
Members, and Social Network]) contribute unique explained variance in a
measure of sexual risk behavior, as measured by the Sexual Risk Scale score from
the BBV-TRAQ instrument, in a regression model.
Results of Pearson correlation test indicated no relationship between network size
and sexual risk scale score, r=.09, p=.20, and density and sexual risk scale score, r=.09,
p=.27. Pearson correlation tests also indicated no relationship between closeness and the
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sexual risk scale score (r=.01, p=.86); beween frequency and sexual risk scale score (r=.05, p=.54); and between trustiness and sexual risk scale score (r=0.09, p=.23).
For the network risk exposure, Pearson correlations indicate no corelation
between the sexual risk scale sore and the Frequency of Injection (r=.07, p=.34),, Years
Network Members Had Injected (r=-.008, p=.91), and Pooling money with Network
Members (r=.02, p .75). Finally, geographical insularism could not be related to the score
points in the sexual risk scale as per spearman correlation test (rho=.10, p=.31).
In terms of relationship among the participants and the 5 closest edges in the
network, Pearson correlations indicate no corelation between sexual risk scale dependent
variable score and the number of edges who are family (r=.11, p=.14); the number of
edges who are lovers (r=- .10, p=.16). However, the number of edges who are friends (r=.17, p=.02) and number of edges who are acquaintances (r=.23, p=.002) are related to the
total score in the sexual risk scale.
Next, ordinal logistic regression was used to test the relationship between
individual characteristics and the scoring in the sexual risk scale (see Table 12). There
were significant relationships between risky sexual practices and: (a) the sex of the
participant (OR=3.32 , 95% IC [0.88 – 1.05]), (b) educational level (having less than high
school in comparison to high school OR=2.56, 95% IC [0.09 – 0.76] and having less than
high school in comparison to having more than high school OR=4.76, 95% IC [0.97 –
25.00]); (c) panhandling (OR=5.88 95% IC [0.93 – 33.33]); (d) community (OR=5.56,
95% IC [1.50 – 20.55]; (e) the time they spent in jail (OR=1.01, 95% IC [0.82 – 1.02])
and (f) the self-reported HIV positive serum-status (OR=2.93 95% IC [0.04 – 10.44]).
Women were 3.32 times more likely to report being HIV positive in comparison to men.
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Those having less than high school were 2.56 times more likely to self-report HIV
positive in comparison to those with high school diploma and 4.76 times more likely in
comparison to those with more than high school. Participants panhandling were 5.88
more likely to self-report an HIV positive serum-status than their counterparts.
For those who did had past history of incarceration the odds ratio for higher
scores in the risky sexual behavior score was 1.01 for each additional month in jail.
Likewise, those self-reporting a positive HIV serum-status were 2.93 times more likely to
report a higher score in the risky sexual behave scale than those reporting a negative HIV
serum-status after controlling for all other variables (p < .05). The way participants
gained their livelihoods [panhandling or not] was marginally related to HIV selfreporting serum status (p < .10). Therefore, these six variables were included in the final
GEE regression model to control bias associated to their omission, as these factors
significantly impact the sexual behaviors of participants.
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Table 11
Ordinal Regression Model for Determining Individuals’ Factors Correlating to Risky
Sexual Behaviors
Factor

Odds ratio

Standard error

Z (p value)

95% CI

Participants’ age

0.96

0.42

-0.84 (.40)

(0.88 – 1.05)

Participants’ sex

3.32

2.17

2.47 (.02)

(1.32 – 11.60)

---

---

---

---

High School

0.39

0.17

-2.06 (.04)

(0.16 – 0.95)

> High School

0.21

0.17

-1.92 (.06)

(0.04 – 1.03)

Panhandling

0.17

0.16

-1.89 (.06)

(0.03 – 1.07)

Being Arrested

1.70

1.03

0. 88 (.38)

(0.51 – 5.59)

Being in jail

1.20

0.86

0. 26 (.80)

(0.29 – 4.89)

Time in jail

1.010

0.004

2.58 (0.01)

(1.003 – 1.02)

Time since last in jail

0.99

0.01

-1.13 (.26)

(0.99 – 1.00)

HCV

0.49

0.22

1.56 (.12)

(0.20 – 1.19)

HIV

2.93

1.90

1.66 (.09)

(0.82 – 10.44)

---

---

---

---

Hato Rey

2.56

2.11

1.14 (.25)

(0.51 – 12.87)

Sellés

4.77

4.28

1. 47 (.08)

(0.82 – 27.65)

La Colectora

4.02

3.33

1.68 (.09)

(0.79 – 20.40)

Vista Hermosa

5.56

3.71

2.57 (.01)

(1.50 – 20.55)

Bitmul

0.24

0.29

-1.17 (.24)

(0.02 – 2.58)

El Guano

3.28

2.75

1.42 (.15)

(0.64 – 16.97)

Others

0.99

1.22

-0.01 (.99)

(0.09 – 11.11)

Stable housing

0.76

0.47

-0.43 (.67)

(0.23 – 2.57)

Injecting times/day

1.01

0.04

0.15 (0.88)

(0.93 – 1.08)

Pseudo R2

0.12

p < 0.001

Educational Level
< High School

Community
Buen Consejo

Note. n=180.
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The GEE analysis used to test the hypothesis included demographic factors in
addition to the structural and social characteristics of the network. The GEE analysis
demonstrate that none of the social network variables were related to sexual behaviors of
participants, and only demographic factors significantly impacted the risky sexual
behaviors of the participants. Thus, the null hypothesis is accepted. Refer to Table 12 for
details.
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Table 12
Generalized Estimated Equation Model for Risky Sexual Behaviors
Factor

β

Standard error

Z (p value)

95% CI

Social network (SN)

-1.08

1.99

-0.55 (.59)

(-4.99 – 2.82)

Density

3.77

5.55

0.68 (.50)

(-7.11 – 14.67)

Geographical insularism

-1.11

1.29

-.86 (.39)

(-3.64 – 1.43)

Trustiness

0.14

0.16

0.92 (.36)

(-0.16 – 0.45)

Closeness

0.35

0.69

0.51 (.61)

(-1.01 - -1.71)

Frequency

0.02

0.80

-0.02 (.98)

(-1.55 – 1.59)

Number of family in SN

7.50

5.56

1.35 (.18)

(-3.40 -18.39)

Number of sexual partners in SN

3.07

3.21

0.95 (.34)

(-3.23 – 9.36)

Number of friends in SN

0.29

1.51

0.20 (.85)

(-2. 65 – 3.24)

Number of acquaintances in SN

0.98

1.52

0.65 (.52)

(-2.00 – 3.97)

-0.21

0.15

-1.36 (.17)

(-0.51 – 0.09)

-0.17

0.22

-0.75 (.45)

(-0.60 – 0.27)

0.00005

0.0004

0.12 (.90)

(-0.007 – 0.008)

SN exposure

0.44

0.40

1.13 (.26)

(-0.33 – 1.23)

Participants’ sex

5.13

1.83

2.78 (.005)

(1.52 – 8.73)

---

---

---

---

Hato Rey

0.85

1.80

0.47 (.64)

(-2.68 – 4.39)

Sellés

3.93

1.90

2.07 (.04)

(0.20 – 7.67)

La Colectora

4.51

1.56

2.89 (.004)

(1.45 – 7.57)

Vista Hermosa

6.68

1.67

4.00 (< 0.00)

(3.41 – 9.96)

Bitmul

-0.47

1.24

-0.38(.70)

(-2.92 – 1.97)

El Guano

2.74

2.08

1.31 (.19)

(-1.34 – 6.84)

Network members frequency of
injection
Pooling money with network
members
Years network members had injected

Community
Buen Consejo

Others

0.03

1.41

0.02 (.98)

(-2.74 – 2.80)

-4.02

2.70

-1.49 (.14)

(-9.31 – 1.27)

---

---

---

---

High School

-1.93

1.12

-1.71 (.08)

(-4.13 – 0.28)

> High School

-3.08

1.26

-2.46 (.01)

(-5.53 – -0.63)

Time in Jail

0.019

0.008

2.24 (0.03)

(0.003 – 0.04)

HIV Self-reported status

1.90

1.31

1.45 (.15)

(-0.67 – 4.47)

Constant

-2.63

3.91

-0.67 (.50)

(-10.30 – 5.04)

Panhandling
Educational Level
< High School
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Injecting Risk Behaviors
Ho1-2: Social network characteristics (Closeness [Psychological Closeness,
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size;
Relationship Type; Personal Network Exposure [Network Member Frequency of
Injection, Years Network Members had Injected, Pooling Money with Network
Members, and Social Network]) do not contribute unique explained variance in a
measure of injecting risk behavior, as measured by the Injecting Risk Behaviors
scale score from the BBV-TRAQ instrument, in a regression model.
Ha1-2: Social network characteristics (Closeness [Psychological Closeness,
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size;
Relationship Type; Personal Network Exposure [Network Member Frequency of
Injection, Years Network Members had Injected, Pooling Money with Network
Members, and Social Network]) contribute unique explained variance in a
measure of injecting risk behavior, as measured by the Injecting Risk Behaviors
Scale score from the BBV-TRAQ instrument, in a regression model.
The relationship between injecting risk behaviors, as measured by the injecting
risk behaviors scale score from the BBV-TRAQ and social network characteristics was
tested next. Pearson correlation indicated that there was a correlation between network
size and injecting risk behaviors (r=.18, p=.01); density and injecting risk behaviors
(r=.18, p=.02); and age and injecting risk behaviors (r=0.25, p=.0008). Conversely,
Pearson correlation test indicate that there is no statistical correlation between closeness
(r=.08, p=.32); ties frequency (r=-.03, p=.68); or trustiness (r =0.06, p=.44). Pearson
correlations indicate that there is not a statistical relationship between injecting risk
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behaviors score and the number of edges who are family (r=.07, p=.36); the number of
edges who are lovers (r=- .10, p=.16); number of edges who are friends (r=-.13, p=.06)
and number of edges who are acquaintances (r=- .02, p=.83).
The network exposure risks were measured as previously described above.
Pearson correlations indicate that there is no relationship between the injecting risk
behaviors score and network member frequency of injection (r=.01, p=.87); the years
network members had injected (r=-.009, p=.91) and pooling money with network
members (r=.12, p=.11). Last, geographical insularism was not be related to injecting
risk behaviors (rho=-.04, p=.56). In conclusion, data analyses at bivariate level suggest
that only the social network size and the density of the network are related to higher
injecting risk scores.
Next, the relationships between individual characteristics and the injecting risk
dependent variables were tested. Results for the injecting risks behaviors showed that
none of the individuals’ characteristics correlating the dependable variable. Table 13
summarizes the results the analysis. Thus, these variables were omitted in the GEE
analysis.
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Table 13
Ordinal Regression Model for Determining Individuals’ Factors Correlating to Risky
Injecting Behaviors
Factor

Odds ratio

Standard error

Z (p value)

95% CI

Participants’ age

0.99

1.12

-1.21 (.23)

(0.95 – 1.01)

Participants’ sex

2.05

.017

1.31 (.19)

(0.69 – 6.01)

---

---

---

---

High School

1.15

0.39

0.43 (.67)

(0.60 – 2.24)

> High School

1.02

0.62

0.03 (.98)

(0.31 – 3.35)

Panhandling

0.74

0.60

-0.36 (.72)

(0.16 – 3.56)

Time in jail

1.00

0.002

-1.66 (.10)

(0.99 – 1.001)

Being Arrested

0.88

0.40

-0.28 (.79)

(0.36 – 2.15)

Ever being incarcerated

0.63

0.40

0.28 (.79)

(0.36 – 2.14)

1.0001

< 0.0001

0.82 (.41)

(0.9998 – 1.0002)

---

---

---

---

Hato Rey

1.68

1.34

0.66 (.51)

(0.35 – 8.00)

Sellés

1.40

1.20

0.40 (.69)

(0.26 – 7.51)

La Colectora

1.82

1.28

0.86 (.39)

(0.46 – 7.23)

Vista Hermosa

1.79

1.41

0.74 (.46)

(0.38 – 8.34)

Bitmul

1.39

1.06

0.42 (.67)

(0.31 – 6.24)

El Guano

2.03

1.54

0.94 (.35)

(0.46 – 8.94)

Others

0.89

0.73

-0.13 (.90)

(0.18 – 4.44)

HCV

0.82

0.24

-0.65 (.51)

(0.46 – 1.48)

HIV

0.64

0.31

-0.91 (.36)

(0.25 – 1.65)

Stable housing

1.82

0.71

1.56 (.12)

(0.87 – 3.89)

Injecting times/day

1.04

0.03

1.46 (.14)

(0.99 – 1.10)

Pseudo R2

0.02

p >.52

Education Level
< High School

Time since last in jail
Geographical Insularism
Buen Consejo

Note. n=180.
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GEE analysis preformed included only the structural and social characteristics of
the network as reported by participants. GEE model shows that the only two
characteristics impacting the harmful injecting practices are average of years the network
members had injected (β=-.02, p=0.03) and the injection practices of the edges (β=2.43,
p=0.007). No other variable was observed to impact the dependable variable. Thus, the
null hypothesis is rejected. Refer to Table 14 for details.
Table 14
Generalized Estimated Equation Model for Risky Injecting Behaviors
Factor

Β

Standard Error

Z (p value)

95% CI

Social Network (SN)

4.63

6.42

0.72 (.47)

(-7.96 – 17.22)

Density

15.94

16.33

0.98 (.33)

(-16.08 – 47.95)

Geographical Insularism

-2.08

6.18

-0.34 (.74)

(-14.20 – 10.04)

Trustiness

0.01

0.55

0.02 (.99)

(-1.08 – 1.09)

Closeness

0.08

2.57

0.03 (.98)

(-4.95 – 5.11)

Frequency

-3.45

2.57

-1.34 (.18)

(-8.48 – 1.59)

Number of Family in SN

-3.59

13.18

-0.27 (.79)

(-29.43 – 22.25)

Number of Sexual Partners in SN

-1.88

5.40

-0.35 (.73)

(-12.48 – 8.70)

Number of Friends in SN

-1.38

4.83

-0.29 (.78)

(-10.85 – 8.09)

Number of Acquaintance in SN

-2.38

5.47

-0.44 (.66)

(-13.11 – 8.33)

Network Members Frequency of Injection

-0.56

1.44

-0.39 (.70)

(-3.38 – 2.25)

Pooling money with Network Members

-1.31

1.02

-1.28 (.20)

(-3.38 – 2.25)

Years Network Members Had Injected

-0.02

0.001

-2.14 (.03)

(-0.003 – -0.0002)

SN exposure

2.43

0.90

2.69 (.007)

(0.66 – 4.21)

Constant

8.30

10.54

0.83 (.40)

(-11.38 – 27.99)

Note. n=180.
Research Question 2. What are the relationships among social network
characteristics and self-reported HIV and HCV status?
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Ho2-1: Social network characteristics (Closeness [Psychological Closeness,
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size;
Relationship Type; Personal Network Exposure [Network Member Frequency of
Injection, Years Network Members had Injected, Pooling Money with Network
Members, and Social Network]) do not correlate with the self-reported HIV and
HCV status, in a regression model.
Ha2-1: Social network characteristics (Closeness [Psychological Closeness,
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size;
Relationship Type; Personal Network Exposure [Network Member Frequency of
Injection, Years Network Members had Injected, Pooling Money with Network
Members, and Social Network]) do correlate with the self-reported HIV and HCV
status, in a regression model.
HIV self-reported status.The relationship between self-reported HIV status and
social network characteristics was tested using independent sample t-test. Only one of the
social network characteristics were associated with HIV status. Closeness was
statistically significant, t (179)=2.00, p=.05; this suggests a marginally significant
relationship with the HIV status of participants.
There are no differences in the social network size (t (179)=1.10, p=.27), social
network density (t (179)=0.15, p=.89), frequency (t (179)=0.69, p=.49) or trustiness (t
(179)=-0.21, p=.83) by HIV status. There were also no differences between personal
network exposure, as measured by the network members frequency of injection (t
(179)=0.65, p=.52), years network members had injected (t (179)=1.44, p=.15), or
pooling money with network members (t (179)=1.24, p=.22).
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There are differences in the percentages for the positive self-reported HIV cases
by geographic isularism of participants and their personal network members, X2 (7, 180)
=14.95, p=.04); where the comunities of Hato Rey (ICI), Sellés and Guano have higher
percentages of cases that what expected. There were no differences in the average
number of edges who were family (t (179)=.63, p=.53), lovers (t (179)=.52, p=.61),
friends (t (179)=.80, p=.43), and number of edges who are acquantices (t (179)=.06,
p=.95) by HIV self reported status.
To control bias associated to the omission of individual characteristics impacting
HIV self-reported serum-status all individual factors were tested using a logistic
regression. Responses of the HCV and HIV (dependent variables) were dichotomized as
“0” for “no” and “1” for “yes”. This regression allowed discriminating among individual
factors significantly correlating the HIV positive self-reported status. Statistical analysis
shows that HIV self-reported status was significantly impacted by the age of the
participants (OR=1.07, 95% CI (1.001 – 1.140) p=0.04). For the population studied, a
one-year increase in the age of participants supposes a 7% risk increase in HIV positive
serum-status.
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Table 15
Logistic Regression Model for Determining Individuals’ Factors Correlating HIV
Positive Self-Reported Status
Factor

Odds Ratio

Standard Error

Z (p value)

95% CI

Participants’ age

1.01

0.02

0.69 (.49)

(0.97 – 1.06)

Participants’ sex

2.79

1.88

1.54 (.12)

(0.75 – 10.41)

---

---

---

---

High School

0.52

0.23

-1.49 (.14)

(0.22 – 1.23)

> High School

0.66

0.48

-0.57 (.57)

(0.16 – 2.73)

Panhandling

1.82

1.78

0.61 (.54)

(0.26 – 12.49)

Being Arrested

1.23

0.64

0.40 (.69)

(0.44 – 3.40)

Ever being incarcerated

1.70

1.00

0.90 (.37)

(0.53 – 5.43)

Time in jail

1.0002

0.003

0.70 (.49)

(0.9957 – 1.009)

Time since last in jail

1.0002

0.0001

1.99 (.05)

(1.00 - 1.0004)

---

---

---

---

Hato Rey

1.82

1.52

0.71 (48)

(0.35 – 9.40)

Sellés

2.04

1.68

0.86 (.39)

(0.40 – 10.25)

La Colectora

1.26

0.98

0.30 (.77)

(0.28 – 5.78)

Vista Hermosa

0.89

0.71

-0.16 (.87)

(0.18 – 4.27)

Bitmul

0.72

0.58

-0.41 (.68)

(0 .15 – 3.44)

El Guano

3.14

2.65

1.36 (.17)

(0.60 – 16.44)

Others

4.14

4.06

1.45 (.15)

(0.60 – 28.29)

HCV Self Report

11.31

6.91

3.97 (<.001)

(3.41 – 37.43)

Stable housing

1.82

0.89

1.21 (.23)

(0.69 – 4.75)

Injecting times/day

0.98

0.04

-0.46 (.64)

(0. .92 – 1.05)

Constant

0.24

0.35

-2.61 (.009)

0.002 - 0.40)

Pseudo R2

0.21

p=.00

Educational level
< High School

Geographical Insularism
Buen Consejo

Note. n=180.
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Taking in to consideration the participant’s age GEE analysis was computed using
the structural and social characteristics of the network. It is observed that the trustiness
(β=-0.14, p=.02) and the closeness (β=0.07, p=.005) did impact the HIV serum-status.
Also the number of family members named among the closest 5 edges in the social
network was inversely related to the HIV serum-status (β=-0.22, p=.05). Refer to Table
16 for all detailed information.
Table 16
Generalized Estimated Equation Model for HIV
Factor

Β

Standard Error

Z (p value)

95% CI

Social Network (SN)

-0.08

0.14

-0.57 (.57)

(-0.35 – 0.19)

Density

0 .37

0.30

1.25 (.21)

(-0.21 – 0.96)

Geographical Insularism

0.03

0.04

0.75 (.52)

(-0.03 – 0.06)

Trustiness

0.009

0.01

0.85 (0.39)

(-0.01 – 0.03)

Closeness

-0.03

0.04

-0.82 (.42)

(-0.10 – 0.04)

Frequency

0.02

0.04

0.37 (.71)

(-0 -.07 – 0.10)

Number of Family in SN

-0.08

0.28

-0.30 (.76)

(-0.63 – 0.46)

Number of Sexual Partners in SN

0.06

0.18

0.34 (.74)

(-0.24 – 0.20)

Number of Friends in SN

-0.02

0.11

-0.19 (.84)

(-0.24 – 0.20)

Number of Acquaintance in SN

-0.02

0.11

-0.17 (.87)

(-0.24 – 0.20)

Network Members Frequency of Injection

-0.01

0.02

-0.65 (51)

(-0.06 – 0.03)

Pooling money with Network Members

0.01

0.02

0.71 (.48)

(-0.02 – 0.04)

Years Network Members Had Injected

0.00001

0.000001

1.59 (.11)

(-0.00001 – 0.001)

SN exposure

-0.02

0.01

-1.87 (.05)

(-0.04 – 0.001)

HCV Self Report

0.50

0.09

5.48 (<.01)

(0.31 – 0.67)

Time since last in jail

0.003

0.00001

2.12 (0.03)

(0.0002 – 0.001)

Constant

0.30

0.17

1.67 (.09)

(-0.05 – 0.61)

Note. n=180.
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HCV self-reported status. The HCV status of participants and the social network
characteristics was also tested using student independent t-test and chi-square test. The
only social network characteristics significantly related to HCV self report status were the
ties strengths as measured by closeness, and the social network exposure when measured
by the edges drug injecting practices (t (168)=2.67, p < .05). Ties strength (frequency of
communication) has a marginal effect on the HCV self report status (t (168)=-1. 80,
p=.07).
Network size (t (168)=-1.46, p=.15) and density (t (166)=-0.40, p=.97) did not
have significant effect on self-reported HCV status. Ties strengths, as measured by
frequency of communication, are marginally different between those self-reporting as
HCV positive and negative (t (165)=1. 80, p=.07), with those having self-reported
negative HCV serum status having stronger ties. Those reporting a HCV positive status
had lower average scores for ties strength (M=3.00 , SD 0.96). There was no effect on
trust by HCV self reported status, t (165)=-1.18, p=.24.
HCV self-reported status did not have an effect on edges’ frequencies of injection,
t (165)=-0.92, p=.36); years edges had injected drugs, t (165)=1.22, p=.22; and money
pooling, t (168)=1.11, p=.27. HCV self-reported status did have an effect on personal
network exposure, t (168)=-2.67, p=.008.
There are no differences in the percentages for the positive self-reported HCV
cases when compared for the geographic location of participants and their edges, X2 (155)
=1.20, p=.28). There were also no differences in the average number of edges who were
family, t (166)=-0.57, p=.56; lovers, t (167)=0.57, p=.57); friends, t (167)=-0.61, p=.54);
and number of edges who are acquantices, t (166)=-0.41, p=.68.
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Next, the relationship between individual characteristics and the odds of having a
positive HCV self-reported serum status were tested using a logistic regression. None of
the individual’s characteristics significantly increase odds of infection. Table 17
summarizes the results.
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Table 17
Logistic Regression Model for Determining Individuals’ Factors Correlating HCV
Positive Self-Reported Status
Factor

Odds Ratio

Standard Error

Z (p value)

95% CI

Participants’ age

2.82

1.89

1.55 (.12)

(0.76 – 10.46)

Participants’ sex

1.01

0.02

0.68 (.50)

(0.97 – 1.06)

---

---

---

---

High School

0.53

0.23

-1.47 (.14)

(0.22 – 1.24)

> High School

0.67

.049

-0.54 (.59)

(0.16 – 2.79)

Panhandling

1.81

1.79

0.60 (.55)

(0.26 – 12.61)

Being Arrested

0.88

0.43

-0.27 (.79)

(0.33 – 2.32)

Ever being incarcerated

0.58

0.34

-0.91 (.36)

(0.18 -1.86)

Time in jail

1.00001

0.0001

0.71 (.47)

(0.9998 – 1.0003)

Time since last in jail

1.0002

0.0001

2.03 (.04)

HIV Self-report status

11.26

6.86

3.97 (<0.000)

(3.41 – 37.18)

Stable housing

1.82

.89

1.22 (.22)

(0.70 – 4.76)

Injecting times/day

0.98

0.04

-0.45 (.65)

(0.92 – 1.05)

---

---

---

---

Hato Rey

1.81

1.52

0.71 (.49)

(0.35 -9.36)

Sellés

2.04

1.68

0.86 (.39)

(0.40 – 10.26)

La Colectora

1.26

0.96

0.29 (.77)

(0.27 – 5.76)

Vista Hermosa

0.88

0.71

-0.17 (.87)

(0.18 – 4.25)

Bitmul

0.72

0.58

-0.40 (.69)

(0.16 – 3.46)

El Guano

3.20

2.70

1.38 (.17)

(0.62 – 16.63)

Others

4.16

4.09

1.45 (.15)

(0.61 – 28.51)

0.05

0.07

-2.05 (0.04)

(.002 - .873)

0.21

p=0.007

Education Level
< High School

(1.00001 –
1.0003)

Geographical Insularism
Buen Consejo

Constant
2

Pseudo R

Note. n=180.
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The final logistic regression model explaining the variance in HCV self-reported
status by social network factors was run including the individual factors “Time since last
in jail” and “HIV Self-report Status”. The final model detailed in Table 18 shows that the
only social network factor significantly related to self-reported HCV was years the edges
had been injecting (social network behaviors), β=-0.02, p=.05. Therefore, the null
hypothesis is rejected.
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Table 18
Generalized Estimated Equation Model for HCV
Factor

Β

Standard
Error

Z (p value)

95% CI

Social Network (SN)

-0.08

0.14

-0.57 (.57)

(-0.35 -0.19)

Density

0.37

0.30

1.18 (.24)

(-0.23 -0.95)

Geographical Insularism

0.04

0.11

0.43 (.67)

(-0.16 – 0.26)

Trustiness

0.01

0.01

0.84 (.40)

(-0.01 – 0.03)

Closeness

-0.03

0.04

-0.78 (.43)

(-.10 – 0.04)

Frequency

0.11

0.43

0.27 (.78)

(-0.08 – 0.10)

Number of Family in SN

-0.08

0.29

-0.26 (.79)

(-0.64 – 0.49)

Number of Sexual Partners in SN

0.06

0.18

0.34 (0.73)

(-0.28 – 0.41)

Number of Friends in SN

-0.02

0.11

-0.18 (.86)

(-0.24 – 0.20)

Number of Acquaintance in SN

-0.02

0.11

-0.16 (.87)

(-0.24 – 0.21)

-0.01

0.02

-0.62 (.54)

(-0.06 – 0.03)

0.01

0.02

0.59 (.55)

(-0.02 – 0.42)

0.00003

0.00002

1.59 (.11)

(0.000007 – 0.00007)

SN exposure

-0.02

0.01

-1.82 (0.05)

(0.0004 – 0.001)

Time since last in jail

0.01

0.005

2.11 (.04)

(0.0008 – 0.02)

HIV Self-report status

0.50

0.09

5.48 (<0.001)

(0.32 – 0.68)

Constant

0.26

0.18

1.39 (.17)

(-0.11 – 0.62)

Network Members Frequency of
Injection
Pooling money with Network
Members
Years Network Members Had
Injected

Note. n=180.
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In summary, the results showed that in respect to the risky sexual behavior, none
of the social network characteristics was related. The injecting risk behaviors were only
impacted by personal network exposures measured by the average of years the edges had
injected and by their injecting practices. HIV self-reported serum status showed to also be
significantly impacted by the same two factors. Last the HCV self-reported serum status
was only impacted by the injecting drugs practices their network performed.
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Chapter 5: Discussion
The purpose of this exploratory quantitative study was to describe how social
network characteristics of Puerto Ricans participating in a needle exchange program
relate to personal engagement in risk behaviors. Risk behaviors included substance use
and sexual behaviors associated with transmission of HCV/HIV. This study was guided
by social network theory. Different from other theories, social networks theory provides
state-of-the-art analysis on how social relationships influence individuals’ health.
Therefore, the research was intended to explain how individual choices concerning
injection drugs and sexual contact (routes for the transmission of HCV and HIV) are
affected by social network characteristics. Adding to existing research that focuses on the
individual attributes impacting health behaviors or status (Hanneman & Riddle, 2005),
this research was intended to foster deep understanding of the phenomena from a more
holistic perspective that takes into account the social and geographical environment in
which an individual operates (Perry & Pescosolido, 2010).
Research suggests that a social network is the infrastructure in which social
support is provided and received (Zhu, Woo, Porter, & Brzezinski, 2013). Cornwell
(2009) broadly discussed how social networks serve as bridges for macrosocial processes
such as (a) diffusion of innovations and information, (b) spread of diseases such as HIV,
and (c) community cohesion. Beyerlein and Hipp (2005) added that social cohesion
among communities shapes how people perform in determinate environments. Thus,
there was a place to think about how social networks impact the availability and
adequacy of health behavior adoption. Nevertheless, literature to date has failed to
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document how social networks impact the health of Hispanic injecting drug users not
living in the continental United States.
This study documented the characteristics of Puerto Rican islander injecting drug
users (PR-IDUs) and some of their social networks’ structural and social characteristics.
Similar to the results founds by Andía et al. (2008), Filinson et al. (2005), and DávilaTorres and Reyes-Ortíz (2010), the PR-IDU had a low socioeducational status, low
education levels, and ages ranging from the mid-30s to early 40s. However, in the present
study, the sample of PR-IDU was mostly unemployed; approximately one fifth reported
that they were working. Labault-Cabeza, Dávila-Torres, and Reyes-Ortiz (2014) reported
that in a 2006 study, the sample of PR-IDU baby boomers had an employment rate (either
part time or full time) of 58.8%. The discrepancy between the study data and their report
can be explained partly by the high unemployment rates reported elsewhere as part of the
worldwide economic crisis. Additionally, the target population of the Labault-Cabeza et
al. (2014) study included only those born between 1946 and 1964, which represented a
generational bias not intended to be explained in the study. In addition, no other study
reported the working status of PR-IDU, making it difficult to establish comparisons.
However, other populations of IDUs outside the island show results similar to the ones
reported in the current study (Wylie, Shah, & Jolly, 2006; Shaw, Jolly, & Wylie, 2014).
The HCV, HIV, and coinfection rates in the sample surveyed show that 35.56%
were HCV positive, 12.29% were HIV positive, and 29.25% reported being positive for
both HCV and HIV. The numbers reported could be lower than actual numbers due to the
lack of a confirmatory test at the time of survey; this presents a potential bias (Shaw,
Jolly, & Wylie, 2014). Even so, these numbers are similar to those reported by Armstrong
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(2007) for populations (incarcerated or not) participating in screening health activities,
among whom prevalence estimates for HCV were about 30%. Shaw, Jolly, and Wylie
(2014) reported that, among Canadian IDU reporting confirmatory laboratory tests, HCV
prevalence was 52%.
Previous studies conducted in Puerto Rico using confirmatory tests showed a
prevalence of 76.1% for those 20–59 years old (Pérez, 2010b). Gelpí-Acosta, Hagan,
Jenness, Wendel, and Neaigus (2011) reported that among their sample of Puerto Rican
IDUs with less than 3years in NYC, 7% tested positive for HIV and 77% tested positive
for HCV. Other studies among islanders reported HCV prevalence to be 42% in the same
population surveyed in this study (Orozco-González et al., 2011). The incongruence
among different studies presented has also been documented in other groups. For
instance, differences between laboratory serum status and self-reported serum status
could account for 30% more cases of HCV (Whitehead, Hearn, Marsiske, Kahn, &
Latimer, 2014). Further, authors have reported that HCV awareness and diagnosis among
IDU are expected to be very low, which coincides with the conclusion of Korthuis et al.
(2014) that there is a need to bring more and better services to IDU to improve
awareness. Reyes-Ortiz et al. (2014) reported that, among those in the HCV Department
of Health Registry for the west and south regions, only 25% had a PCR7 confirmatory
test; this reaffirms the need for better services for the HCV-positive population.
Despite the congruence of the results with the literature, I cannot explain the
differences in percentages reported for HCV between Orozco et al. (2011) and the present

7

Polymerase chain reaction (PCR) is a biological test for genetic identification.
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study, other than attributing the discrepancy to sampling techniques. The results
documented by Orozco et al, (2011) were obtained through a nonprobabilistic sampling
technique. The authors selected the participants based on their availability during a 2week period and recruited in 12 locations where the CBO was offering needle exchange
services. Although inclusion criteria were the same as those used in this study,
recruitment was expanded to all participants meeting inclusion criteria who could be
interviewed during the needle exchange in a period of 2 weeks during the summer
season. This sampling technique used by Orozco et al., (2011) cannot be generalized to
all syringe exchange participants; thus, this could explain the differences documented
between their study and the present one.
The present study differs from other studies in terms of sampling. First, this study
was conducted after a budget reduction that limited CBO services to only nine spots in
comparison to 12 that would have been available during the planning stages of the study.
Second, the sample was randomly selected, with participants recruited using an “N/n”
technique. Therefore, a more robust sampling technique was performed, assuring that
results would be representative of participants currently using the syringe exchange
program. Third, approximately 55% of all participants in the Orozco et al. (2011) study
were recruited from the CBO headquarters, whose clients Arce et al. (2011) reported to
have worse health status than those using the syringe exchange services within their
communities. These three reasons support these findings of lower HCV self-reported
results as well as the lower HIV self-reported serum status.
HIV prevalence in the sample obtained by Orozco et al. (2011) was 16%, which is
slightly higher than the 12.29% reported in the present study. Both results compare well
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with those of Shaw, Jolly, and Wylie (2014), who reported 16% prevalence using a
similar population in Canada. However, these numbers are higher that the global trend
reported by Strathdee and Stockman (2010), who attributed 10% of all HIV infections to
injecting drug users. Pérez (2010a, 2010b) posited that, because PR-IDUs have higher
HIV prevalence than elsewhere, the primary cause of HIV transmission must be injecting
drug use. In addition, Amill et al. (2004) and Colón et al. (2001) reported higher risks for
PR-IDU because they face more risk factors such as (a) more exposure to drug
environments, (b) more access to drugs, and (c) more money pooling for buying drugs.
Pérez (2010b) documented high rates of unawareness in comparison to other jurisdictions
in the continental United States. All this evidence helps to explain the higher HIV
prevalence reported for this sample.
Injecting risk behaviors were assessed. Findings suggested that most participants
had a low risk profile (high risk behaviors n=159; low risk behaviors n=21). As all
participants had been participating in the syringe exchange program, which included
health education for HIV/HCV prevention, this result was expected. The purpose of
syringe exchange programs is to reduce and control the transmission of blood-borne
pathogens and other adverse effects related to drug injection (Batos & Strathdee, 2000;
Delgado, 2004; Downing et al., 2005; Hagan et al., 1999; Pollack, 2001; Stancliff et al.,
2003; Vlahov, Robertson & Strathdee, 2010). It can be said that the syringe exchange
program had been effective in working with participants to reduce and control risky
behaviors that increase odds for contagion with blood-borne pathogens. It could be
theorized that most IDU within the program have internalized the harm reduction
interventions independently of their characteristics.
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Ordinal regression showed that none of the individuals’ attributes significantly
impacted the risky injecting behaviors of participants. IDU characteristics identified in
literature such as sex (Tracy, 2014), frequency of injection and zone within the city where
IDU live (Jain et al., 2014), illegal income and stable housing (Havinga, van der Velden,
de Gee, & van der Poel, 2014), age, frequency of injection, and prior incarceration
history (Todd et al. 2011) are commonly associated with increased risk of risky injecting
behaviors. However, these factors did not correlate to risky injecting behaviors. The
regression model showed that these characteristics only explained 2% of the variance and
were not statistically significant. This demonstrates that the adoption of risky behaviors is
explained by other factors that do not necessarily include individual characteristics.
Therefore, it is possible that the syringe exchange program has positively impacted the
health behaviors of participants and thus reduced health disparities attributable to their
intrinsic characteristics.
Many of the participants during interviews expressed high distrust of each other.
The distrust could also explain why they refused to share syringes with most of their
peers (Cepeda et al., 2011). They were very likely to express that when sharing syringes,
drug stealing could result, and thus they would not share their syringes with other social
network members. However, they did express sharing cockers and cotton (for filtering
drugs) for two reasons: (a) limited availability of the materials and (b) low perception of
risk related to paraphernalia. In general, IDU reported that rinsing with clean water
and/or the Clorox solution provided by the CBO would protect them from contagion.
Other studies also documented similar behaviors among migrant Puerto Ricans in
NYC with less than 3 years (Gelpí-Acosta, Hagan, Jenness, Wendel, and Neaigus, 2011).
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This sample reported in 40.5% of cases being receptive to sharing syringes, in
comparison to 52.5% who were receptive to sharing the cooker, cotton, or water. Thus, it
seems more common to share paraphernalia than to share syringes in this population. In
conversations with the CBO representatives, a historical bias was observed, as they had
ran out of cockers and cottons but kept handing syringes to participants. Thus, it will be
important to clarify this finding to correctly establish whether paraphernalia sharing is a
behavior commonly practiced by IDU or whether it was something circumstantial.
Sexual risk behaviors were rated very low among participants. All participants
reported themselves in the low risk profile, which was unexpected. One hundred and
twenty-three of all participants reported either no sexual intercourse or not practicing
risky behaviors. In comparison, Gelpí-Acosta, Hagan, Jenness, Wendel, and Neaigus
(2011) found that 37.4% of the PR IDU living in NYC for less than 3 years reported
having unprotected intercourse with a casual/exchange partner. Likewise, 28.7% of their
Puerto Rican sample had three sexual partners or more, and up to 82% were sexually
active. However, the authors pointed out that having sexual encounters could be a way to
survive within a new environment.
Anecdotal information was obtained through participants’ statements in
interviews that other than for sexual trade, they preferred not to have sex because, as one
participant put it, heroin becomes your life … no other pleasure or thing is worthy or
need it. This was a comment of one of the participants (in his 40’s) who reported having
gone years without sexual contact. Over time, the physical attributes and hygiene of most
IDUs decay, and it becomes more difficult for them to attract others. Also, Pearson
correlation tests showed an inverse statistically significant relationship between age and
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risky sexual behavior scores, which confirms anecdotal information (as time when first
injected was not collected).
The only individual factors in ordinal regression that correlated to risky sexual
behaviors were time spent in jail, educational level, panhandling, and HCV self-reported
status. These factors have been widely documented in literature as ones that impact highrisk sexual behaviors. It could be argued that the fact that most of the participants
reported not engaging in any risky sexual practices or not being sexually active could be
masking individual characteristics impacting the score in the scale. Although outside the
scope of this study, the CBO could gain useful information by analyzing individual
factors impacting high-risk sexual behaviors using the scale in the study, which had high
internal consistency (Cronbach’s alpha=.96).
The social networks of the PR-IDU showed characteristics that differed from
those of other IDU social networks studied in the literature. For instance, literature shows
that social networks are bigger elsewhere, ranging from 1-32 social network members but
averaging between 3 and 5 members (Cepeda et al., 2011; El-Bassel, 2006; Latkin et al.
1995; Suh et al., 1997; Wylie, Shah & Jolly, 2006). PR-IDU surveyed in the present
study reported smaller social networks than those in literature; averaging 2.66 nodes
(range 0-3). However, Suárez et al., (2000) reported that Puerto Ricans have smaller
social networks than any other Latino/Hispanic group studied. Suárez and colleagues
urged researchers to study other network structural properties such as density, linkages,
durability, intensity, and homogeneity to better explain the phenomena that seem to be
important factors among women with breast cancer. The authors also explained that in
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the case of Puerto Rican women with cancer living in the United States, the quality of
social network interactions is much more important than social network size.
Therefore, this small network size can be explained by factors inherent to the
Puerto Rican culture not observed in other cultures. The quality of the relations could
also help to explain the low scores for risky injecting and sexual behaviors. Michael,
Berkman, Colditz, Holmes, and Kawachi (2002) argued that adequate composition and
not the size of the social network brings support to people, preventing adverse impacts to
health; this was also supported by Zhu, Woo, Porter, and Brzezinski (2013).
Also, several researchers have shown how small social network size impacts
blood-borne virus transmission (Cepeda et al., 2011; El-Bassel, 2006; Latkin et al., 1995;
Suh et al., 1997). Indeed, Cepeda et al. (2011) showed the impact of the network size in
trust (a protective factor), where larger network sizes were associated with less trust and
lower risky injection practices. Network sizes reported by Costenbader, Astone, and
Latkin (2006) were also consistent, illustrating differences between the network sizes of
PR-IDU and those reported in the United States.
Low network density in PR-IDU networks is not consistent with the work of
several authors elsewhere who also measured network density among IDUs
(Costenbader, Astone and Latkin, 2006; El-Bassel, 2006 & Cepeda et al. 2011; Latkin et
al., 1995; Suh et al., 1997;). Several researchers worldwide have reported IDU network
average density to vary between 0.50 and 0.80; PR-IDU in the present study had an
average social network density of 0.33. This lower density was an unexpected result
based primarily on reports by Hatzenbuehler, Phelan, and Link (2013) and Harris and
Rhodes (2013). The IDU in the present study had a high number of persons in the
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network and geographic insularism. Thus, if a high level of social cohesion is observed, a
corresponding high density is expected, which was not found here. These authors
explained that stigma related to an undesirable behavior or condition plays a crucial role
in the types of relations established among people as well as the preventive health
measures they take. In addition, Cornwell (2009) explained that people with very similar
health problems tend to have high-density networks with more stringent (rigid) rules and
highly defined roles and expectations. However, based in the distrust reported among
many of the participants, it could be explained why the social networks are not dense as
in the literature documented elsewhere. Anonymity of actions taken and people with
whom they hang out might be serving as protection factors for PR-IDU.
In terms of the type of people within the network, PR-IDU networks were very
homogenous for sex composition and route of drug administration (injecting). Not
surprisingly, these results are consistent with literature indicating that low injecting risk
and sexual risk behaviors have networks with very low heterogeneity regarding sex
composition (Latkin et al., 1995; Latkin et al., 2009; Rothenberg, 2006; Tobin, and
Latkin, 2008; Tucker et al., 2009). The age of the members in the network did not
statistically differ from participants’; this concordance is associated with reduced
injecting and sexual risk behaviors (Rothenberg, 2006; Tobin, and Latkin, 2008). Several
studies have indicated that people very similar in terms of age and sex will have similar
injecting and sexual risk behaviors, which in this case were low. For example,
geographical insularism (Braine et al., 2008), means of generating income (Braine et al.,
2008; Latkin et al., 2009, 2009a), educational level (Costenbader, Astone, & Latkin,
2006; De et al., 2007; Latkin et al., 1995, 2009, 2009a; Wylie, Shah, & Jolly, 2006);
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pooling resources for drug acquisition (Koester, Glanz, & Barón, 2005); injection
frequency (Aitken, Higgs, & Bowden, 2008; De et al., 2007; Latkin et al., 1995; Paintsil
et al., 2009) and years injecting (Aitken, Higgs & Bowden, 2008; De et al., 2007; De et
al., 2007a; Latkin et al., 1995, 2009; Paintsil et al., 2009; Wylie, Shah, & Jolly, 2006) are
related to low risk profiles allowing survival. When the profiles of the people in a
network are very similar in terms of these characteristics, social structures develop
through which individuals recodify their reality, adopting collectively similar risk
behaviors (Gelpí-Acosta, Hagan, Jenness, Wendel, & Neaigus, 2011).
Other structural network characteristics of PR-IDU differ from other IDU
networks reported in the literature in terms of their composition. For instance, the
quantity of lovers or sex networks in our sample was “0” for most of our participants,
with an average of 0.14. Several researchers have posited that IDU in mainland USA and
other locations do not report participants to stop having sex due to their addiction. Their
sex-network average size ranges from 1.03 – 2.6 (Costenbader, Astone and Latkin, 2006;
El-Bassel, 2006; Latkin et al. 1995; Suh et al. 1997). The average number of family
members in the network 0.21 (range 0 – 1) is consistent with the reported number by ElBassel (2006) and Wylie, Shah and Jolly (2006) that average 0.8 (range 0.33 – 1.0) and 08
(range 0.0 – 1.0) respectively. El-Bassel (2006) and Wylie, Shah and Jolly (2006)
documented that IDU are frequently left behind by family members, and social roles are
substituted by acquaintances and friends. These observations are consistent with our data
in which networks were mainly acquaintances and friends (1.00 and 1.58 respectively).

8

Median value, not average.
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In addition to the composition of the network, the study explored the social
bonding among members using three measures: the psychological closeness of
participants with the participant; the frequency participants communicate with those
members; and the level of trust they share with the network members. As expected,
bonding among the participants was low in terms of trust. In general, participants scored
2 points in an 8 point scale meaning that most of the edges are in lower 25% of the scale.
This result validates the anecdotal information in which participants commonly report
distrust as participants expressed there are no friends, no love, no one you can trust. Other
researchers of PR-IDU also have argued the need to evaluate how trust differs by gender
and could lead to increasing health disparities (Labault-Cabeza, Dávila-Torres, ReyesOrtiz, 2010), however the generalized low scored among participants for trustiness does
not sustain such statement. As expected, the surveyed population in this study did not
communicate frequently with the edges. Although the few edges within the network were
reported to have a close relationship with participants, the concept closeness seems to
need more analysis. The data suggest that even when communication patters aren’t
frequent nor they are too intimate, participants greatly value the relationship with the
network members.
In the case of the population surveyed by Labault-Cabeza, Dávila-Torres and
Reyes-Ortiz (2010), social isolation helps explaining why and how older adults valorize
the strength of ties. Machielse (2015) posited that older populations suffer higher levels
of social isolation, which implies less frequent communication and feeling unconnected
to their social network. This sense of non-connection makes older members over-value
ties. More research is required to be able to explain the possible social isolation not
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observed in other IDU populations (Wylie, Shah, & Jolly, 2006) and how it correlates to
the value ones gives to a tie.
Wylie, Shah and Jolly (2006) described stronger social ties among the IDU
originally using the questionnaire. Crawford, et al. (2014) also described that the social
discrimination suffered by IDU commonly causes social agglutination9 forming as de
facto stronger ties. However, although our sample shows high geographical insularism
their connections among them are weak. Crawford, et al. (2013) had also documented
that stronger ties and high homogeneity in networks promotes more drug-using ties and
other high risk behaviors. Likewise, our finding is not in agreement with Cornwell (2009)
who postulates, that smaller network sizes have higher density and stronger ties.
Nevertheless, the lower density and weak ties helps explaining the low risky injection and
sexual practices scores (Crawford, et al., 2013, 2014).
PR-IDU networks are different than those commonly documented in literature.
Therefore, in terms of social network approaches, it seems convenient to follow Suárez
(2000) recommendation for Puerto Rican populations. Anthropological research using
phenomenological and ethnography approaches would help understand better why PRIDU networks are atypical.
In the other hand, some structural and social characteristics of the PR-IDU helped
explain risky behavior adoption. For instance, after controlling for all network and
individual characteristics, sexual risky behaviors are only explained by individual factors.
For instance the community they reported to spent more time at, the low educational level

9

Social agglutination—aggregates of people with similar characteristics due to environmental
forces and not necessary self-motivated.
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and the longer time they had spent in jail. Yet, risky injecting behaviors are better
explained by the years the social network members have been injecting and the injecting
practices they had. Both results are broadly consistent with previous research
demonstrating that having biggest networks also increases the odds of risky behaviors
(Adams, Moody, & Morris, 2013; DeRubeis & Jolly, 2010;Wylie, Shah, & Jolly, 2006;
Wylie, Shaw, Finneran, & Stephenson, 2014). Literature suggests that smaller IDU
networks usually have more rigid rules that serve as a preventive factor for riskier
behaviors such as those increasing HIV transmission (Cornwell, 2009). Among those
IDU with lower density and weaker ties, adoption of risky behaviors is less likely to
happen (Crawford, et al., 2013, 2014). Another factor that helps explain the risky sexual
behaviors adoption is the social network demographic characteristics. Networks lack
lovers within their closer 5 nodes and are share the participant’s same sex (in a mostly
heterosexual community). Therefore, chances for risky sexual behaviors are less likely to
occur (no lovers), and network homogeneity is acting as a protecting factor as well.
In terms of the injecting risky behaviors, it was expected that network size
impacts risk score. Štulhofer, Chetty, Rabie, Jwehan, and Ramlawi (2012) reported that
network size was the only network characteristic predicting risky injecting practices. It
was not the case for the sample in the study. The only social characteristic impacting the
dependent variable was years the social network members had reported to be injecting
drugs and their practices at the time of injection. Wylie, Shah, and Jolly, (2006)
documented a positive relation between reporting nodes who had 5 or more years
injecting drugs and higher scores in risky injecting behaviors. Wylie et al., (2006)
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reported risks for these IDU to be almost 4 times higher than for those reporting noninjecting nodes.
Arce et al. (2011), who completed analysis of secondary data involving the same
population used in this study, found that most of the participants had been in the SEP for
more than 10 years. This is important, as SEP also includes other services such as health
information support, condoms, paraphernalia, drug treatment, and rehabilitation to IDU
during the exchange (Batos & Strathdee, 2000; Stancliff et al., 2003). This population
may be more highly educated on risk prevention practices lowering the risk behaviors
adoption; therefore the SEP could have successfully modified behaviors in accordance
with the harm reduction model.
Several authors and health authorities have established how Puerto Rican HCV
and HIV virus transmission epidemic differs from similar populations in the continental
USA, the Caribbean, and in other areas of the world (Amill et al., 1999; Colón et al.,
2001; CDC, 2008, 2009c; Delgado, Lundgren, Deshpande, Lonsdale, Purington (2008);
WHO, 2009). In the effort to fight the epidemic, the present study also assessed how the
social networks of IDU participating in the SEP impact risk for HCV and HIV. The
hypothesis tests indicated that HIV is explained by at least one relation characteristic of
the social network but none of the structural characteristics. GEE analysis demonstrated
that the correlations among HIV are held towards the social network exposure. This
means that the only network characteristic being related to the self-reported HIV positive
status was the social network exposure as measured by the practices the network
members had when injecting.
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Networks in the present study have very low number of family members, lovers
and weak ties consistent with lack of support and environments shortage similar to those
reported by El-Bassel (2006) and Wylie, Shah, and Jolly (2006). Kalichman, Watt,
Sikkema, Skinner, and Pieterse (2012) documented the adoption of riskier drug behaviors
and sexual practices to meet survival needs among South African shebeens10. These
authors explained that the lack of resources is somehow buffered by resources provided
by the network. But those lacking such social support will adapt to survive and satisfy
their needs. As El-Bassel (2006) documented, PR IDU substitute the roles that family
normally plays with acquaintances or friends in the network. These new networks
eventually determine the risks that the IDU will accept, as a form of social normalization
in the group even when the “acceptance” implies engaging in higher risk behaviors
(Gottileb, 1985). For example, if the network shares needles that have not been bleached,
the new member will go along with taking the risk although before joining the network
they would not. Thus, the inclusion of family members and reinforcement of ties with
low risk profile people in the network of PR-IDU could serve to prevent transmission of
HIV.
In terms of HCV, the multivariate analysis shows that social network exposure is
the only relational network exposure significantly correlated to self-reported positive
status. Therefore, if those considered low risk profilers, meaning those that are not IDUs,
such as pastors, community leaders, CBOs, get involved in the lives of the IDU, by
becoming part of their network, it may be helpful in stopping the transmission of
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Shebeens—ethnic group in South Africa.
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HCV/HIV. In other words, replacing network members with lower profile members will
reduce the number of members that will not automatically follow the high risk behavior.
It is also important to mention, that in both HIV and HCV the number of years the
participants had been incarcerated was statistically associated with the serum-status selfreport. This implies that reducing the time a person is incarcerated could significantly
reduce the odds of self-reporting as a HIV/HCV serum positive.
Gottileb, (1985) posited that drug addicts engage in an undesirable social behavior
that threats their health and that these threats not only increase with time, but the IDU are
more vulnerable as they age and face other biopsychosocial complications inherent to the
addiction environment in which they live. Thus, IDU behave within social norms pattern
that allow them attenuate the level of social arousal even when they are conscious of the
unhealthy behavior. Following the results reported by Pollack (2001), that HCV
contagion after a single injection occurred in 3–9% of all cases in comparison to 1% for
HIV, the social network interactions needs to be carefully observed.
However, Puerto Rico’s laws do not allow having sanitary measures that allow
harm reduction in jails. For instance, to have a syringe exchange program within jails or
the use of condoms are prohibited for prisoners. Also Puerto Rico’s laws keep a punitive
approach upon drug use and drug users. Subject approaches make it hard to avoid
imprisonment, reinforcing environment shortage and the adoption of survival behaviors
that include higher risk of blood born transmission.
Limitations
It is important also to mention that are some limitations that could impact
generalization of the study results. For instance, at the time of the study, the CBO suffer a
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budget reduction that forced the CBO to limit the services from nine locations from its
original 12. This was accompanied by multiple police operations forcing IDUs to a
diaspora that limited access for many to the syringes exchange spots. In some locations,
data collection was stopped for many reasons, such as (a) drugs dealers were reorganizing the “order” (meaning that due to police interventions and arrests, new leaders
emerge and a new “order” and bylaws are created); (b) drugs dealers turn the syringe
exchange spot too dangerous to make the transactions; (c) they start to control the CBO:
instead of each individual making the exchange of syringes for their own needs, one
individual was making needle exchange for the entire shooting gallery; and (d) CBO was
alerted to stop making the exchange by IDUs or the drugs dealers. For this reason the
study ended collecting data only in seven locations instead of the original nine.
Therefore, because of the number of police interventions and the subsequent
instability they caused in the communities, there may have been a volunteer bias in that
we got the healthiest participants or those who felt they could go out for exchanges more
safely. The availability of volunteers for this study was limited by the CBO’s ability to
penetrate the communities. Whatever reached the CBO had in attracting individuals to
come out and exchange their needles represents the sample. Those that are the most
unlikely to seek help, that use drugs more often, and those that are too ill to come out in
public were outliers that did not participate by recruiting through the CBO. Finally,
although participants agreed to disclose highly unsociable behaviors, as with any survey,
they were still likely to provide socially desired responses.
On the other hand, the fact that we did not ask notes questions about how long
they had been participating in the CBO program or the time at first injection limits the
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assessment of the role SEP could be playing in the prevention of HCV/HIV epidemic and
the adoption of risky behaviors. Results cannot be generalized to all PR-IDU, PR-IDU
not participating in SEP programs, or in rural areas that injecting drug behaviors are
theorized to be different. Finally, the results suggest association of network
characteristics to injecting and sexual behaviors as well as HCV/HIV self-reported status;
the analyses cannot be used to support causal associations.
The study did not assess knowledge of preventive measures for HCV/HIV
contagion. Knowledge plays an important role in the risky behaviors adoption and
HCV/HIV transmission to uninfected nodes (Korthuis et al., 2012). Knowledge of
HCV/HIV prevention among participants could have played an important explanatory
role in understanding differences in the risky behaviors adoption and self-reported status.
Implications for Positive Social Change
Based in the results and limitation of the study, the CBO currently participating in
this study should search for strategies that allow PR-IDU to have more contact with
family. Family contact has been shown elsewhere and confirmed in this study to be a
protective factor. In this way, IDU also increase the network size with low risk profilers;
this is also a protective factor for the HIV/HCV transmission and for reducing risky
behaviors. It is also important that the CBO measure the knowledge of IDU and their
networks on HCV/HIV protecting measures.
In the other side, it is necessary to lobby for adoption of non-punitive policies that
allow IDU to receive treatment and clean syringes independently of the police
interventions. Government is being called to reflect on the effectiveness of their actions
in the long term, taking in consideration health impact of punitive laws in the HCV/HIV
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transmission and adoption of injecting/sexual risky behaviors. Unfortunately, Puerto
Rico’s drug policies do not seem to favor change towards the decriminalization of drugs
and much less its legalization.
This study was also an evaluation for a CBO. This requires being able to reach to
circumstantial everyday life of people using drugs in Puerto Rico. For the first time, a
study has pointed to the loneliness of PR-IDU. Theoretically, IDU face lot of threats in
the streets, and elsewhere we observed the adverse results of drugs use in the society.
Nevertheless, during the study, people spoke of their invisibility to the health system and
to the society.
The results indicate that most of the IDU reported low syringe sharing, suggests
that CBO work had positively impacted the knowledge and health practices among PRIDU. However, the study brings evidence that there is a need to improve the cohesion in
the IDU networks and the investment in social capital is that helps also reducing
HCV/HIV contagion. In addition, the research demonstrates how universities can
collaborate with CBO to evaluate health services and improve the health of those
receiving their services. For example as the results of this project were obtained new
initiatives were taken for improving health outcomes. For instance, the CBO developed a
HCV knowledge questionnaire for their population, in that way knowledge regarding
HCV was measured and a new scale adapted for PR-IDU is under construction (ZayasRíos, et al. 2015). Peer counseling groups are being organized and to some point the CBO
is expanding services and spending less money but increasing empowerment. Two of the
outreach works also stated that the current study brings to outreach workers an expanded
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scope of their work and to understand their relevance within organization which at times
is underestimated.
Conclusion
The study brings evidence that PR-IDU networks of those participating in the SEP
differ from other IDU networks in size and closeness, with both being smaller and
weaker than those observed in the literature. Also PR-IDUs were likely to report that they
did not have sexual contact due to drug use. In terms of their injecting practices, PR-IDU
scored very low for risky injection and sexual practices. Nevertheless, the HCV/HIV
prevalence status was higher than those reported worldwide. The HCV/HIV positive
serum-status reported was directly related to the years of the people within the network
had been in jail, their HIV status and the injecting practices they attach to. Likewise,
injecting practices were positively related to the years of people in the network had been
injecting as well as the injecting practices they attach to and the sexual practices were not
positively related to any of the network characteristics.
Based in these findings, CBO in charge of the SEP program needs to improve
their strategies for changing injecting behaviors among participants. In one or other way
it would be ideal that CBO could encourage communities to become part of IDU
everyday life; actions that could help in the reduction of HIV/HCV transmission. The
awareness among community members about their role in the life of these people may
impact the empowerment of IDU for reducing unsafety injections and better community
health. Although this is an expansion of the current CBO functions besides the IDU
population data suggest potential benefits for both the CBO and the communities.
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Last, for public health practitioners, it becomes fundamental to understand key
differences between the Puerto Rican IDU islanders and Puerto Rican IDU elsewhere or
other IDU populations documented in literature. Therefore, interventions for Puerto
Rican IDU had to be tailored taking in consideration their uniquely unsafe injection
behaviors and sexual practices. Otherwise, intervention programs may be condemned to
failure due to the intrinsic properties of the Puerto Rican IDU population.
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Appendix A: Hypothesis and Statistical Testing Plan
Hypothesis
Ho1-1: There is no relationship between network size, as measured by the sum of
network members reported by the participant, and harmful injecting practices, as measured by
a Blood Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ) developed
by WHO in combination with Social Network Instrument develop by Wyllie (2006), among
participants in the NEP.
Ha1-1: There will be a relationship between network size, as measured by the sum of
network members reported by the participant, and harmful injecting practices, as measured by
a Blood Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ) developed
by WHO in combination with Social Network Instrument develop by Wyllie (2006), among
participants in the NEP.
Ho2-1: There is no relationship between network size, as measured by the number of
participants reported in the network, and risky sexual practices among reported network
members, as measured by an average level of risks calculated using the Blood Borne Virus
Transmission Risk Assessment Questionnaire (BBV-TRAQ) developed by WHO in
combination with Social Network Instrument develop by Wyllie (2006).
Ha2-1: There will be a relationship between network size, as measured by the number of
participants reported in the network, and risky sexual practices among reported network
members, as measured by an average level of risks calculated using the Blood Borne Virus
Transmission Risk Assessment Questionnaire (BBV-TRAQ) developed by WHO in
combination with Social Network Instrument develop by Wyllie (2006).
Ho1-2: There is no relationship between network density, as measured by the sum
connections to others in the personal networks, and harmful injecting practices, as measured
by a Blood Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ)
developed by WHO in combination with Social Network Instrument develop by Wyllie (2006),
among participants of the NEP.
Ha1-2: There will be a relationship between network density, as measured by the sum
connections to others in the personal networks, and harmful injecting practices, as measured
by a Blood Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ)
developed by WHO in combination with Social Network Instrument develop by Wyllie (2006),
among participants of the NEP.

Dependent
Variable
Harmful
Injecting
Practices –
continuous

Independent
Variable
Network size –
continuous

Statistics test
Univariate –
per cent, mean,
median, etc.
Bivariate –
Pearson
correlation
Multivariate GEE

Risky sexual
practices continuous

Harmful
Injecting
Practices –
continuous

Network density
– continuous

Univariate –
per cent, mean,
median, etc.
Bivariate –
Pearson
correlation
Multivariate GEE
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Ho2-2: There is no relationship between density network, as measured by the sum of
the connections to others in the personal networks, and risky sexual practices as measured by
an average level of risks calculated using the Blood Borne Virus Transmission Risk
Assessment Questionnaire (BBV-TRAQ) developed by WHO in combination with Social
Network Instrument develop by Wyllie (2006), among participants of the NEP.
Ha2-2: There will be a relationship between density network, as measured by the sum of the
connections to others in the personal networks, and risky sexual practices as measured by an
average level of risks calculated using the Blood Borne Virus Transmission Risk Assessment
Questionnaire (BBV-TRAQ) developed by WHO in combination with Social Network
Instrument develop by Wyllie (2006), among participants of the NEP.
Ho1-4 : There is no relationship between tie relations, as measured by an index based
on sum of the responses to five questions in the questionnaire, and harmful injecting
practices, as measured by a Blood Borne Virus Transmission Risk Assessment Questionnaire
(BBV-TRAQ) developed by WHO in combination with Social Network Instrument develop by
Wyllie (2006), among participants of the NEP.
Ha1-4 : There will be a relationship between tie relations, as measured by an index
based on sum of the responses to five questions in the questionnaire, and having riskier
harmful injecting practices, as measured by a Blood Borne Virus Transmission Risk
Assessment Questionnaire (BBV-TRAQ) developed by WHO in combination with Social
Network Instrument develop by Wyllie (2006), among participants of the NEP.
Ho2-4: There is no relationship between tie relations, as measured by an index based
on sum of the responses of the five questions in the questionnaire, and risky sexual practices,
as measured by an average level of risks calculated using the Blood Borne Virus
Transmission Risk Assessment Questionnaire (BBV-TRAQ) developed by WHO in
combination with Social Network Instrument develop by Wyllie (2006), among participants of
the NEP.
Ha2-4: There will be a relationship between tie relations, as measured by an index
based on sum of the responses of the five questions in the questionnaire, and risky sexual
practices, as measured by an average level of risks calculated using the Blood Borne Virus
Transmission Risk Assessment Questionnaire (BBV-TRAQ) developed by WHO in
combination with Social Network Instrument develop by Wyllie (2006), among participants of
the NEP.
Ho1-5: There is no relationship between personal network exposure to HCV/HIV, as
measured by the type of risky behaviors characterized by the network members as reported
by the participant, and harmful injecting practices, as measured by a Blood Borne Virus
Transmission Risk Assessment Questionnaire (BBV-TRAQ) developed by WHO in

Risky sexual
practices –
continuous

Harmful
Injecting
Practices –
continuous

Tie relations –
continuous

Univariate –
per cent, mean,
median, etc.
Bivariate –
Pearson
correlation
Multivariate –
GEE

Risky sexual
practices –
continuous
Harmful
Injecting
Practices –
continuous

Personal network
exposure –
continuous

Univariate –
per cent, mean,
median, etc.
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combination with Social Network Instrument develop by Wyllie (2006), among participants of
the NEP.
Ha1-5: There will be a relationship between personal network exposure to HCV/HIV, as
measured by the type of risky behaviors characterized by the network members as reported
by the participant, and harmful injecting practices, as measured by a Blood Borne Virus
Transmission Risk Assessment Questionnaire (BBV-TRAQ) developed by WHO in
combination with Social Network Instrument develop by Wyllie (2006), among participants of
the NEP.

Bivariate –
Pearson
correlation
Multivariate –
GEE

Ho2-5: There is no relationship between personal network exposure to HCV/HIV, as
measured by the type of risky behaviors characterized by the network members and as
reported by the participant, and risky sexual practices, as measured by an average level of
risks calculated using the Blood Borne Virus Transmission Risk Assessment Questionnaire
(BBV-TRAQ) developed by WHO in combination with Social Network Instrument develop by
Wyllie (2006), among participants of the NEP.
Ha2-5: There will be a relationship between personal network exposure to HCV/HIV, as
measured by the type of risky behaviors characterized by the network members and as
reported by the participant, and risky sexual practices, as measured by a Blood Borne Virus
Transmission Risk Assessment Questionnaire (BBV-TRAQ) developed by WHO in
combination with Social Network Instrument develop by Wyllie (2006), among participants of
the NEP.

Risky sexual
practices –
continuous

Ho1-6: There is no relationship between propinquity, as measured by the physical
distance from the participant to other actors in the network using participant zip code, and
harmful injecting practices, as measured by a Blood Borne Virus Transmission Risk
Assessment Questionnaire (BBV-TRAQ) developed by WHO in combination with Social
Network Instrument develop by Wyllie (2006), among participants of the NEP.
Ho1-6: There will be a relationship between propinquity, as measured by the physical distance
from the participant to other actors in the network using participant zip code, and harmful
injecting practices, as measured by a Blood Borne Virus Transmission Risk Assessment
Questionnaire (BBV-TRAQ) developed by WHO in combination with Social Network
Instrument develop by Wyllie (2006), among participants of the NEP.

Harmful
Injecting
Practices –
continuous

Ho2-6: There is no relationship between propinquity, as measured by the physical
distance from the participant to other actors in the network using participant zip code, and
risky sexual practices, as measured by a Blood Borne Virus Transmission Risk Assessment

Risky sexual
practices –
continuous

Propinquity –
categorical

Univariate –
per cent, mode,
etc.
Bivariate – ttest student
(parametric) or
M-Whitney test
(non
parametric)
Multivariate –
GEE
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Questionnaire (BBV-TRAQ) developed by WHO in combination with Social Network
Instrument develop by Wyllie (2006), among participants of the NEP.
Ha2-6: There will be a relationship between propinquity, as measured by the physical
distance from the participant to other actors in the network using participant zip code, and
risky sexual practices, as measured by a Blood Borne Virus Transmission Risk Assessment
Questionnaire (BBV-TRAQ) developed by WHO in combination with Social Network
Instrument develop by Wyllie (2006), among participants of the NEP.
Ho1-7: There is no relationship between profile relations (number of people in the
network at high risk for HIV and/or Hepatitis C based on criteria defined in the literature) and
harmful injecting practices, as measured by a Blood Borne Virus Transmission Risk
Assessment Questionnaire (BBV-TRAQ) developed by WHO in combination with Social
Network Instrument develop by Wyllie (2006), among participants of the NEP.
Ha1-7: There will be a relationship between profile relations (number of people in the network at
high risk for HIV and/or Hepatitis C based on criteria defined in the literature) and harmful
injecting practices, as measured by a Blood Borne Virus Transmission Risk Assessment
Questionnaire (BBV-TRAQ) developed by WHO in combination with Social Network
Instrument develop by Wyllie (2006), among participants of the NEP.

Harmful
Injecting
Practices –
continuous

Ho2-7: There is no relationship between profile relations (number of people in the
network who are at high risk for HIV and/or Hepatitis C as indicated in the literature) and risky
sexual practices, as measured by a Blood Borne Virus Transmission Risk Assessment
Questionnaire (BBV-TRAQ) developed by WHO in combination with Social Network
Instrument develop by Wyllie (2006), among participants of the NEP.
Ha2-7: There will be a relationship between profile relations (number of people in the
network who are at high risk for HIV and/or Hepatitis C as indicated in the literature) and risky
sexual practices, as measured by a Blood Borne Virus Transmission Risk Assessment
Questionnaire (BBV-TRAQ) developed by WHO in combination with Social Network
Instrument develop by Wyllie (2006), among participants of the NEP.

Risky sexual
practices –
continuous

Profile relations –
continuous

Univariate –
per cent, mean,
median, etc.
Bivariate –
Pearson
correlation
Multivariate –
GEE
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Appendix B: Operational Variables Plan
Place in the
questionnaire

Variable name
Age

English question
What is your date of birth?

Spanish translation
¿Cuál es tu fecha de
nacimiento?

Operational variable
Continuous variable collected as year/month/day.
For inferential analysis will recode as ordinal variable:

DEM1

Gender

What gender do you identify
yourself as?

Con cuál género te
identificas más?

Place of birth

Where were you born?

¿Dónde nació usted?

Educational level

What is the highest level of
education you have completed?

¿Cuál es el grado educativo
más alto completado?

DEM2

DEM3

DEM4

< 29 years
30-39 years
40-49 years
> 50 years
Nominal variable with 4 categories:
0
Male
1
Female
2
Transgender female
3
Transgender male
Nominal variable with 3 categories:
1
Puerto Rico
2
USA
3
Other: _____________________
Ordinal variable with 7 categories:
0
Did not complete HS / grade school
1
Graduated grade 12
2
Trade school
3
Some University / College
4
Associate Degree
5
Bachellor
6
Other, (specify_______________)
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Place in the
questionnaire

Variable name
Primary Income
Source

English question

Spanish translation

Over the last year what was the
main way you got money to live
on? (circle only one)

Durante el último año ¿cuál
fue la manera más frecuente
en la que conseguiste dinero
para vivir? Marque sólo una.

City Postal Code

Using your postal code, what part
of the city do you live in??

¿Cuál es el zip-code del área
donde vives o en que barrio o
sector vives?

Immigrant

Have you moved to Puerto Rico
within the past 12 months?

¿Hace menos de un año que
vives en Puerto Rico?

DEM5

DEM6

DEM7

DEM8

Previous Living
Place

Where were you living before you
came to Puerto Rico?

¿Dónde vivías antes de venir
a Puerto Rico?

Arrested

Have you been arrested in the last
6 months?

¿Has sido arrestado en los
pasados 6 meses?

DEM9
Incarcerated
DEM10

Have you been incarcerated?

¿Has estado en la cárcel?

Operational variable
Nominal variable with 7 categories:
0
1

Regular work (full, part time or contract)
Welfare, EI, pension or other government
support
2
Money from family/friends
3
Sex trade/prostitution
4
Dealing or doing drug runs
5
Panhandling
6
Stealing
7
Other,
(specify_________________)
Qualitative variable. Two options are provide to the
participant to responds the question: (1) zip-code or (2)
neighborhood name. Based on the answers a nominal
variable will be constructed.
Nominal variable with 2 categories:
0 No
1 Yes
Qualitative variable. A blank is provide to include the town
or place of the previous residency. Based on the answers a
nominal variable will be constructed.
Nominal variable with 2 categories:
0 No
1 Yes
Nominal variable with 2 categories:
0 No
1 Yes
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Place in the
questionnaire

Variable name
Time Incarcerated

English question
How long time was you
incarcerated?

Spanish translation

Operational variable

¿Por cuánto tiempo estuviste
encarcelado?

Continuous variable collected as a number of years/months/
days in the jail.
For inferential analyses an ordinal variable will be
constructed such as:

DEM11

Time Release

When you were last released?

¿Cuándo saliste de la cárcel?

For inferential analyses an ordinal variable will be
constructed such as:

DEM12

HIV

Are you HIV +?

¿Eres VIH positivo?

DEM13
HIV Confirmation
DEM14

Is the HIV serostatus test
confirmed?

¿Ese diagnóstico fue
confirmado por una prueba
de laboratorio?

Date of Test

Date last tested?

¿Cuándo fue la última vez
que te realizaste la prueba?

Incarcerated

Have you been incarcerated in the
last 6 months?

¿Tienes Hepatitis C?

DEM15:

DEM16

DEM17

1. less than one year
2. 1-5 years
3. 6-10 years
4. 11 or more years
Continuous variable collected as a number of years/months/
days since release

Time of
incarcerated

How much time was you
incarcerated?

¿Ese diagnóstico fue
confirmado por una prueba
de laboratorio?

1. less than one year
2. 1-5 years
3. 6-10 years
4. 11 or more years
Nominal variable with 2 categories:
0 No
1 Yes:
Nominal variable with 2 categories:
0 No
1 Yes
Qualitative variable. A blank is provides to include the age.
Based on the answers a continuous variable will be
constructed.
Nominal variable with 2 categories:
0 No
1 Yes:
Nominal variable with 2 categories:
0 No
1 Yes
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HIV

Are you HIV positive?

¿Cuándo fue la última vez
que te realizaste la prueba?

HCV

The first time you injected, how
old were you?

Cuándo te inyectaste la
primera vez ¿Qué edad
tenías?

Drugs Lifetime

What of the following drugs have
you use in your lifetime? (drug of
choice, circle all that apply)

Cuál de las siguientes drogas
haz utilizado durante tu vida?

What drug is your favourite to
inject? (circle only oney)

¿Cuál es tu droga favorita
para inyectar? Circule sólo
una de la opciones

DEM18

DEM19

DEM21

Nominal and multiple choices variable such as:
1 Alcohol
2 Methamphetamines
3 Xanax/Valium
4 Amphetamines
5 Barbiturates
6 Cocaine
7 Crack
8 Demerol/morphine/opium
9 Downers/tranquilizers
10 Ecstasy
11 Gasoline/solvents
12 Marijuana
13 PCP/Angel dust
14 Tylenol/Panado PM
15 Heroin
16 Mushrooms
17 Percoset
18 Methadone prescribed
19 Methadone unprescribed
20 None
21 Other,
(specify_______________)
55 Unsure
66 Not applicable
99 Refused to answer

DEM20

Prefer Injecting
Drugs

Qualitative variable. A blank is provides to include the age.
Based on the answers a continuous variable will be
constructed.
Qualitative variable. A blank is provides to include the age.
Based on the answers a continuous variable will be
constructed.

Nominal variable such as:
0
Cocaine (uptown)
1
Morphine
2
Heroin (horse, junk, smack, downtown)
3
Heroin and cocaine (speedball)
4
Heroin mixed with another drug
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5
6
7
8
9
10
11
12
13
13

DEM22

Frequency of
Injection

In the past month, how often did
you inject (shoot up)? (circle only
one)

En los últimos seis meses
¿cuántas veces te has
inyectado? Marcar sólo una
de las opciones.

Amphetamines (speed, uppers)
Methadone
Crack/rock cocaine
Methamphetamine (crystal meth)
PCP (angel dust)
Dilaudid
Barbiturates (downers)
Ritalin alone
Xylacym (horse anestesia)
Other,
(specify___________________)
55 Unsure
66 Not applicable
99 Refused to answer
Nominal variable such as:
0
Not at all
1
Once in a while, not every week
2
Regularly, once or twice a week
3
Regularly, three or more times a week
4
Every day (How many times per day
________)
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Place in the
questionnaire

Variable name
Exchange

English question

Spanish translation

In the last month, how many times
have you injected with another
person’s used needle/syringe?

Durante el pasado mes,
¿Cuántas veces al inyectarte
usaste una jeringuilla de otra
persona?

On those occasions, how often did
you rinse it with a combination of
full strength bleach and water (i.e,
the ‘2x2x2’ method) before you
used it?

En esa/s ocasión/es que tantas
veces lavaste la jeringuilla
con una solución fuerte de
agua y cloro antes de usarla?
Ej. Método 2X2X2

In the last month, how many times
have you injected with a
needle/syringe after another
person has already injected some
of its contents?

En el pasado mes ¿cuántas
veces te has inyectado parte
de la droga de otra persona
con la misma jeringuilla que
ella?

In the last month, how many times
have you received an accidental
needle stick/ prick from another
person’s used needle/syringe?

En el pasado mes ¿Cuántas
veces te has pinchado con
una jeringuilla/aguja utilizada
por otra persona
accidentalmente?

NeSyrCo1a

Rinse
NeSyrCo1b

Needle Exchange

NeSyrCo2

Accidental needle
stick
NeSyrCo3

Operational variable
Ratio variable of five categories:
0. No times (go to question 2)
1. Once
2. Twice
3. 3 – 5 times
4. 6 -10 times
5. More than 10 times
Ordinal variable of five categories:
1. Never
2. Rarely
3. Sometimes
4. Often
5. Every time
Ratio variable of five categories:
0.
1.
2.
3.
4.
5.

No times (go to question 2)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

Ratio variable of five categories:
0.
1.
2.
3.
4.
5.

No times (go to question 2)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

187

Place in the
questionnaire

Variable name
Frequency of rinse

English question

En esa/s ocasión/es con
cuanta frecuencia lavaste la
jeringuilla/aguja con cloros
puro antes de usarla?

Ordinal variable of five categories:

In the last month, how many
times have you injected a drug
that was filtered through another
person’s filter?

En el pasado mes ¿cuántas
veces te has inyectado drogas
que son filtradas a través del
filtro de otra persona?

Ratio variable of five categories:

In the last month, how many
times have you injected a drug
that was prepared in another
person’s used spoon or mixing
container?

Durante el pasado mes,
¿cuántas veces te has
inyectado drogas preparadas
en el cooker de otra persona?

Ratio variable of five categories:

On those occasions how often did
you clean the spoon or mixing
container before using it?

En esa/s ocasión/es ¿con qué
frecuencia limpiaste el cooker
antes de usarlo?

Ordinal variable of five categories:

NeSyrCo5

Used spoon

NeSyrCo6a

Spoon

NeSyrCo6b

Operational variable

On those occasions, how often did
you rinse it only with full-strength
bleach before you re-used it?

NeSyrCo4b:

Filtered

Spanish translation

1.
2.
3.
4.
5.

0.
1.
2.
3.
4.
5.

0.
1.
2.
3.
4.
5.

1.
2.
3.
4.
5.

Never
Rarely
Sometimes
Often
Every time

No times (go to question 2)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

No times (go to question 2)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

Never
Rarely
Sometimes
Often
Every time
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Place in the
questionnaire

Variable name

English question

Spanish translation

Water

In the last month, how many times
have you injected a drug prepared
with water which had been used
by another person

En el pasado mes ¿cuántas
veces te has inyectado drogas
preparadas con agua que ha
sido utilizada por otra
persona?

In the last month, how many times
have you injected a drug which
had come into contact with
another person’s used
needle/syringe?

En el pasado mes ¿cuántas
veces te has inyectado drogas
que han estado en contacto
con la jeringuilla/aguja usada
por otra persona?

In the last month, how many times
have you wiped your own
injection site with an object (e.g,
swab, tissue, hanky, towel etc)
which had been used by another
person?

En el pasado mes ¿Cuántas
veces te has limpiado el lugar
de la inyección con un objeto
(gasa, trapo, algodón, gasa de
alcohol, toalla etc.) que ha
sido utilizado por otra
persona?

In the last month, how many times
have you injected a drug that you
prepared immediately after
‘assisting’ another person with
their injection (e.g, injecting them,
holding their arm, handling used
needle/syringe; touching their
injection site to feel for a vein, to
wipe blood away, or to stop
bleeding)?

En el pasado mes ¿cuántas
veces te has inyectado luego
de ayudar a otra persona a
inyectarse (ej. Los has
inyectado, les has aguantado
el brazo, has manejado la
aguja o jeringuilla, le has
ayudado a conseguir la vena,
has limpiado la sangre del
área de inyección, o has
ayudado para que no sangre
más)?

NeSyrCo7:

NeSyrCo8

Drugs used

Wiped

NeSyrCo9

Frecuency of
injected

2PerCo10a

Operational variable
Ratio variable of five categories:
0. No times (go to question 2)
1. Once
2. Twice
3. 3 – 5 times
4. 6 -10 times
5. More than 10 times
Ratio variable of five categories:
0. No times (go to question 2)
1. Once
2. Twice
3. 3 – 5 times
4. 6 -10 times
5.
More than 10 times
Ratio variable of five categories:
0. No times (go to question 2)
1. Once
2. Twice
3. 3 – 5 times
4. 6 -10 times
5. More than 10 times
Ratio variable of five categories:
0.
1.
2.
3.
4.
5.

No times (go to question 2)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times
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Place in the
questionnaire

Variable name
Wash

English question

Spanish translation

On those occasions, how often did
you wash your hands before
preparing your mix?

En dichas ocasiones, ¿cuántas
veces te lavaste las manos
antes de preparar la mezcla?

In the last month, how many times
have you injected a drug that was
prepared by another person who
had already injected or assisted
someone else’s injection?

En el pasado mes, ¿cuántas
veces te has inyectado droga
que ha sido preparada por
otra persona que ya se ha
inyectado o ha ayudado a
otro/a a inyectarse?

On those occasions, how often did
the person preparing the mix wash
their hands before preparing the
mix?

En dichas ocasiones: ¿cuántas
veces esa persona se lavó las
manos antes de preparar la
mezcla?

In the last month, how many times
have you been injected by another
person who had already injected
or assisted in someone else’s
injection?

En el pasado mes ¿cuántas
veces has sido inyectado por
otra persona que ya se ha
inyectado o ha ayudado a
otro/a a inyectarse?

On those occasions, how often
did the person injecting you
wash their hands before
injecting you?

En dichas ocasiones:
¿cuántas veces esa
persona se lavó las manos
antes de inyectarte?

2PerCo10b

Prepared Drug Mix

2PerCo11a

Wash hands
2PerCo11b

Injected drugged

2PerCo12a

Frequency of
people wash their
hands
2PerCo12b

Operational variable
Ordinal variable of five categories:
1. Never
2. Rarely
3. Sometimes
4. Often
5. Every time
Ratio variable of five categories:
0. No times (go to question 2)
1. Once
2. Twice
3. 3 – 5 times
4. 6 -10 times
5. More than 10 times
Ordinal variable of five categories:
1. Never
2. Rarely
3. Sometimes
4. Often
5. Every time
Ratio variable of five categories:
0. No times (go to question 2)
1. Once
2. Twice
3. 3 – 5 times
4. 6 -10 times
5.
More than 10 times
Ordinal variable of five categories:
1.
2.
3.
4.
5.

Never
Rarely
Sometimes
Often
Every time
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Place in the
questionnaire

Variable name
Spoiled Syringe

2PerCo13a

Spoiled Wash Hand
2PerCo13b

Frequency of
touched

2PerCo14a

Frequency of wash
hands
2PerCo14b

English question

Spanish translation

In the last month, how many times
have you injected with a
needle/syringe which had been
handled or touched by another
person who had already injected?

En el pasado mes ¿cuántas
veces has inyectado a alguien
con una jeringuilla/aguja
usada o tocada por otra
persona que ya se ha
inyectado?

Ratio variable of five categories:

On those occasions, how often did
they wash their hands prior to
handling the needle/syringe that
you used?

En esas ocasiones ¿cuántas
veces la persona que usó o
tocó la jeringuilla se lavó las
manos antes de usar o tocar la
jeringuilla/aguja?

Ordinal variable of five categories:

In the last month, how many times
have you touched your own
injection site (e.g, to feel for a
vein, to wipe away blood, or to
stop bleeding) soon after
‘assisting’ another person with
their injection (e.g, injecting them,
holding their arm, handling their
use needle/syringe; touching their
injection site to feel for a vein, to
wipe away blood, or to stop
bleeding)?

En el pasado mes, ¿cuántas
veces has tocado el área
donde te inyectas (ej. Palpar
la vena antes de inyectarte,
limpiado tu sangre, o
aguantado el sangrado)
rápido luego de ayudar a otra
persona a inyectarse (ej. Los
has inyectado, les has
aguantado el brazo, has
manejado la aguja o
jeringuilla, le has ayudado a
conseguir la vena, has
limpiado la sangre del área de
inyección, o has ayudado
para que no sangre más)?
En dichas ocasiones, ¿cuántas
veces te lavaste las manos
antes de tocarte el área donde
te inyectas?

On those occasions, how often did
you wash your hands before
touching your own injection site?

Operational variable

0.
1.
2.
3.
4.
5.

No times (go to question 2)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

1. Never
2. Rarely
3. Sometimes
4. Often
5. Every time
Ratio variable of five categories:
0.
1.
2.
3.
4.
5.

No times (go to question 2)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

Ordinal variable of five categories:
1.
2.
3.
4.
5.

Never
Rarely
Sometimes
Often
Every time
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Injection site touch

In the last month, how many times
has another person touched your
injection site (e.g, to feel for a
vein, to wipe away blood, or to
stop bleeding)?

En el pasado mes, ¿cuántas
veces otra persona ha tocado
el área donde te inyectas (ej.
Palpar la vena antes de
inyectarte, limpiado tu
sangre, o aguantado el
sangrado)?

Ratio variable of five categories:

On those occasions, how often did
the person wash their hands
before they touched your injection
site?

En dichas ocasiones, ¿cuántas
veces la persona que tocó el
área donde te inyectas se lavó
las manos antes de tocar?

Ordinal variable of five categories:

In the last month, how many times
have you engaged in unprotected
vaginal sex with another person
(ie. penetration of the vagina with
the penis)?

En el pasado mes, ¿cuántas
veces haz tenido sexo vaginal
(ej. penetración de la vagina
con el pene) sin protección
con otra persona?

Unprotected
Menstruation
Vaginal Sex

In the last month, how many times
have you engaged in unprotected
vaginal sex with another person
(ie. penetration of the vagina with
the penis) during menstruation?

En el pasado mes ¿cuántas
veces haz tenido sexo vaginal
(ej. penetración de la vagina
con el pene) sin protección
con otra persona durante la
menstruación?

Vaginal Sex No
Lubrication

In the last month, how many times
have you engaged in unprotected
vaginal sex with another person
(ie. penetration of the vagina with
the penis) without lubrication?

En el pasado mes ¿cuántas
veces haz tenido sexo vaginal
(ej. penetración de la vagina
con el pene) sin protección
con otra persona sin
lubricación?

2PerCo15a

Injection Site Hand
Wash
2PerCo15b

Unprotected
Vaginal Sex
SexPra16:

SexPra17:

SexPra18

0.
1.
2.
3.
4.
5.

No times (go to question 2)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

1. Never
2. Rarely
3. Sometimes
4. Often
5.
Every time
Ratio variable of five categories:
0.
1.
2.
3.
4.
5.

No times (go to question 2)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

Ratio variable of five categories:
0. No times (go to question 2)
1. Once
2. Twice
3. 3 – 5 times
4. 6 -10 times
5. More than 10 times
Ratio variable of five categories:
0.
1.
2.
3.
4.
5.

No times (go to question 2)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

192

Place in the
questionnaire

Variable name
Frequency if
engaged oral sex

Spanish translation

Operational variable

En el pasado mes ¿cuántas
veces has tenido sexo oral (ej.
que los labios o la lengua
tengan contacto con el pene,
la vagina y/o el ano) con otra
persona sin protección?

Ratio variable of five categories:

In the last month, how many times
have you engaged in unprotected
manual sex with another person
(ie. fingers and hands come into
contact with the vagina, penis
and/or anus) during
menstruation?

En el pasado mes ¿cuántas
veces has tenido sexo manual
(ej. que tus manos o dedos
hayan tenido contacto con la
vagina, pene, y/o ano) con
otra persona mientras está en
menstruación?

Ratio variable of five categories:

Frequency of
engaged manual sex
with other

In the last month, how many times
have you engaged in unprotected
manual sex with another person
(ie. fingers and hands come into
contact with the vagina, penis
and/or anus) after injecting?

En el pasado mes ¿cuántas
veces has tenido sexo manual
(ej. que tus manos o dedos
hayan tenido contacto con la
vagina, pene, y/o ano) con
otra persona luego de
inyectarte?

Ratio variable of five categories:

Frequency of
engaged of manual
sex with another

In the last month, how many times
have you engaged in unprotected
manual sex with another person
(ie. fingers and hands come into
contact with the vagina, penis
and/or anus) without lubrication?

En el pasado mes ¿cuántas
veces has tenido sexo manual
(ej. que tus manos o dedos
hayan tenido contacto con la
vagina, pene, y/o ano) con
otra persona sin lubricación?

Ratio variable of five categories:

SexPra19

Frequency of
engaged manual sex
SexPra20

SexPra21

SexPra22

English question
In the last month, how many times
have you engaged in unprotected
oral sex with another person (ie.
lips and tongue come into contact
with the vagina, penis and/or
anus)?

0.
1.
2.
3.
4.
5.

0.
1.
2.
3.
4.
5.

0.
1.
2.
3.
4.
5.

0.
1.
2.
3.
4.
5.

No times (go to question 2)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

No times (go to question 2)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

No times (go to question 2)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

No times (go to question 2)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times
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Place in the
questionnaire
Social Network
Step 1

Variable name

English question

Spanish translation

Network

Which of these people has injected
drugs in the last 6 months:

Smoker/snorted

Not including marijuana use,
which of these people has
smoked/snorted/inhaled drugs in
the last 6 months
Which of these people has been a
sex partner of yours in the last 6
months
What is the gender of each of
these people?

¿Cuál de estas personas se
han inyectado drogas en los
pasados 6 meses?:
Sin incluir marihuana, ¿cuál
de estas personas ha fumado,
inhalado o utilizado drogas
en los pasados 6 meses?
¿Cuál de estas personas han
sido tu pareja sexual en los
últimos 6 meses?
¿Cuál es el sexo de cada una
de estas personas?

Social Network
Step 1
Social Network
Step 1

Sex partner
Gender

Social Network
Step 1
Age network

What is the age of each of these
people?

¿Cuál es la edad de cada una
de estas personas?

Operational variable
Nominal variable of three categories:
2. Y (Yes) or 1. N (No) or 0. U (Unsure)
Nominal variable of three categories:
2. Y (Yes) or 1. N (No) or 0. U (Unsure)
Nominal variable of two categories:
2. Y (Yes) or 1. N (No)
Nominal variable of four categories:
4. M male, 3. F female, 2. TM transgender male, 1. TF
transgender female.
Continuous variable collected as years old.
For inferential analysis will recode as ordinal variable:

Social Network
Step 1

Relationship
Social Network
Step 1
Social Network
Step 1

Social Network
Step 3

What is this person's relationship
to you:?

Size

Number of network members

Density

Interaction of network members

¿Qué tipo de relación tiene
esta persona contigo?
Número de miembros de la
red
Interacción de los miembros
de la red

< 29 years
30-39 years
40-49 years
> 50 years
Nominal variable of four categories:
4. F (Friend), 3. L (lover, spouse, girl/boyfriend), 2. R
(Relative), 1. C (Acquaintance/Stranger).
Continuos variable. The participant indicated the name or
nickname of the people in their network.
Is the degree to which a person’s ties are connected to one
another. Entails summing the degree to which each of the
alter is connected to others in the personal networks.
DE=l/N(λ) where
l=number of links
N=network size
λ=maximum numbers of nominations requested
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Place in the
questionnaire
Social Network
Step 1

Variable name

English question

Out-degree

Number of network members

Type of relations

What is this person's relationship
to you?

Spanish translation
Número de miembros de la
red
¿Qué tipo de relación tiene
esta persona contigo?

Social Network
Step 2
Propinquity

Using your postal code, what part
of the city do you live in?

¿Cuál es el zip-code del área
donde?

Sexual Risk
Practices

In the last month, how many
times have you engaged in
unprotected vaginal sex with
another person (ie. penetration of
the vagina with the penis)?

En el pasado mes, ¿cuántas
veces haz tenido sexo vaginal
(ej. penetración de la vagina
con el pene) sin protección
con otra persona?

In the last month, how many
times have you engaged in
unprotected vaginal sex with
another person (ie. penetration of
the vagina with the penis) during
menstruation?

En el pasado mes ¿cuántas
veces haz tenido sexo vaginal
(ej. penetración de la vagina
con el pene) sin protección
con otra persona durante la
menstruación?

DEM6

SexPra16 to
SexPra22

In the last month, how many
times have you engaged in
unprotected vaginal sex with
another person (ie. penetration of
the vagina with the penis) without
lubrication?
In the last month, how many
times have you engaged in
unprotected oral sex with another
person (ie. lips and tongue come

En el pasado mes ¿cuántas
veces haz tenido sexo vaginal
(ej. penetración de la vagina
con el pene) sin protección
con otra persona sin
lubricación?
En el pasado mes ¿cuántas
veces has tenido sexo oral (ej.
que los labios o la lengua
tengan contacto con el pene,
la vagina y/o el ano) con otra
persona sin protección?

Operational variable
Using size variable we can establish how sociable the
participant is.
Nominal variable with 4 categories:
F (family member),
L (lover, spouse, girl/boyfriend),
R (Friend),
C (Acquaintance/Stranger).
Qualitative variable. Two options are provide to the
participant to responds the question: (1) zip-code or (2)
neighborhood name. Based on the answers a nominal
variable will be constructed.
An index will me make based on the responses of the seven
questions. The index is the sum of the: number in each
question. The higher score the riskier the sexual behavior
is.
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into contact with the vagina, penis
and/or anus)?
In the last month, how many
times have you engaged in
unprotected manual sex with
another person (ie. fingers and
hands come into contact with the
vagina, penis and/or anus) during
menstruation?
In the last month, how many
times have you engaged in
unprotected manual sex with
another person (ie. fingers and
hands come into contact with the
vagina, penis and/or anus) after
injecting?
In the last month, how many
times have you engaged in
unprotected manual sex with
another person (ie. fingers and
hands come into contact with the
vagina, penis and/or anus)
without lubrication?

En el pasado mes ¿cuántas
veces has tenido sexo manual
(ej. que tus manos o dedos
hayan tenido contacto con la
vagina, pene, y/o ano) con
otra persona mientras está en
menstruación?
En el pasado mes ¿cuántas
veces has tenido sexo manual
(ej. que tus manos o dedos
hayan tenido contacto con la
vagina, pene, y/o ano) con
otra persona luego de
inyectarte?
En el pasado mes ¿cuántas
veces has tenido sexo manual
(ej. que tus manos o dedos
hayan tenido contacto con la
vagina, pene, y/o ano) con
otra persona sin lubricación?
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Risk Injection
Practices

In the last month, how many
times have you injected with
another person’s used
needle/syringe?

Durante el pasado mes,
¿Cuántas veces al inyectarte
usaste una jeringuilla de otra
persona?

On those occasions, how often did
you rinse it with a combination of
full strength bleach and water (i.e,
the ‘2x2x2’ method) before you
used it?

En esa/s ocasión/es que tantas
veces lavaste la jeringuilla
con una solución fuerte de
agua y cloro antes de usarla?
Ej. Método 2X2X2

In the last month, how many
times have you injected with a
needle/syringe after another
person has already injected some
of its contents?

NeSyrCo1a to
2PerCo15b

In the last month, how many
times have you received an
accidental needle stick/ prick from
another person’s used
needle/syringe?
On those occasions, how often did
you rinse it only with full-strength
bleach before you re-used it?
In the last month, how many
times have you injected a drug
that was filtered through another
person’s filter?
In the last month, how many
times have you injected a drug
that was prepared in another
person’s used spoon or mixing
container?

En el pasado mes ¿cuántas
veces te has inyectado parte
de la droga de otra persona
con la misma jeringuilla que
ella?
En el pasado mes ¿Cuántas
veces te has pinchado con
una jeringuilla/aguja utilizada
por otra persona
accidentalmente?
En esa/s ocasión/es con
cuanta frecuencia lavaste la
jeringuilla/aguja con cloros
puro antes de usarla?
En el pasado mes ¿cuántas
veces te has inyectado drogas
que son filtradas a través del
filtro de otra persona?
Durante el pasado mes,
¿cuántas veces te has
inyectado drogas preparadas
en el cooker de otra persona?
En esa/s ocasión/es ¿con qué
frecuencia limpiaste el cooker
antes de usarlo?

An index will me make based on the responses of the
twenty two questions. The index is the sum of the: number
in each question. The higher score the riskier the injecting
behavior is
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On those occasions how often did
you clean the spoon or mixing
container before using it?
In the last month, how many
times have you injected a drug
prepared with water which had
been used by another person
In the last month, how many
times have you injected a drug
which had come into contact with
another person’s used
needle/syringe?
In the last month, how many
times have you wiped your own
injection site with an object (e.g,
swab, tissue, hanky, towel etc)
which had been used by another
person?

In the last month, how many
times have you injected a drug
that you prepared immediately
after ‘assisting’ another person
with their injection (e.g, injecting
them, holding their arm, handling
used needle/syringe; touching
their injection site to feel for a
vein, to wipe blood away, or to
stop bleeding)?

En el pasado mes ¿cuántas
veces te has inyectado drogas
preparadas con agua que ha
sido utilizada por otra
persona?
En el pasado mes ¿cuántas
veces te has inyectado drogas
que han estado en contacto
con la jeringuilla/aguja usada
por otra persona?
En el pasado mes ¿Cuántas
veces te has limpiado el lugar
de la inyección con un objeto
(gasa, trapo, algodón, gasa de
alcohol, toalla etc.) que ha
sido utilizado por otra
persona?
En el pasado mes ¿cuántas
veces te has inyectado luego
de ayudar a otra persona a
inyectarse (ej. Los has
inyectado, les has aguantado
el brazo, has manejado la
aguja o jeringuilla, le has
ayudado a conseguir la vena,
has limpiado la sangre del
área de inyección, o has
ayudado para que no sangre
más)?
En el pasado mes, ¿cuántas
veces te has inyectado droga
que ha sido preparada por
otra persona que ya se ha
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In the last month, how many
times have you injected with a
needle/syringe which had been
handled or touched by another
person who had already injected?
On those occasions, how often did
they wash their hands prior to
handling the needle/syringe that
you used?
On those occasions, how often did
you wash your hands before
preparing your mix?
In the last month, how many
times have you injected a drug
that was prepared by another
person who had already injected
or assisted someone else’s
injection?
On those occasions, how often did
the person preparing the mix wash
their hands before preparing the
mix?
In the last month, how many
times have you been injected by
another person who had already
injected or assisted in someone
else’s injection?

On those occasions, how often did
the person injecting you wash
their hands before injecting you?

inyectado o ha ayudado a
otro/a a inyectarse?
En dichas ocasiones: ¿cuántas
veces esa persona se lavó las
manos antes de preparar la
mezcla?
En dichas ocasiones, ¿cuántas
veces te lavaste las manos
antes de preparar la mezcla?
En el pasado mes ¿cuántas
veces has sido inyectado por
otra persona que ya se ha
inyectado o ha ayudado a
otro/a a inyectarse?
En dichas ocasiones: ¿cuántas
veces esa persona se lavó las
manos antes de preparar la
mezcla?
En el pasado mes, ¿cuántas
veces otra persona ha tocado
el área donde te inyectas (ej.
Palpar la vena antes de
inyectarte, limpiado tu
sangre, o aguantado el
sangrado)?
En dichas ocasiones, ¿cuántas
veces la persona que tocó el
área donde te inyectas se lavó
las manos antes de tocar?
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In the last month, how many
times have you injected with a
needle/syringe which had been
handled or touched by another
person who had already injected?
On those occasions, how often did
they wash their hands prior to
handling the needle/syringe that
you used?

In the last month, how many
times have you touched your own
injection site (e.g, to feel for a
vein, to wipe away blood, or to
stop bleeding) soon after
‘assisting’ another person with
their injection (e.g, injecting
them, holding their arm, handling
their use needle/syringe; touching
their injection site to feel for a
vein, to wipe away blood, or to
stop bleeding)?

En el pasado mes ¿cuántas
veces has inyectado a alguien
con una jeringuilla/aguja
usada o tocada por otra
persona que ya se ha
inyectado?
En esas ocasiones ¿cuántas
veces la persona que usó o
tocó la jeringuilla se lavó las
manos antes de usar o tocar la
jeringuilla/aguja?
En el pasado mes, ¿cuántas
veces has tocado el área
donde te inyectas (ej. Palpar
la vena antes de inyectarte,
limpiado tu sangre, o
aguantado el sangrado)
rápido luego de ayudar a otra
persona a inyectarse (ej. Los
has inyectado, les has
aguantado el brazo, has
manejado la aguja o
jeringuilla, le has ayudado a
conseguir la vena, has
limpiado la sangre del área de
inyección, o has ayudado
para que no sangre más)?
En dichas ocasiones, ¿cuántas
veces te lavaste las manos
antes de tocarte el área donde
te inyectas?
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On those occasions, how often did
you wash your hands before
touching your own injection site?
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Tie strengths

How close are you to
[person]?

¿Qué tan cercano te
sientes de esta
pesona?

Would you talk to
[person] about things
that are very personal
and private?

¿Hablarias con esta
persona de cosas
privadas y muy
personales?

. If you needed to
borrow $25, would
[person] lend or give
it to you if they had
the money?

Si necesitaras $25
prestados, ¿tu crees
que esta persona de
los prestaría o daría si
los tuviera?

Would you ask
[person] for advice
or help about health
problems like
infections, AIDS, or
hepatitis C?
INT1 to
INT9

If I had an
emergency this
[Person] would be
there for me.
If I ask this [Person]
would do anything
for me if it is legal
If I ask this [Person]
would do anything
for me even if it is
not legal
If I ask this [Person]
would obtain drugs
for me

CDR1
CDR2,
CDR3 and
CDR4 to
CDR14

Personal
network
exposure will
be measured by
three measures.
CDR1, CDR2,
CDR3 and the
sum of
variables

An index will me make
based on the responses of
the four questions. The
index is the sum of the:
number (1) in each
question. The higher score
the strongest the tie is.

Le preguntaría o
pedirías ayuda a esta
persona si tuvieras
problemas de salud
tales como VIH o
Hepatitis C?
Si tuviera una
emergencia esta
persona estaría
conmigo
Si le preguntase a esta
persona él/ella haría
cualquier cosa por mí
si es legal:
Si le preguntase a esta
persona él/ella haría
cualquier cosa por mí
si aún sino es legal:
Esta persona
obtendría drogas para
mí
Esta persona
obtendría parafernalia
y jeringuillas para mi.

If I ask this [Person]
would obtain needles
or other equipment
for me.
CDR1 - To the best
of your knowledge,
in the past month,
how often did
[person] shoot up?

A tu mejor
conocimiento, en el
pasado mes, ¿que tan
frecuente esa persona
se inyectó?

CDR2
Approximately, how
long have they been
injecting drugs?

Aproximadamente,
¿por cuánto tiempo
estas personas han
estado inyectándose
drogas?

CDR1 will be using an
ordinal variable ranking
from 0 to 4, where the
higher the number the
higher the frequency the
person in the network
injects.
CDR2 will be an open
ending question in which
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(Record as day,
month or year and
specify which {d, m
or y})

CDR4 to
CDR14, each
ranking
different
ordinal values.
In the scale
higher score are
representative
of higher
personal
network
exposure risks
to HCV/HIV.

CDR3 In the past
month, how many
times have you and
[person] combined or
pooled money so that
you had enough
money to buy drugs
or injecting
equipment?

In the past month,
how often did you
inject with [person]?
Have you ever
injected with a
needle after [person]
used it first?

In the past month,
how often have you
injected with a
needle after [person]
used it first?

In the past month,
how often has
[person] injected
with a needle after
you used it first?

In the past month,
how often have you
used [person’s]
cooker, rinse water,
or cotton after they
had already used
them?

In the past month,
how often did you

En los pasados 6
meses, ¿cuántas veces
has combinado o
juntado dinero para
comprar drogas o
equipo con esta
persona por que no
has tenido suficiente
dinero?

participant will provide the
number of years in a
continuous variable.

CDR3 will be using an
ordinal variable ranking
from 0 to 6 were the higher
the number the higher the
frequency the behavior is
observed.

En los pasados 6
meses que tan
frecuente te has
inyectado con esa
persona?
¿Te has inyectado
alguna vez con una
jeringuilla luego de
que esta persona la
haya utilizado?
En los pasados 6
meses ¿qué tan
frecuente te has
inyectado con una
aguja que ha sido
utilizada por alguna
de las personas en tu
red social?
En los pasados 6
meses, que tan
frecuente esta persona
se ha inyectado con
una jeringuilla luego
que tú te has
inyectado?
En los últimos 6
meses ¿cuántas veces
has usado el cooker,
el agua de limpiar la
parafernalia, o el
algodón luego de que
cualquiera de las
personas en tu red lo
hayan utilizado?
En los pasados 6
meses ¿qué tan
frecuente te has
inyectado tu droga
luego de que la hayan
mezclado con la

Last, the personal network
exposure will be measured
by creating an index by
adding the responses of
questions CDR4to CDR9,
each ranking ordinal values
from 0 to 4. In the scale
conformed by CDR3 to
CDR9 higher score are
representative of higher
personal network exposure
risks to HCV/HIV.

Each of this variables
[CDR1, CDR2, CDR3, and
the index] will be entered
separately in the GEE
analysis.
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inject drugs after
[person] mixed your
drugs in a syringe
that they had already
injected with?

To the best of your
knowledge, in the
past month, how
often has [person]
had share
needles/syringe with
someone besides
you?

To the best of your
knowledge, in the
past month, how
often has [person]
had done sex work or
trade sex for drugs?

jeringuilla de otra
persona en tu red?
A tu mejor
entendimiento durante
el pasado mes, ¿qué
tan frecuente las
personas en tu red
social han compartido
las jeringuilla con
otras personas además
de contigo?
A tu mejor
entendimiento durante
el pasado mes, ¿qué
tan frecuente las
personas en tu red
social se han
prostituido o han
tenido sexo a cambio
de sexo?
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Appendix C: Spanish Questionnaire
Cuestionario Influencia de las redes sociales en los comportamientos de riesgo para la transmisión del
virus de Hepatitis C y VIH en una población de usuarios de drogas inyectables en Puerto Rico.
Número de control:
Fecha/Hora:
Perfil Socio-demográfico:
Lea al participante: La primera sección
de preguntas son acerca de usted:

DEM 5: Durante el último año ¿cuál fue la
manera más frecuente en la que conseguiste
dinero para vivir? Marque sólo una.
0

DEM1: ¿Cuál es tu edad? (Años)
___________________________
DEM2: Con cuál género te identificas
más? (Sólo si es necesario)
0
1
2
3
55
66
99

Masculino
Femenino
Mujer Transgénero
Hombre Transgénero
Indeciso/inseguro
No aplica
No contesta

Trabajo Regular (a tiempo completo
o parcial, contrato, etc.)
1 Cupones u otra asistencia
gubernamental como pensión,
seguridad social, etc.
2 Dinero que me daban mis
amigos/familiares
3 Trabajos sexuales / prostitución
4 Trabajos como mula o en venta de
drogas
5 Pidiendo limosna / mendingando
6 Robando
7 Otro:
55 Indeciso/inseguro
66 No aplica
99 No contesta

DEM3: ¿Dónde nació usted?
1
2
3

Puerto Rico
USA
Other:
_____________________

DEM 4: ¿Cuál es el grado educativo
más alto completado?
0

No complete la Escuela
Superior
1 Completé la Escuela
Superior.
2 Escuela Vocacional
3 Estudios universitarios sin
completar
4 Grado Associado
5 Bachillerato
6 Otro:
99 No contesta

DEM 6: ¿Cuál es el zip-code del área donde
vives o en que barrio o sector vives?

DEM 7: ¿Hace menos de un año que vives en
Puerto Rico?
0
1
55
66
99

Sí (Pasa pregunta DEM8)
No (Pasa pregunta DEM9)
Indeciso/inseguro
No aplica
No contesta

DEM 8: ¿Dónde vivías antes de venir a Puerto
Rico?
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DEM 9: ¿Has sido arrestado en los
pasados 6 meses?
0
1
55
66
99

Sí
No
Indeciso/inseguro
No aplica
No contesta

0
1
55
66
99

DEM 10: ¿Has estado en la cárcel?
0
12)
1
11)
55
66
99

DEM 14: Ese diagnóstico fue confirmado por
una prueba de laboratorio?
Sí
No
Indeciso/inseguro
No aplica
No contesta

DEM 15: ¿Cuándo fue la última vez que te
realizaste la prueba?

Sí (pasa la pregunta DEM
No (pasa la pregunta DEM
DEM 16: ¿Tienes Hepatitis C?
Indeciso/inseguro
No aplica
No contesta

DEM 11: ¿Por cuánto tiempo estuviste
encarcelado?
Años

Meses

0
1
55
66
99

Sí
No (Pasa a DEM 18)
Indeciso/inseguro
No aplica
No contesta

DEM 17: Ese diagnóstico fue confirmado por
una prueba de laboratorio?

Días
DEM 12: ¿Cuándo saliste de la cárcel?
Años

Meses

0
1
55
66
99

Sí
No
Indeciso/inseguro
No aplica
No contesta

Días
DEM 18: ¿Cuándo fue la última vez que te
realizaste la prueba?
DEM 13: ¿Eres VIH positivo?
0
1
55
66
99

Sí
No (Pasa a DEM 16)
Indeciso/inseguro
No aplica
No contesta

DEM19: Cuándo te inyectaste la primera vez
¿Qué edad tenías?
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DEM 20: ¿Cuál de las siguientes drogas
haz utilizado durante tu vida?
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Alcohol
Metanfetaminas
Xanax/Valium
Anfetaminas
Barbitúricos
Cocaína
Crack
Demerol/morfina/opio
Sedantes o tranquilizantes
Ecstasy
Gasolina/solventes [Cinel}
Marihuana
PCP/Polvo de Ángel
Tylenol o Panadol PM
Heroína
Hongos
Percocet
Metadona prescrita
Metadona no prescrita
None
Other,
(specify_______________)
55 Indeciso/inseguro
66 No aplica
99 No contesta
DEM21: ¿Cuál es tu droga favorita para
inyectar? Circule sólo una de la
opciones
0
1
2
3

Cocaína
Morfina
Heroína
Heroína y cocaína
(speedball)
4 Heroína mezclada con otras
drogas
5 Anfetaminas (estimulantes)
6 Metadona
7 Crack/ cocaína en piedra
8 Metanfetamina (crystal
meth)
9 PCP (polvo de ángel )
10 Dilaudid
11 Barbitúricos (sedantes)
12 Ritalin
13 Xylacym (Anestesia de
caballo)
14 Otro,
(especifique
_______________)
55 Indeciso/inseguro

66 No aplica
99 No contesta
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DEM 22: En los último mes ¿cuántas
veces te has inyectado? Marcar sólo
una de las opciones.

2
3
4

Nunca
De vez en cuando pero no
todas las semanas
Regularmente 1 ó 2 veces
por semana.
Regularmente 3 ó más
veces por semana.
Todos los días (¿Cuántas
veces al día
?)

ESPACIO DEJADO EN BLANCO
INTENCIONALMENTE

0
1

NeSyrCo1a: Durante el pasado mes, ¿Cuántas
veces al inyectarte usaste una jeringuilla de otra
persona?
0.
1.
2.
3.
4.
5.

Nunca (ir a la pregunta NeSyrCo2)
Una vez
Dos veces
Entre 3 – 5 veces
entre 6 -10 veces
Más de 10 veces

NeSyrCo1b: En esa/s ocasión/es que tantas
veces lavaste la jeringuilla con una solución
fuerte de agua y cloro antes de usarla?
1.
2.
3.
4.
5.

Nunca
Raras veces
Algunas veces
Casi siempre
Todo el tiempo

NeSyrCo2: En el pasado mes ¿cuántas veces
te has inyectado parte de la droga de otra
persona con la misma jeringuilla que ella?
0.
1.
2.
3.
4.
5.

Nunca
Una vez
Dos veces
Entre 3 – 5 veces
entre 6 -10 veces
Más de 10 veces

NeSyrCo3: En el pasado mes ¿Cuántas veces
te has pinchado con una jeringuilla/aguja
utilizada por otra persona accidentalmente?
0.
1.
2.
3.
4.
5.

Nunca
Una vez
Dos veces
Entre 3 – 5 veces
entre 6 -10 veces
Más de 10 veces

NeSyrCo4a: En el pasado mes ¿cuántas veces
has utilizado una jeringuilla/aguja que has
sacado del zafacón o un recipiente de
jeringuillas/agujas?
0.
1.
2.
3.
4.
5.

Nunca (ir a la pregunta NeSyrCo5)
Una vez
Dos veces
Entre 3 – 5 veces
entre 6 -10 veces
Más de 10 veces
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NeSyrCo4b: En esa/s ocasión/es con
cuanta frecuencia lavaste la
jeringuilla/aguja con una solución fuerte
de agua y cloro antes de usarla?
1.
2.
3.
4.
5.

Nunca
Raras veces
Algunas veces
Casi siempre
Todo el tiempo

NeSyrCo5: En el pasado mes ¿cuántas
veces te has inyectado drogas que son
filtradas a través del filtro de otra
persona?
0.
1.
2.
3.
4.
5.

Nunca
Una vez
Dos veces
Entre 3 – 5 veces
entre 6 -10 veces
Más de 10 veces

NeSyrCo6a: Durante el pasado mes,
¿cuántas veces te has inyectado drogas
preparadas en el cooker de otra
persona?
0. Nunca (ir a la pregunta
NeSyrCo8)
1. Una vez
2. Dos veces
3. Entre 3 – 5 veces
4. entre 6 -10 veces
5. Más de 10 veces
NeSyrCo6b: En esa/s ocasión/es ¿con
qué frecuencia limpiaste el cooker antes
de usarlo?
1.
2.
3.
4.
5.

Nunca
Raras veces
Algunas veces
Casi siempre
Todo el tiempo

NeSyrCo7: En el pasado mes ¿cuántas
veces te has inyectado drogas
preparadas con agua que ha sido
utilizada por otra persona?
0. Nunca
1. Una vez
2. Dos veces

3. Entre 3 – 5 veces
4. entre 6 -10 veces
5. Más de 10 veces
NeSyrCo8: En el pasado mes ¿cuántas veces
te has inyectado drogas que han estado en
contacto con la jeringuilla/aguja usada por otra
persona?
0.
1.
2.
3.
4.
5.

Nunca
Una vez
Dos veces
Entre 3 – 5 veces
entre 6 -10 veces
Más de 10 veces

NeSyrCo9: En el pasado mes ¿Cuántas veces
te has limpiado el lugar de la inyección con un
objeto (gasa, trapo, algodón, gasa de alcohol,
toalla etc.) que ha sido utilizado por otra
persona?
0.
1.
2.
3.
4.
5.

Nunca
Una vez
Dos veces
Entre 3 – 5 veces
entre 6 -10 veces
Más de 10 veces

2PerCo10a: En el pasado mes ¿cuántas veces
te has inyectado luego de ayudar a otra persona
a inyectarse (ej. Los has inyectado, les has
aguantado el brazo, has manejado la aguja o
jeringuilla, le has ayudado a conseguir la vena,
has limpiado la sangre del área de inyección, o
has ayudado para que no sangre más)?
0.
1.
2.
3.
4.
5.

Nunca (Pase a 2PerCo11)
Una vez
Dos veces
Entre 3 – 5 veces
entre 6 -10 veces
Más de 10 veces

2PerCo10b: En dichas ocasiones, ¿cuántas
veces te lavaste las manos antes de preparar la
mezcla?
1.
2.
3.
4.
5.

Nunca
Raras veces
Algunas veces
Casi siempre
Todo el tiempo

ESPACIO DEJADO EN
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2PerCo11a: En el pasado mes,
¿cuántas veces te has inyectado droga
que ha sido preparada por otra persona
que ya se ha inyectado o ha ayudado a
otro/a a inyectarse?
0. Nunca (ir a la pregunta
2PerCo12a)
1. Una vez
2. Dos veces
3. Entre 3 – 5 veces
4. entre 6 -10 veces
5. Más de 10 veces
2PerCo11b: En dichas ocasiones:
¿cuántas veces esa persona se lavó las
manos antes de preparar la mezcla?
1.
2.
3.
4.
5.

Nunca
Raras veces
Algunas veces
Casi siempre
Todo el tiempo

2PerCo12a: En el pasado mes
¿cuántas veces has sido inyectado por
otra persona que ya se ha inyectado o
ha ayudado a otro/a a inyectarse?
0. Nunca (ir a la pregunta
2PerCo13a)
1. Una vez
2. Dos veces
3. Entre 3 – 5 veces
4. entre 6 -10 veces
5. Más de 10 veces
2PerCo12b: En dichas ocasiones:
¿cuántas veces esa persona se lavó las
manos antes de inyectarte?
1.
2.
3.
4.
5.

Nunca
Raras veces
Algunas veces
Casi siempre
Todo el tiempo

2PerCo13a: En el pasado mes
¿cuántas veces has inyectado a alguien
con una jeringuilla/aguja usada o tocada
por otra persona que ya se ha
inyectado?

0. Nunca (ir a la pregunta 2PerCo14a)
1. Una vez
2. Dos veces
3. Entre 3 – 5 veces
4. entre 6 -10 veces
5. Más de 10 veces
2PerCo13b: En esas ocasiones ¿cuántas veces
la persona que usó o tocó la jeringuilla se lavó
las manos antes de usar o tocar la
jeringuilla/aguja?
1.
2.
3.
4.
5.

Nunca
Raras veces
Algunas veces
Casi siempre
Todo el tiempo

2PerCo14a: En el pasado mes, ¿cuántas veces
has tocado el área donde te inyectas (ej. Palpar
la vena antes de inyectarte, limpiado tu sangre,
o aguantado el sangrado) rápido luego de
ayudar a otra persona a inyectarse (ej. Los has
inyectado, les has aguantado el brazo, has
manejado la aguja o jeringuilla, le has ayudado
a conseguir la vena, has limpiado la sangre del
área de inyección, o has ayudado para que no
sangre más)?
0.
1.
2.
3.
4.
5.

Nunca (ir a la pregunta 2PerCo15a)
Una vez
Dos veces
Entre 3 – 5 veces
entre 6 -10 veces
Más de 10 veces

2PerCo14b: En dichas ocasiones, ¿cuántas
veces te lavaste las manos antes de tocarte el
área donde te inyectas?
1.
2.
3.
4.
5.

Nunca
Raras veces
Algunas veces
Casi siempre
Todo el tiempo

2PerCo15a: En el pasado mes, ¿cuántas veces
otra persona ha tocado el área donde te
inyectas (ej. Palpar la vena antes de inyectarte,
limpiado tu sangre, o aguantado el sangrado)?
0.
1.
2.
3.

Nunca (ir a la pregunta 2PerCo16)
Una vez
Dos veces
Entre 3 – 5 veces
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4. entre 6 -10 veces
5. Más de 10 veces

2PerCo15b: En dichas ocasiones, ¿cuántas
veces la persona que tocó el área donde te
inyectas se lavó las manos antes de tocar?
1.
2.
3.
4.
5.

Nunca
Raras veces
Algunas veces
Casi siempre
Todo el tiempo

SexPra16: En el pasado mes, ¿cuántas veces
haz tenido sexo vaginal (ej. penetración de la
vagina con el pene) sin protección con otra
persona?
0.
1.
2.
3.
4.
5.

Nunca
Una vez
Dos veces
Entre 3 – 5 veces
entre 6 -10 veces
Más de 10 veces

SexPra17: En el pasado mes ¿cuántas veces
haz tenido sexo vaginal (ej. penetración de la
vagina con el pene) sin protección con otra
persona durante la menstruación?
0.
1.
2.
3.
4.
5.

Nunca
Una vez
Dos veces
Entre 3 – 5 veces
entre 6 -10 veces
Más de 10 veces

SexPra18: En el pasado mes ¿cuántas veces
haz tenido sexo vaginal (ej. penetración de la
vagina con el pene) sin protección con otra
persona sin lubricación?
0.
1.
2.
3.
4.
5.

Nunca
Una vez
Dos veces
Entre 3 – 5 veces
entre 6 -10 veces
Más de 10 veces
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SexPra19: En el pasado mes ¿cuántas
veces has tenido sexo oral (ej. que los
labios o la lengua tengan contacto con
el pene, la vagina y/o el ano) con otra
persona sin protección?
0.
1.
2.
3.
4.
5.

Nunca
Una vez
Dos veces
Entre 3 – 5 veces
entre 6 -10 veces
Más de 10 veces

Sex Pra20: En el pasado mes ¿cuántas
veces has tenido sexo manual (ej. que
tus manos o dedos hayan tenido
contacto con la vagina, pene, y/o ano)
con otra persona mientras está en
menstruación?
0.
1.
2.
3.
4.
5.

Nunca
Una vez
Dos veces
Entre 3 – 5 veces
entre 6 -10 veces
Más de 10 veces

SexPra21: En el pasado mes ¿cuántas
veces has tenido sexo manual (ej. que
tus manos o dedos hayan tenido
contacto con la vagina, pene, y/o ano)
con otra persona luego de inyectarte?
0.
1.
2.
3.
4.
5.

Nunca
Una vez
Dos veces
Entre 3 – 5 veces
entre 6 -10 veces
Más de 10 veces

SexPra22: En el pasado mes ¿cuántas
veces has tenido sexo manual (ej. que
tus manos o dedos hayan tenido
contacto con la vagina, pene, y/o ano)
con otra persona sin lubricación?
0.
1.
2.
3.
4.
5.

Nunca
Una vez
Dos veces
Entre 3 – 5 veces
entre 6 -10 veces
Más de 10 veces

Fuente de Jeringuillas:
NS1: En los pasados 6 mes, ¿has obtenido o
intercambiado jeringuillas en un centro de
intercambio de jeringuillas?
0
1
55
66
99

Sí
No
Indeciso/inseguro
No aplica
No contesta

NS2: En los pasados 6 meses, ¿cuántas de tus
jeringuillas tú obtuviste de un programa de
intercambio de jeringuillas?
0
1
2
3

Todas
La mayoría pero no todas
La mitad de las jeringuillas
Menos de la mitad de las
jeringuillas.
4 Ninguna
55 Indeciso/inseguro
66 No aplica
99 No contesta
NS3: En los pasados 6 meses, ¿has
intercambiado tus propias jeringuillas o alguien
realiza el intercambio por ti?
0
1

Por lo regular lo hago yo mismo
Por lo regular hay alguien que lo
hace por mí.
55 Indeciso/inseguro
66 No aplica
99 No contesta
NS4: En los pasados 6 meses ¿que tan fácil fue
para ti obtener una jeringuilla nueva cuando la
necesitaste?
0
1
2
3
55
66
99

Muy fácil
Bastante fácil
Bastante difícil
Muy difícil
Indeciso/inseguro
No aplica
No contesta.
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Red Social:
1.

Miembros de la red social:
Leer: Esta parte del cuestionario tiene la intención de evaluar la relación
entre el contacto personal y las enfermedades infecciosas que pueden
transmitirse a través de jeringuillas usadas, como el VIH y la hepatitis. Me
gustaría hacerle algunas preguntas acerca de las personas con las que
normalmente usted se comparte. El investigador no se le pedirá ninguna
información que pueda ser utilizada para identificar a las personas y la
información que proporcione será confidencial.
Primero quiero que pienses acerca de los últimos 30 días y recuerdes
aquellas personas con las que has tenido algo más que un contacto
casual11. Estas personas son aquellas a las que ves y con las que hablas
regularmente. En su mayoría estas personas suelen ser amigos, familiares,
parejas sexuales, personas con las que te inyectas drogas o aquellos que
viven contigo.
Vamos a realizar una lista de estas personas (entrevistador – el máximo de
personas permitidas en la lista son 20. Si el individuo nombra a las 20
personas pídale que le pregunte a cuantas personas más adicionales él o
ella pueden nombrar y apunta el número en la hoja de contestaciones).
Utilice la naturaleza de la relación para identificar a estas personas. En el
caso de que haya más de uno dime un número después de la relación, por
ejemplo, amigo-1, amigo-2 etc. Por favor, no utilices sus nombres o
apellidos. Voy a ofrecer un seudónimo (nombre falso) para cada contacto
(Por ejemplo, si usted dice cónyuge le daré el nombre falso de María, si
dices hermano le daré el nombre falso de José). Vamos a utilizar estos
nombres falsos en la lista para asegurarse de que la identidad de un
contacto que no se da a conocer. Recuerde que estamos interesados en la
gente que ha tenido contacto en los últimos 30 días.

11

Se refiere a una conversación que va más allá de la conversación de mendicidad o una conversación tipo
“hola / adiós”.
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Para ayudar a recordar el máximo de personas el entrevistador puede
hacer las siguientes preguntas:


Personas con las que haz compartido drogas en los últimos 30 días;



Personas con las que haz tenido sexo en los últimos 30 días (si la
persona es un/a trabajador/a sexual liste no más de 10 parejas
sexuales, si no conoce el nombre del cliente puede nombrarlo como
desconocido #1, desconocido #2, etc. si tienen una pareja sexual
regular asegúrese de que la incluya en el grupo);



Amigos, familiares, o personas que estén de alguna manera
cercanos a el o ella;



Las personas con las que vive;



Las personas con las que se pasa el tiempo.

2. Tipo de contacto;
Entrevistador: Una vez el participante de las relaciones y se le asignen los
nombres falsos, por favor pregúntele a los participantes las preguntas que
se dan abajo y circule la letra apropiada para cada uno de los nombre en la
siguiente página.
Preguntas a hacer acerca de cada miembro de la red social que se incluyen en la
siguiente página:
1. ¿Cuál de estas personas se han inyectado drogas en los pasados 6
meses?: Circule Y (Sí) o N (No) o U (Inseguro)
2. Sin incluir marihuana, ¿cuál de estas personas ha fumado, inhalado o
utilizado drogas en los pasados 6 meses? Circule Y (Sí) o N (No) o U
(Inseguro)
3. ¿Cuál de estas personas han sido tu pareja sexual en los últimos 6
meses? Circule Y (Sí) o N (No) o U (Inseguro)
4

¿Cuál es el género de cada una de estas personas? Circule M

(Masculino), F (Femenino), TM (Transgénero Masculino), TF (Transgénero
Femenino).
5

¿Cuál es la edad de cada una de estas personas?

6

¿Qué tipo de relación tiene esta persona contigo? Circule F (Miembro de

la Familia), L (Amante, esposo, novio/a); R (Amigo); C (Conocido/extraño).
7

¿Es esta persona Puertoriqueña? Circule Y (Sí) Si no especifique:_____
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Lista de los miembros de la red
# de
miembro
en la
Red

Identificador del
Miembro en la
Red
(Nombre Falso)

Usuario de
drogas
inyectables

Fuma/Inhal
a o utiliza
Drogas

Pareja
Sexual

Género

1

Y

N

U

Y

N

U

Y

N

2

Y

N

U

Y

N

U

Y

N

3

Y

N

U

Y

N

U

Y

N

4

Y

N

U

Y

N

U

Y

N

5

Y

N

U

Y

N

U

Y

N

6

Y

N

U

Y

N

U

Y

N

7

Y

N

U

Y

N

U

Y

N

8

Y

N

U

Y

N

U

Y

N

9

Y

N

U

Y

N

U

Y

N

10

Y

N

U

Y

N

U

Y

N

M
TM
M
TM
M
TM
M
TM
M
TM
M
TM
M
TM
M
TM
M
TM
M
TM

F
TF
F
TF
F
TF
F
TF
F
TF
F
TF
F
TF
F
TF
F
TF
F
TF

Edad

Relación
Es esta
(Compañeros de trabajo,
persona
suplidores de droga, “panas” puertorriqueña
ect. deben de ser
Y (sí) & N (no)
clasificados como
especifique
conocidos, a menos que
persona diga que son
amigos (R).

F

L

R

C

F

L

R

C

F

L

R

C

F

L

R

C

F

L

R

C

F

L

R

C

F

L

R

C

F

L

R

C

F

L

R

C

F

L

R

C

Y
N
__________
Y
N
__________
Y
N
__________
Y
N
__________
Y
N
__________
Y
N
__________
Y
N
__________
Y
N
__________
Y
N
__________
Y
N
__________
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# de
miembro
en la
Red

Identificador del
Miembro en la
Red
(Iniciales/Apodo,
etc)

Usuario de
drogas
inyectables

Fuma/Inhal
a o utiliza
Drogas

Pareja
Sexual

Género

11

Y

N

U

Y

N

U

Y

N

12

Y

N

U

Y

N

U

Y

N

13

Y

N

U

Y

N

U

Y

N

14

Y

N

U

Y

N

U

Y

N

15

Y

N

U

Y

N

U

Y

N

16

Y

N

U

Y

N

U

Y

N

17

Y

N

U

Y

N

U

Y

N

18

Y

N

U

Y

N

U

Y

N

19

Y

N

U

Y

N

U

Y

N

20

Y

N

U

Y

N

U

Y

N

M
TM
M
TM
M
TM
M
TM
M
TM
M
TM
M
TM
M
TM
M
TM
M
TM

F
TF
F
TF
F
TF
F
TF
F
TF
F
TF
F
TF
F
TF
F
TF
F
TF

Edad

Relación
Es esta
(Compañeros de trabajo,
persona
suplidores de droga, “panas” puertorriqueña
ect. deben de ser
Y (sí) & N (no)
clasificados como
especifique
conocidos, a menos que
persona diga que son
amigos (R).

F

L

R

C

F

L

R

C

F

L

R

C

F

L

R

C

F

L

R

C

F

L

R

C

F

L

R

C

F

L

R

C

F

L

R

C

F

L

R

C

Y
N
__________
Y
N
__________
Y
N
__________
Y
N
__________
Y
N
__________
Y
N
__________
Y
N
__________
Y
N
__________
Y
N
__________
Y
N
__________

Si el encuestado incluye a 20 miembros de su red social, pregúntele cuantas personas adicionales ellos pueden nombrar y apunte el
número aquí:
Numero de miembros adicionales de la red:
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Interacción entre los miembros de la red:
Entrevistador: Luego de terminar el paso 2, transfiera los nombres de
todos los miembros de la red a la tabla que se muestra a continuación.
Para cada persona enumerada, pídale al participante cual de las personas
en la lista está en contacto o conoce a cualquier otro de los miembros de la
lista. Si la persona está en contacto o conoce a otro de los miembros de la
red haga una marca de cotejo (√) de lo contrario deje el espacio en blanco.

ESPACIO DEJADO EN
BLANCO
INTENCIONALMENTE
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Identificador
Identificador del Miembro de la Red que Conoce

del Miembro

Persona # 1
Persona # 2
Persona # 3
Persona # 4
Persona # 5
Persona # 6
Persona # 7
Persona # 8
Persona # 9
Persona # 10
Persona # 11
Persona # 12
Persona # 13
Persona # 14
Persona # 15

20

Persona #

19

18

Persona #

17

Persona #

16

Persona #

Persona #

15

14

Persona #

13

Persona #

12

Persona #

Persona #

11

10

Persona #

Persona #

Persona # 9

Persona # 8

Persona # 7

Persona # 6

Persona # 5

Persona # 4

Persona # 3

etc)

Persona # 2

(Iniciales/Apodo,

Persona # 1

en la Red

(Iniciales/Apodo,

etc)

Persona # 16

Persona # 17

Persona # 18

Persona # 19

Persona # 20
20

Persona #

19

Persona #

18

Persona #

17

Persona #

16

Persona #

15

Persona #

14

Persona #

13

Persona #

12

Persona #

11

Persona #

10

Persona #

Persona # 9

Persona # 8

del Miembro

Persona # 7

Persona # 6

Persona # 5

Persona # 4

Persona # 3

Persona # 2

Persona # 1
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Identificador
Identificador del Miembro de la Red que Conoce

en la Red

221
4

Escoge los miembros:
Entrevistador – Tranfiera los identificadores de todos los usuarios de
drogas inyectables [IDUs] en la siguiente parte del cuestionario. Si hay más
de 5 IDUs en la lista escoja los primeros 5 que el participante nombró en el
listado original para el seguir con el cuestionario.
Preguntas sobre la reorganización de los contactos en la red
Entrevistador – Enumere los 5 miembros siguiendo la lista anterior
[recuerde nunca usar los nombres completos sólo apodos o las iniciales
de estos nombres] de la red según las instrucciones mencionadas arriba y
asigne un código a cada contacto según las siguientes instrucciones (esta
información será usada por la persona que entrará los datos para
identificar cada participante.
a) Enumera las primeras iniciales de los contactos escogidos de la
lista bajo la categoría “Identificador del Miembro en la Red
(Iniciales/Apodo, etc)”
b) Asigne el código nuevo a cada uno de los participantes desde el
número 1 hasta el 5.
Ej.

Identificador del Miembro en la Red

Código

Ejemplo Eustakio Pérez=EP;

1

Macho de las gladiolas=MG

2

El Bizco=EB

3
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Para las siguientes premisas haz una
marca de cotejo a menos que la pregunta
requiera una contestación completa.
Información demográfica de los contactos
de los participantes.
CD1 ¿Qué tipo de relación tiene esta persona
contigo? Esta pregunta es básicamente
repetida de la parte anterior pero en esta
ocasión las opciones son mucho más
detalladas por lo que se le vuelve a preguntar
a la participante nuevamente acerca de sus 5
contactos.
# del Miembro de la Red
1
2
3
4
5
0 Amigo
1 2ndo
esposo/a
2 Novio/a
Amante
3 Ex - amante
4 Ex- esposo/a
5 Madre
6 Padre
7 Hermano
8 Hermana
9 Hijo
10 Hija
11 Primo/a
12 Suegro/a
13 Sobrina
14 Sobrina
15 Tio
16 Tia
17 Otro
familiar
18 Conocido
19 Extraño
20 Dueño del
Punto
21 Mula
22. Persona
con la que
comparto
jeringuillas
22 Otro
especifique*
55 No seguro /
indeciso
99 No contestó
* Si ha seleccionado otro en alguno de los
encasillados anteriores por favor especifique en la
tabla adelante:

# de Miembro
de la Red
#1
#2
#3
#4
#5

Otro, especifique

CD2 ¿Por cuánto tiempo has conocido a esta
persona?
# de Miembro
de la Red
#1
#2
#3
#4
#5

Meses//Años

CD3 ¿Cuál es el nivel educativo más alto que
tiene la persona?
# del Miembro de la Red
1
2
3
4
5
0. Graduado
de 4to año
1. Todavía en
la escuela
2. Desertor
escolar en el
grado _____
3.Escuela
nocturna
4. Universidad
5. Escuela
técnica
6. Otro
especifique*
55 No seguro /
indeciso
99 No contestó
* Si ha seleccionado otro en alguno de los
encasillados anteriores por favor especifique en la
tabla que se muestra adelante:

# de Miembro
de la Red
#1
#2
#3
#4
#5

Otro, especifique
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CD4 Durante el último año ¿cuál fue la fuente de ingreso de esta persona?
# del Miembro de la Red
1
2
3
4
5
0. Trabajo Regular (Part time / Full time)
1. Cupones // Asistencia Social // Pensión
2. Trabajador sexual // Prostituta
3. Trabajando en el punto
4. Pidiendo en las calles // Mendigando
5. Robando
6. Boosting
7. Otro
55 No seguro / indeciso
66 No Aplica
99 No Contestó
CD5 ¿En que parte de la ciudad vive esta persona? Utiliza el código postal, o el nombre del
vecindario (Si vive fuera de la ciudad, pregúntale el nombre de la ciudad y el barrio).
# del
Miembro de
la Red
1

Código Postal o el nombre Indeciso o No
del vecindario
Seguro

No aplica.

No
contestó

2
3
4
5

CD9. ¿En que parte de la ciudad estas personas pasan el tiempo? Utiliza el zip code, o el
nombre del vecindario (Si vive fuera de la ciudad, pregúntale el nombre de la ciudad y el barrio).

# del
Miembro de
la Red
1
2
3
4
5

Código Postal o el nombre Indeciso o No
del vecindario
Seguro

No aplica.

No
contestó
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Riesgo Relacionado a la Inyección de

CDR2. Aproximadamente, ¿por cuánto

Drogas de los Miembros de la Red

tiempo estas personas han estado
inyectándose drogas?

CDR1 A tu mejor conocimiento, en el pasado
# del Miembro de la
Red
1

mes, ¿que tan frecuente esa persona se
inyectó?
# del Miembro de la Red
1

2

3

4

5

Día, Mes o años

2
3

0. Nunca

4

1. De vez en cuando

5

pero no todas las
semanas

CDR3 En los pasados 6 meses, ¿cuántas

2. Regularmente, 1 ó
2 veces por semana.
3. Regularmente, 3 ó
4 veces por semana

veces has combinado o juntado dinero para
comprar drogas o equipo con esta persona
por que no has tenido suficiente dinero?

4. Todos los días
# del Miembro de la Red

55 No seguro /
indeciso
66 No Aplica

1

2

3

4

5

0. Nunca

55 No seguro /
indeciso

1. Una vez
2. 2 a 4 veces

Si dijo que se inyectaba todos los días por

3. 5 a 9 veces

favor especifique ¿cuántas veces en un día?

4. 10 a 24 veces

# de Miembro
de la Red
#1
#2
#3
#4
#5

Otro, especifique

5. 25 a 49 veces
6. 50 a 99 veces
7. 100 veces o más
55 No seguro /
indeciso
66 No Aplica
99. No contestó
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CDR4. En los pasados 6 meses ¿qué tan

CDR6. En los últimos 6 meses ¿cuántas

frecuente te has inyectado con una aguja que

veces has usado el cooker, el agua de limpiar

ha sido utilizada por alguna de las personas

la parafernalia, o el algodón luego de que

en tu red social?

cualquiera de las personas en tu red lo hayan
utilizado?
# del Miembro de la Red
1

2

3

4

# del Miembro de la Red

5

1

0. Nunca

0. Nunca

1. Ocasionalmente

1. Ocasionalmente

2. Algunas veces

2. Algunas veces

3. Usualmente

3. Usualmente

4. Siempre

4. Siempre

55 No seguro /
indeciso
66 No Aplica

55 No seguro /
indeciso
66 No Aplica

99. No contestó

99. No contestó

2

3

4

5

CDR5. En los pasados 6 meses, ¿qué tan

CDR7. En los pasados 6 meses ¿qué tan

frecuente esta persona se ha inyectado con

frecuente te has inyectado tu droga luego de

una jeringuilla luego que tú te has inyectado?

que la hayan mezclado con la jeringuilla de

# del Miembro de la Red
1

2

3

4

otra persona en tu red?

5

# del Miembro de la Red

0. Nunca

1

1. Ocasionalmente

0. Nunca

2. Algunas veces

1. Ocasionalmente

3. Usualmente

2. Algunas veces

4. Siempre

3. Usualmente

55 No seguro /
indeciso
66 No Aplica

4. Siempre

99. No contestó

2

3

4

55 No seguro /
indeciso
66 No Aplica
99. No contestó
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CRD8. A tu mejor entendimiento durante el

Intimidad

pasado mes, ¿qué tan frecuente las
personas en tu red social han compartido las
jeringuilla con otras personas además de
contigo?

INT1 ¿Qué tan cercano te sientes de esta
persona?

# del Miembro de la Red
1

2

3

4

# del Miembro de la Red

5

0. Nunca

1

cerca

4. Siempre

3. Cerca

55 No seguro /
indeciso
66 No Aplica

4. Muy Cerca
55 No seguro /
indeciso
66 No Aplica

99. No contestó
CRD9. A tu mejor entendimiento durante el

pasado mes, ¿qué tan frecuente las
personas en tu red social se han prostituido o
han tenido sexo a cambio de drogas?
# del Miembro de la Red
1

3. Usualmente

2

3

4

99. No contestó

INT2 ¿Cuán frecuente dirías que te comunicas
con esta persona?
# del Miembro de la Red
1
2
3
4

5
0. Todos los
días (5 veces
por semana o
más)

4. Siempre

1. 2 – 4 veces
por semanas

55 No seguro /
indeciso
66 No Aplica

2. Una vez por
semana

99. No contestó

5

2. De alguna manera

3. Usualmente

2. Algunas veces

4

1. Distante

2. Algunas veces

1. Ocasionalmente

3

0. Muy distante

1. Ocasionalmente

0. Nunca

2

3. 1 – 3 veces
por mes
4. Menos de
una vez al mes
55 No seguro /
indeciso
99 No contestó

5
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INT3 ¿Hablarías con esta persona de cosas
privadas y muy personales?

INT6 Si tuviera una emergencia ¿esta
persona estaría conmigo?
# del Miembro de la Red

# del Miembro de la Red
1

2

3

4

5

0. Sí

1

2

3

4

5

0. Sí
1. No

1. No

55 No seguro /
indeciso
66 No Aplica

55 No seguro /
indeciso
66 No Aplica

99. No contestó

99. No contestó

INT7 Si le preguntase a esta persona,

INT4. Si necesitaras $25.00 prestados ¿tú

¿él/ella haría cualquier cosa por ti, si es legal:

crees que esta persona te los prestaría o
daría si los tuviera?

# del Miembro de la Red
# del Miembro de la Red
1

2

3

4

5

1

3

4

5

0. Sí

0. Sí

1. No

1. No

55 No seguro /
indeciso
66 No Aplica

55 No seguro /
indeciso
66 No Aplica

2

99. No contestó

99. No contestó

INT8 Si le preguntase a esta persona ¿él/ella
INT5 ¿Le preguntarías o pedirías ayuda a

haría cualquier cosa por ti aún si no es

estas personas si tuvieras problemas de

legal?:

salud tales como VIH/SIDA o hepatitis C?

# del Miembro de la Red

# del Miembro de la Red
1

2

3

4

5

1
0. Sí

0. Sí

1. No

1. No

55 No seguro /
indeciso
66 No Aplica

55 No seguro /
indeciso
66 No Aplica
99. No contestó

99. No contestó

2

3

4

5
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INT9 ¿Esta persona obtendría drogas para
mí?
# del Miembro de la Red
1

2

3

4

5

0. Sí
55 No seguro /
indeciso
66 No Aplica
99. No contestó

INT10. ¿Esta persona obtendría parafernalia
y jeringuillas para mi?
# del Miembro de la Red
1

2

3

0. Sí
1. No
55 No seguro /
indeciso
66 No Aplica
99. No contestó

¡GRACIAS!

4

5
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Appendix D: English Questionnaire
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DEMOGRAPHICS:
Read: "The first set of questions is general
questions about yourself".
DEM1. How old are you? (years)
____________________________
DEM2. What gender do you identify yourself
as?
(Only ask about gender if necessary to clarify):
0
1
2
3
55
66
99

Male
Female
Transgender female
Transgender male
Unsure
Not applicable
Refused to answer

DEM3. Where were you born?
1
2
3

Puerto Rico
USA
Other: _____________________

DEM4. What is the highest level of education
you have completed?
0

Did not complete HS / grade
school
1
Graduated grade 12
2
Trade school
3
Some University / College
4
Associate Degree
5
Bachellor
6
Other,
(specify_______________)
99 Refused to answer
DEM5. Over the last year what was the main
way you got money to live on? (circle
only one)
0

Regular work (full, part time or
contract)
1
Welfare, EI, pension or other
government support
2
Money from family/friends
3
Sex trade/prostitution
4
Dealing or doing drug runs
5
Panhandling
6
Stealing
7
Other,
(specify_________________)

DEM6. Using your postal code, what part of
the city do you live in?

Questionnaire #

____________________________
DEM7. Have you moved to Puerto Rico
within the past 12 months?
0
1
55
66
99

No
Yes
Unsure
Not applicable
Refused to answer

DEM8 Where were you living before you
came to Puerto Rico?
____________________________
DEM9 Have you been arrested in the last 6
months?
0
1
55
66
99

No
Yes
Unsure
Not applicable
Refused to answer

DEM10 Have you been incarcerated?
0
1
55
66
99

No
Yes
Unsure
Not applicable
Refused to answer

DEM11 How long time was you
incarcerated?
_______ Years

_______ Months

_______ Days
DEM12 When you were last released?
_______ Years

_______ Months

_______ Days
DEM13 Are you HIV +?
0
1
55
66
99

No
Yes
Unsure
Not applicable
Refused to answer

Interviewer #

Date/Hour:
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DEM14 Is the HIV serostatus test confirmed?
0
1
55
66
99

No
Yes
Unsure
Not applicable
Refused to answer

DEM15 Date last tested?
____________________________
DEM16 Are you HCV +?
0
1
55
66
100

No
Yes
Unsure
Not applicable
Refused to answer

DEM17 Is the HCV serostatus test confirmed?
0
1
55
66
100

No
Yes
Unsure
Not applicable
Refused to answer

DEM18 Date last tested?
____________________________
DEM19 The first time you injected, how old were
you?
____________________________

DEM21 What drug is your favourite to inject?
(circle only oney)
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
56
67
99

Cocaine (uptown)
Morphine
Heroin (horse, junk, smack,
downtown)
Heroin and cocaine (speedball)
Heroin mixed with another drug
Amphetamines (speed, uppers)
Methadone
Crack/rock cocaine
Methamphetamine (crystal meth)
PCP (angel dust)
Dilaudid
Barbiturates (downers)
Ritalin alone
Xylacym (horse anestesia)
Other,
(specify___________________)
Unsure
Not applicable
Refused to answer

DEM22 In the past month, how often did you
inject (shoot up)? (circle only one)
0
1
2
3

Not at all
Once in a while, not every week
Regularly, once or twice a week
Regularly, three or more times a
week
4
Every day (How many times per
day ________)

3
4
5
6
7
8
9
10
11
12
13
14
55
66
99

Cocaine (uptown)
Morphine
Heroin (horse, junk, smack,
downtown)
Heroin and cocaine (speedball)
Heroin mixed with another drug
Amphetamines (speed, uppers)
Methadone
Crack/rock cocaine
Methamphetamine (crystal meth)
PCP (angel dust)
Dilaudid
Barbiturates (downers)
Ritalin alone
Xylacym (horse anestesia)
Other,
(specify___________________)
Unsure
Not applicable
Refused to answer

INTENTIONALLY

0
1
2

LEFT BLANK

DEM20 What of the following drugs have you use
in your lifetime? (drug of choice, circle all
that apply)
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NeSyrCo1. In the last month, how many times
have you injected with another person’s used
needle/syringe??

NeSyrCo4b On those occasions, how often did
you rinse it only with full-strength bleach before
you re-used it?

0.
1.
2.
3.
4.
5.

1.
2.
3.
4.
5.

No times
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

NeSyrCo1b. On those occasions, how often did
you rinse it with a combination of full strength
bleach and water (i.e, the ‘2x2x2’ method) before
you used it?
1.
2.
3.
4.
5.

Never
Rarely
Sometimes
Often
Every time

NeSyrCo2. In the last month, how many times
have you injected with a needle/syringe after
another person has already injected some of its
contents??
0.
1.
2.
3.
4.
5.

No times
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

NeSyrCo3. In the last month, how many times
have you received an accidental needlestick/
prick from another person’s used needle/syringe?
0.
1.
2.
3.
4.
5.

No times
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

NeSyrCo4a. In the last month, how many times
have you re-used a needle/syringe taken out of a
shared disposal/sharps container?
0.
1.
2.
3.
4.
5.

No times (go to question NeSyrCo5)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

Never
Rarely
Sometimes
Often
Every time

NeSyrCo5. In the last month, how many times
have you injected a drug that was filtered
through another person’s filter?
0.
1.
2.
3.
4.
5.

No times
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

NeSyrCo6a In the last month, how many times
have you injected a drug that was prepared in
another person’s used spoon or mixing container?
0.
1.
2.
3.
4.
5.

No times
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

NeSyrCo6b. On those occasions, how often did
you clean the spoon or mixing container before
using it?
1.
2.
3.
4.
5.

Never
Rarely
Sometimes
Often
Every time

NeSyrCo7. In the last month, how many times
have you injected a drug prepared with water
which had been used by another person?
0.
1.
2.
3.
4.
5.

No times
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

NeSyrCo8. In the last month, how many times
have you injected a drug which had come into
contact with another person’s used
needle/syringe?
0.
1.
2.
3.
4.
5.

No times
Once
Twice
3 – 5 times
6 -10 times
More than 10 times
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NeSyrCo9. In the last month, how many times have
you wiped your own injection site with an object (e.g,
swab, tissue, hanky, towel etc) which had been used by
another person?
0.
1.
2.
3.
4.
5.

No times
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

2PerCo10a.
In the last month, how many times
have you injected a drug that you prepared immediately
after ‘assisting’ another person with their injection (e.g,
injecting them, holding their arm, handling used
needle/syringe; touching their injection site to feel for a
vein, to wipe blood away, or to stop bleeding)?
0.
1.
2.
3.
4.
5.

No times (go to question 2PerCo 11)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

2PerCo10b. On those occasions, how often did you
wash your hands before preparing your mix?
1.
2.
3.
4.
5.

Never
Rarely
Sometimes
Often
Every time

2PerCo11a. In the last month, how many times have
you injected a drug that was prepared by another person
who had already injected or assisted someone else’s
injection?
0.
1.
2.
3.
4.
5.

No times (go to question 2PerCo 12)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

2PerCo11b. On those occasions, how often did the
person preparing the mix wash their hands before
preparing the mix?
1.
2.
3.
4.
5.

Never
Rarely
Sometimes
Often
Every time

2PerCo12a. In the last month, how many times have
you been injected by another person who had already
injected or assisted in someone else’s injection?
0.
1.
2.
3.
4.
5.

No times (go to question 2PerCo 13)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

2PerCo12b. On those occasions, how often did the
person injecting you wash their hands before injecting
you?
1.
2.
3.
4.
5.

Never
Rarely
Sometimes
Often
Every time

2PerCo13a. In the last month, how many times have
you injected with a needle/syringe which had been
handled or touched by another person who had already
injected?
0.
1.
2.
3.
4.
5.

No times (go to question 2PerCo 14)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

2PerCo13b. On those occasions, how often did they
wash their hands prior to handling the needle/syringe
that you used?
1.
2.
3.
4.
5.

Never
Rarely
Sometimes
Often
Every time

2PerCo14a. In the last month, how many times have
you touched your own injection site (e.g, to feel for a
vein, to wipe away blood, or to stop bleeding) soon after
‘assisting’ another person with their injection (e.g,
injecting them, holding their arm, handling their use
needle/syringe; touching their injection site to feel for a
vein, to wipe away blood, or to stop bleeding)?
0.
1.
2.
3.
4.
5.

No times (go to question 2PerCo 15)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times
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2PerCo14b.
On those occasions, how
often did you wash your hands before touching
your own injection site?
1.
2.
3.
4.
5.

Never
Rarely
Sometimes
Often
Every time

2PerCo15a. In the last month, how many
times has another person touched your injection
site (e.g, to feel for a vein, to wipe away blood,
or to stop bleeding)?
0.
1.
2.
3.
4.
5.

No times (go to question SexPra16)
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

2PerCo15b. On those occasions, how often
did the person wash their hands before they
touched your injection site?
1.
2.
3.
4.
5.

Never
Rarely
Sometimes
Often
Every time

SexPra16. In the last month, how many times
have you engaged in unprotected vaginal sex
with another person (ie. penetration of the
vagina with the penis)?
0.
1.
2.
3.
4.
5.

No times
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

SexPra17. In the last month, how many times
have you engaged in unprotected vaginal sex
with another person (ie. penetration of the
vagina with the penis) during menstruation?
0.
1.
2.
3.
4.
5.

No times
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

SexPra18. In the last month, how many times
have you engaged in unprotected vaginal sex
with another person (ie. penetration of the
vagina with the penis) without lubrication?
0.
1.
2.
3.
4.
5.

No times
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

SexPra19. In the last month, how many times
have you engaged in unprotected oral sex with
another person (ie. lips and tongue come into
contact with the vagina, penis and/or anus)?
0.
1.
2.
3.
4.
5.

No times
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

SexPra20. In the last month, how many times
have you engaged in unprotected manual sex
with another person (ie. fingers and hands come
into contact with the vagina, penis and/or anus)
during menstruation?
0.
1.
2.
3.
4.
5.

No times
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

SexPra21. In the last month, how many times
have you engaged in unprotected manual sex
with another person (ie. fingers and hands come
into contact with the vagina, penis and/or anus)
after injecting?
0.
1.
2.
3.
4.
5.

No times
Once
Twice
3 – 5 times
6 -10 times
More than 10 times

SexPra22. In the last month, how many times
have you engaged in unprotected manual sex
with another person (ie. fingers and hands come
into contact with the vagina, penis and/or anus)
without lubrication?
0.
1.
2.
3.
4.
5.

No times
Once
Twice
3 – 5 times
6 -10 times
More than 10 times
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NEEDLE SOURCES
NS1. In the last 6 months, have you exchanged
needles or gotten new needles at a needle
exchange program?
No
Yes
Unsure
Not applicable
Refused to answer

0
1
2
3
4
55
66
99

All
Most, but not all
About half
Less than half
None
Unsure
Not applicable
Refused to answer

NS3. In the last 6 months, have you usually
exchanged your own needles, or does someone
else do it for you?
0
1

Usually do it myself
Usually done for me by someone
else
55 Unsure
66 Not applicable
99 Refused to answer
NS4. In the last 6 months how easy was it for
you to obtain a brand new needle/syringe when
you needed one?
0
1
2
3
55
66
99

Very easy
Somewhat easy
Somewhat difficult
Very difficult
Unsure
Not applicable
Refused to answer

LEFT BLANK

NS2. In the last 6 months, how many of your
needles did you usually get at a needle
exchange program?

INTENTIONALLY

0
1
55
66
99
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SOCIAL NETWORKS
1.) Network members:
Read: This part of the questionnaire intends to assess the relationship between close personal
contact and infectious diseases that are transmissible through used syringes, like HIV and hepatitis.
I would like to ask you some questions about the people you normally associate with. The
Researcher will not ask you for any information that could be used to identify those individuals and
any information you provide will be confidential.
First, please think back over the last 30 days about the people with whom you have had more than
casual contact12. These would be people that you have seen or have spoken to on a regular basis.
Most of these close contacts would be people such as friends, family, sex partners, people you
inject drugs with, or people you live with.
Let's make a list of these people (Interviewer - the maximum allowed on the list is 20 people. If the
individual reaches 20 people ask them how many additional people they would be able to nominate and note
their response on the answer sheet). Please use the nature of the relationship for identifies these
people. In the case there are more than one just tell me a number after the relationship; for instance
Friend-1, Friend-2 etc. Please do not use their names or last names. I will provide a pseudonym (fake
name) for each contact (For example if you say spouse I will give her the fake name María; if you say
brother I will give him the fake name José). We will use these fake names in the list to make sure we
the identity of a contact is not disclosed. Remember that we are interested in people that you've had
contact with in the last 30 days.
Interviewer: use the following prompts as needed, to help clients recall their associates.
People that you used drugs with in the last 30 days.
People who you had sex with during the last 30 days.
For subjects who are sex workers: list a maximum of 10 sex partners. If the name of
a client is not known they can be listed as unknown1, unknown2, etc. If they have a
regular sex partner(s) try to ensure that they are included on the list)
Friends, relatives or other individuals that you feel close to?
People you live with.
People you hang out with.
2.) Type of contact: Interviewer: Once fake names are listed, please ask the participant the questions
listed below and circle the appropriate letter by each name on the following page.
Questions to ask regarding each of the network members listed on the following page:
1. Which of these people has injected drugs in the last 6 months: Enter Y (Yes) or N (No) or U
(Unsure)
2.

Not including marijuana use, which of these people has smoked/snorted/inhaled drugs in the
last 6 months: Enter Y (Yes) or N (No) or U (Unsure)

3.

Which of these people has been a sex partner of yours in the last 6 months: Enter Y (Yes) or N
(No)

4.

What is the gender of each of these people? Enter M Male, F female, TM transgender male, TF
transgender female.

5.

What is the age of each of these people?

6.

What is this person's relationship to you: Enter F (family member), L (lover, spouse, girl/boyfriend),
R (Friend), C (Acquaintance/Stranger).

7.

Is this person's Puerto Rican? Enter Y (Yes) If not specify:________________________

12

It refers to a conversation that goes beyond the beggary conversation or a hi/bye conversation.
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List of network members
Network
member
#

Network member
Identifier (Fake Name.)

IV drug use

Smoke/Snort
/Inhale

Sex
partner

Gender

1

Y

N

U

Y

N

U

Y

N

M F
TM TF

2

Y

N

U

Y

N

U

Y

N

3

Y

N

U

Y

N

U

Y

N

M
TM
M
TM

4

Y

N

U

Y

N

U

Y

5

Y

N

U

Y

N

U

6

Y

N

U

Y

N

7

Y

N

U

Y

8

Y

N

U

9

Y

N

10

Y

11

Age

Relationship
(Co-workers, dealers,
tricks, etc should be
categorized as
acquaintances unless
person considers
them a friend)
F L R C

F
TF
F
TF

F

L

R

C

F

L

R

C

N

M F
TM TF

F

L

R

C

Y

N

M F
TM TF

F

L

R

C

U

Y

N

M F
TM TF

F

L

R

C

N

U

Y

N

L

R

C

N

U

Y

N

F

L

R

C

U

Y

N

U

Y

N

F
TF
F
TF
F
TF

F

Y

M
TM
M
TM
M
TM

F

L

R

C

N

U

Y

N

U

Y

N

L

R

C

N

U

Y

N

U

Y

N

F

L

R

C

12

Y

N

U

Y

N

U

Y

N

F

L

R

C

13

Y

N

U

Y

N

U

Y

N

F

L

R

C

14

Y

N

U

Y

N

U

Y

N

F

L

R

C

15

Y

N

U

Y

N

U

Y

N

F
TF
F
TF
F
TF
F
TF
F
TF
F
TF

F

Y

M
TM
M
TM
M
TM
M
TM
M
TM
M
TM

F

L

R

C

16

Y

N

U

Y

N

U

Y

N

L

R

C

Y

N

U

Y

N

U

Y

N

F

L

R

C

18

Y

N

U

Y

N

U

Y

N

F

L

R

C

19

Y

N

U

Y

N

U

Y

N

F

L

R

C

20

Y

N

U

Y

N

U

Y

N

F
TF
F
TF
F
TF
F
TF
F
TF

F

17

M
TM
M
TM
M
TM
M
TM
M
TM

F

L

R

C

If the study participant nominates 20 network members, ask them how many additional people they could
nominate and enter the number here:
Number of additional network members:

238

3.) Interaction of network members: Interviewer: Following step 2), transfer the names of all of the network members to the table shown below. For each
person listed ask the subject to indicate which of the other individuals on the list that particular person knows. If the person listed knows other individuals on the list
please make a check mark (√) otherwise leave blank.

Identifier of Known Relations among Network Member

Identifier of Network

Person # 1
Person # 2
Person # 3
Person # 4
Person # 5
Person # 6
Person # 7
Person # 8
Person # 9
Person # 10
Person # 11
Person # 12
Person # 13
Person # 14
Person # 15
Person # 16
Person # 17
Person # 18
Person # 19
Person # 20

Person # 20

Person # 19

Person # 18

Person # 17

Person # 16

Person # 15

Person # 14

Person # 13

Person # 12

Person # 11

Person # 10

Person # 9

Person # 8

Person # 7

Person # 6

Person # 5

Person # 4

Person # 3

Person # 2

etc)

Person # 1

Member
(Initials/Nickname,
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4.) Choose members: Interviewer: Now transfer the names of all injection drug users onto the next part of
the questionnaire shown below. If there are more than 5 IDU on the list place them, to a maximum of 5, on
the questionnaire in the order the study participant placed them on the network member list.
Network questions re each contact:
Interviewer: List the 5 network members chosen [remember never use these people’s name only nicknames or
the initials] as per the above instructions and assign a code to each contact as follows (this information will be
used by data entry to identify each contact of a given study participant.

a) List the initials of the contacts chosen from the list under "initials/first name"
b) Enter the subject code from page 1 of the questionnaire on each of the "subject code" lines.
c) Assign a contact code (1 through 5) after the dash
Initial/identifier

Subject
code

Contact

Subject
code

Contact

code (1-5)

Transfer the “initial/identifier” to a separate sheet
of paper so you and the study participant can refer
to it.

Example shown below:
Initial/identifier
code (1-5)
John

121

1

AJ

121

2
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For the following sections, check the appropriate boxes
unless full answer is requested

CD2. How long have you known [person]?
Network
Member #
1

CONTACT DEMOGRAPHICS
CD1. What is [person]'s relationship to you? This is
partially a repeat from the initial network member list, but
more detailed types of relationships are listed here, so the
participant must be asked the question again for the 5
chosen network members.
Network Member #
1
2
3
4

3
5

0 Friend
1 2 Spouse
2 Girl/Boyfriend,
lover
3 Ex-lover
4 Ex-spouse
5 Mother
6Father
7 Brother
8 Sister
9 Son
10 Daughter
11 Cousin
12 In-laws
13 Niece
14 Nephew
15 Uncle
16 Aunt
17 Other relative
18 Acquaintance
19 Stranger
20 Dealer
21 Trick
22. Injecting
Partner
23 Other, specify
below
55 Unsure
99 Refused to
answer
If “other” is selected above, specify what “other” means in
the box below.
Network
Member #
1
2
3

Other, specify

2

4

5

CD3. What is the highest level of education [person] has
completed?
Network Member #
1 2 3 4 5
0 Graduated grade 12
1 In grade school now
(Grade _______)
2 Dropped out before grade
12 (grade______)
3 Trade school
4 University
5 College
6 Other, specify below
55 Unsure
66 Not applicable
99 Refused to answer
If “other” is selected above, specify what “other” means
in the box below.
Network
Member
#
1
2
3
4

4
5

5

Other, specify
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CD4. Over the last year what was [person’s] main source of income?
Network Member #
1 2 3 4 5
0 Regular work (full, part time or contract)
1 Welfare, EI, pension or other government
support
2 Money from family/friends
3 Sex trade/prostitution
4 Dealing or doing drug runs
5 Panhandling
6 Stealing
7 Boosting
8 Other
55 Unsure
66 Not applicable
99 Refused to answer
CD5. What part of the city do they live in? Use the first 3 digits of their postal code (preferred) or
neighborhood name, if you know it. (If they live outside of city, ask for name of town or reserve).
Network
Member #
1
2
3
4
5

Postal Code
(1st three digits only)
or Neighbourhood name

Unsure

Not
app.

Refused to
answer
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CONTACT INJECTION DRUG RISK
CDR1. To the best of your knowledge, in the past
month, how often did [person] shoot up?
Network Member #
1 2 3 4 5
0 Not at all
1 Once in a while,
not every week
2 Regularly,
once or twice a week
3 Regularly,
three or more times per
week
4 Every day
55 Unsure
66 Not Applicable
If “Every Day” is selected above, specify approximately
“how many times per day” means in the box below.
Network
Member
#
1

Approximately “how many times per
day”

2
3
4
5
CDR2. Approximately, how long have they been
injecting drugs? (Record as day, month or year and
specify which {d, m or y})
Network
Member
#
1
2
3
4
5

Day, month or year

CDR3. In the past month, how many times have you and
[person] combined or pooled money so that you had
enough money to buy drugs or injecting equipment?
Network Member #
1 2 3 4
0 0 times, never
1. 1 time
2. 2-4 times
3. 5-9 times
4. 10-24 times
5. 25-49 times
6. 50-99 times
7. 100 times or
more
55 Unsure
66 Not applicable
99 Refused to
answer

5

CDR4. In the past month, how often have you injected
with a needle after [person] used it first?
Network Member #
1 2 3 4 5
0 Never
1 Occasionally
2 Sometimes
3 Usually
4 Always
55 Unsure
66 Not
Applicable
99 Refused to
answer
CDR5. In the past month, how often has [person]
injected with a needle after you used it first?
Network Member #
1 2 3 4 5
0 Never
1 Occasionally
2 Sometimes
3 Usually
4 Always
55 Unsure
66 Not
Applicable
99 Refused to
answer
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CDR6. In the past month, how often have you
used [person’s]cooker, rinse water, or cotton after
they had already used them?

CDR9 To the best of your knowledge, in the past month,
how often has [person] had done sex work or trade sex for
drugs?

Network Member #
1 2 3 4 5
0 Never
1 Occasionally
2 Sometimes
3 Usually
4 Always
55 Unsure
66 Not
Applicable
Refused to
answer

0 Never
1 Occasionally
2 Sometimes
3 Usually
4 Always
55 Unsure
66 Not
Applicable
Refused to
answer

CDR7. In the past month, how often did you inject
drugs after [person] mixed your drugs in a syringe
that they had already injected with?
Network Member #
1 2 3 4 5
0 Never
1 Occasionally
2 Sometimes
3 Usually
4 Always
55 Unsure
66 Not
Applicable
99. Refused to
answer

INTIMACY
INT1. How close are you to [person]?

Network Member #
1

2

3

4

5

0 Very distant
1 Distant
2 Somewhat close
3 Close
4 Very close
55 Unsure
66 Not applicable
Refused to answer
INT2. How frequently would you say you have contact with
[person]?

CDR8 To the best of your knowledge, in the past
month, how often has [person] had share
needles/syringe with someone besides you?
Network Member #
1
0 Never
1 Occasionally
2 Sometimes
3 Usually
4 Always
55 Unsure
66 Not
Applicable
Refused to
answer

Network Member #
1 2 3 4 5

2

3

4

5

Network Member #
1 2 3 4
0 Daily (5 or more
times per week)
2. 2-4 times per week
3. Once a week
4. 1-3 times per
month
5. Less than once per
month
55 Unsure
66 Not applicable
99 Refused to answer

5
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INT3. If you needed to borrow $25, would [person] lend
or give it to you if they had the money?
Network Member #
1 2 3 4 5
0 No
1 Yes
55 Unsure
66 Not
applicable
Refused to
answer
INT4. Would you ask [person] for advice or help about
health problems like infections, AIDS, or hepatitis
C?
Network Member #
1 2 3 4 5
0 No
1 Yes
55 Unsure
66 Not
applicable
Refused to answer

INT7. If I ask this [Person] would do anything for me if
it is legal.
Network Member #
1 2 3 4 5
No
Yes
Unsure
Refused to
answer
INT8. If I ask this [Person] would do anything for me
even if it is not legal.
Network Member #
1 2 3 4 5
No
Yes
Unsure
Refused to
answer
INT9. If I ask this [Person] would obtain drugs for me.
Network Member #
1 2 3

INT5. Would you talk to [person] about things that are
very personal and private?
Network Member #
1 2 3 4 5
0 No
1 Yes
55 Unsure
66 Not
applicable
Refused to
answer
INT6. If I had an emergency this [Person] would be
there for me.
Network Member #
1 2 3 4 5
No
Yes
Unsure
Refused to
answer

4

5

No
Yes
Unsure
Refused to
answer
INT9. If I ask this [Person] would obtain needles or
other equipment for me.
Network Member #
1 2 3 4 5
No
Yes
Unsure
Refused to
answer

